<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for 0 1612915605297 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KONG_E2F3_TARGETS'>KONG_E2F3_TARGETS</a></td><td><a href='KONG_E2F3_TARGETS.html'>Details ...</a></td><td>89</td><td>-0.71</td><td>-3.08</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2136</td><td>tags=74%, list=20%, signal=92%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN'>FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN</a></td><td><a href='FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN.html'>Details ...</a></td><td>158</td><td>-0.64</td><td>-3.06</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1908</td><td>tags=63%, list=18%, signal=75%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BROWNE_INTERFERON_RESPONSIVE_GENES'>BROWNE_INTERFERON_RESPONSIVE_GENES</a></td><td><a href='BROWNE_INTERFERON_RESPONSIVE_GENES.html'>Details ...</a></td><td>54</td><td>-0.77</td><td>-3.06</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1407</td><td>tags=76%, list=13%, signal=87%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP'>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP</a></td><td><a href='SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP.html'>Details ...</a></td><td>146</td><td>-0.65</td><td>-3.04</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2261</td><td>tags=60%, list=22%, signal=75%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP'>DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP</a></td><td><a href='DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP.html'>Details ...</a></td><td>281</td><td>-0.59</td><td>-3.01</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1908</td><td>tags=55%, list=18%, signal=65%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR'>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR</a></td><td><a href='ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR.html'>Details ...</a></td><td>80</td><td>-0.69</td><td>-3.01</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1891</td><td>tags=68%, list=18%, signal=82%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN'>BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN</a></td><td><a href='BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN.html'>Details ...</a></td><td>148</td><td>-0.63</td><td>-2.97</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1908</td><td>tags=63%, list=18%, signal=76%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SANA_RESPONSE_TO_IFNG_UP'>SANA_RESPONSE_TO_IFNG_UP</a></td><td><a href='SANA_RESPONSE_TO_IFNG_UP.html'>Details ...</a></td><td>55</td><td>-0.72</td><td>-2.87</td><td>0.000</td><td>0.000</td><td>0.000</td><td>789</td><td>tags=64%, list=8%, signal=68%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PUJANA_BRCA2_PCC_NETWORK'>PUJANA_BRCA2_PCC_NETWORK</a></td><td><a href='PUJANA_BRCA2_PCC_NETWORK.html'>Details ...</a></td><td>364</td><td>-0.54</td><td>-2.85</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2614</td><td>tags=53%, list=25%, signal=69%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MORI_IMMATURE_B_LYMPHOCYTE_DN'>MORI_IMMATURE_B_LYMPHOCYTE_DN</a></td><td><a href='MORI_IMMATURE_B_LYMPHOCYTE_DN.html'>Details ...</a></td><td>85</td><td>-0.65</td><td>-2.84</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2451</td><td>tags=75%, list=23%, signal=97%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CROONQUIST_NRAS_SIGNALING_DN'>CROONQUIST_NRAS_SIGNALING_DN</a></td><td><a href='CROONQUIST_NRAS_SIGNALING_DN.html'>Details ...</a></td><td>64</td><td>-0.70</td><td>-2.83</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2166</td><td>tags=75%, list=21%, signal=94%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP'>BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP</a></td><td><a href='BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP.html'>Details ...</a></td><td>133</td><td>-0.61</td><td>-2.82</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1238</td><td>tags=56%, list=12%, signal=62%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE'>BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE</a></td><td><a href='BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE.html'>Details ...</a></td><td>57</td><td>-0.71</td><td>-2.82</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1107</td><td>tags=61%, list=11%, signal=68%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP'>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP</a></td><td><a href='HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP.html'>Details ...</a></td><td>143</td><td>-0.60</td><td>-2.79</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2053</td><td>tags=59%, list=20%, signal=72%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP'>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP</a></td><td><a href='PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP.html'>Details ...</a></td><td>53</td><td>-0.71</td><td>-2.79</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2515</td><td>tags=79%, list=24%, signal=104%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PUJANA_XPRSS_INT_NETWORK'>PUJANA_XPRSS_INT_NETWORK</a></td><td><a href='PUJANA_XPRSS_INT_NETWORK.html'>Details ...</a></td><td>157</td><td>-0.58</td><td>-2.79</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2515</td><td>tags=61%, list=24%, signal=79%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SONG_TARGETS_OF_IE86_CMV_PROTEIN'>SONG_TARGETS_OF_IE86_CMV_PROTEIN</a></td><td><a href='SONG_TARGETS_OF_IE86_CMV_PROTEIN.html'>Details ...</a></td><td>48</td><td>-0.72</td><td>-2.78</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2041</td><td>tags=71%, list=19%, signal=88%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR'>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR</a></td><td><a href='ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR.html'>Details ...</a></td><td>119</td><td>-0.62</td><td>-2.78</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1891</td><td>tags=61%, list=18%, signal=73%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KANG_DOXORUBICIN_RESISTANCE_UP'>KANG_DOXORUBICIN_RESISTANCE_UP</a></td><td><a href='KANG_DOXORUBICIN_RESISTANCE_UP.html'>Details ...</a></td><td>52</td><td>-0.70</td><td>-2.74</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2637</td><td>tags=87%, list=25%, signal=115%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_3'>BURTON_ADIPOGENESIS_3</a></td><td><a href='BURTON_ADIPOGENESIS_3.html'>Details ...</a></td><td>97</td><td>-0.63</td><td>-2.73</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2383</td><td>tags=68%, list=23%, signal=87%</td></tr><tr><td class='lessen'>21</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WHITEFORD_PEDIATRIC_CANCER_MARKERS'>WHITEFORD_PEDIATRIC_CANCER_MARKERS</a></td><td><a href='WHITEFORD_PEDIATRIC_CANCER_MARKERS.html'>Details ...</a></td><td>107</td><td>-0.61</td><td>-2.71</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2804</td><td>tags=73%, list=27%, signal=98%</td></tr><tr><td class='lessen'>22</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER'>ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER</a></td><td><a href='ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER.html'>Details ...</a></td><td>136</td><td>-0.59</td><td>-2.71</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2338</td><td>tags=65%, list=22%, signal=82%</td></tr><tr><td class='lessen'>23</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MORI_LARGE_PRE_BII_LYMPHOCYTE_UP'>MORI_LARGE_PRE_BII_LYMPHOCYTE_UP</a></td><td><a href='MORI_LARGE_PRE_BII_LYMPHOCYTE_UP.html'>Details ...</a></td><td>82</td><td>-0.64</td><td>-2.71</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2490</td><td>tags=72%, list=24%, signal=94%</td></tr><tr><td class='lessen'>24</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MOSERLE_IFNA_RESPONSE'>MOSERLE_IFNA_RESPONSE</a></td><td><a href='MOSERLE_IFNA_RESPONSE.html'>Details ...</a></td><td>23</td><td>-0.85</td><td>-2.70</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1640</td><td>tags=100%, list=16%, signal=118%</td></tr><tr><td class='lessen'>25</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP'>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP</a></td><td><a href='BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP.html'>Details ...</a></td><td>183</td><td>-0.56</td><td>-2.69</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1730</td><td>tags=50%, list=16%, signal=59%</td></tr><tr><td class='lessen'>26</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WU_APOPTOSIS_BY_CDKN1A_VIA_TP53'>WU_APOPTOSIS_BY_CDKN1A_VIA_TP53</a></td><td><a href='WU_APOPTOSIS_BY_CDKN1A_VIA_TP53.html'>Details ...</a></td><td>47</td><td>-0.71</td><td>-2.69</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2309</td><td>tags=74%, list=22%, signal=95%</td></tr><tr><td class='lessen'>27</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN'>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN</a></td><td><a href='GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN.html'>Details ...</a></td><td>78</td><td>-0.63</td><td>-2.67</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2286</td><td>tags=65%, list=22%, signal=83%</td></tr><tr><td class='lessen'>28</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CROONQUIST_IL6_DEPRIVATION_DN'>CROONQUIST_IL6_DEPRIVATION_DN</a></td><td><a href='CROONQUIST_IL6_DEPRIVATION_DN.html'>Details ...</a></td><td>85</td><td>-0.62</td><td>-2.65</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2471</td><td>tags=69%, list=24%, signal=90%</td></tr><tr><td class='lessen'>29</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_PR_UP'>ZHAN_MULTIPLE_MYELOMA_PR_UP</a></td><td><a href='ZHAN_MULTIPLE_MYELOMA_PR_UP.html'>Details ...</a></td><td>42</td><td>-0.70</td><td>-2.63</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2309</td><td>tags=76%, list=22%, signal=97%</td></tr><tr><td class='lessen'>30</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/EINAV_INTERFERON_SIGNATURE_IN_CANCER'>EINAV_INTERFERON_SIGNATURE_IN_CANCER</a></td><td><a href='EINAV_INTERFERON_SIGNATURE_IN_CANCER.html'>Details ...</a></td><td>21</td><td>-0.82</td><td>-2.63</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1181</td><td>tags=81%, list=11%, signal=91%</td></tr><tr><td class='lessen'>31</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ISHIDA_E2F_TARGETS'>ISHIDA_E2F_TARGETS</a></td><td><a href='ISHIDA_E2F_TARGETS.html'>Details ...</a></td><td>51</td><td>-0.66</td><td>-2.60</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2340</td><td>tags=76%, list=22%, signal=98%</td></tr><tr><td class='lessen'>32</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WINNEPENNINCKX_MELANOMA_METASTASIS_UP'>WINNEPENNINCKX_MELANOMA_METASTASIS_UP</a></td><td><a href='WINNEPENNINCKX_MELANOMA_METASTASIS_UP.html'>Details ...</a></td><td>152</td><td>-0.54</td><td>-2.59</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2315</td><td>tags=51%, list=22%, signal=64%</td></tr><tr><td class='lessen'>33</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_LITERATURE'>WHITFIELD_CELL_CYCLE_LITERATURE</a></td><td><a href='WHITFIELD_CELL_CYCLE_LITERATURE.html'>Details ...</a></td><td>41</td><td>-0.70</td><td>-2.57</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2592</td><td>tags=80%, list=25%, signal=106%</td></tr><tr><td class='lessen'>34</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ZHANG_INTERFERON_RESPONSE'>ZHANG_INTERFERON_RESPONSE</a></td><td><a href='ZHANG_INTERFERON_RESPONSE.html'>Details ...</a></td><td>20</td><td>-0.82</td><td>-2.56</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1640</td><td>tags=90%, list=16%, signal=106%</td></tr><tr><td class='lessen'>35</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP'>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP</a></td><td><a href='ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP.html'>Details ...</a></td><td>105</td><td>-0.58</td><td>-2.55</td><td>0.000</td><td>0.000</td><td>0.000</td><td>804</td><td>tags=38%, list=8%, signal=41%</td></tr><tr><td class='lessen'>36</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KAMMINGA_EZH2_TARGETS'>KAMMINGA_EZH2_TARGETS</a></td><td><a href='KAMMINGA_EZH2_TARGETS.html'>Details ...</a></td><td>40</td><td>-0.68</td><td>-2.55</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1791</td><td>tags=60%, list=17%, signal=72%</td></tr><tr><td class='lessen'>37</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MEBARKI_HCC_PROGENITOR_FZD8CRD_UP'>MEBARKI_HCC_PROGENITOR_FZD8CRD_UP</a></td><td><a href='MEBARKI_HCC_PROGENITOR_FZD8CRD_UP.html'>Details ...</a></td><td>392</td><td>-0.48</td><td>-2.54</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2474</td><td>tags=54%, list=24%, signal=68%</td></tr><tr><td class='lessen'>38</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DAUER_STAT3_TARGETS_DN'>DAUER_STAT3_TARGETS_DN</a></td><td><a href='DAUER_STAT3_TARGETS_DN.html'>Details ...</a></td><td>38</td><td>-0.71</td><td>-2.54</td><td>0.000</td><td>0.000</td><td>0.000</td><td>890</td><td>tags=58%, list=8%, signal=63%</td></tr><tr><td class='lessen'>39</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KOBAYASHI_EGFR_SIGNALING_24HR_DN'>KOBAYASHI_EGFR_SIGNALING_24HR_DN</a></td><td><a href='KOBAYASHI_EGFR_SIGNALING_24HR_DN.html'>Details ...</a></td><td>229</td><td>-0.50</td><td>-2.54</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2355</td><td>tags=55%, list=22%, signal=70%</td></tr><tr><td class='lessen'>40</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KAUFFMANN_MELANOMA_RELAPSE_UP'>KAUFFMANN_MELANOMA_RELAPSE_UP</a></td><td><a href='KAUFFMANN_MELANOMA_RELAPSE_UP.html'>Details ...</a></td><td>57</td><td>-0.64</td><td>-2.54</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2865</td><td>tags=72%, list=27%, signal=98%</td></tr><tr><td class='lessen'>41</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ODONNELL_TFRC_TARGETS_DN'>ODONNELL_TFRC_TARGETS_DN</a></td><td><a href='ODONNELL_TFRC_TARGETS_DN.html'>Details ...</a></td><td>96</td><td>-0.58</td><td>-2.53</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2847</td><td>tags=67%, list=27%, signal=91%</td></tr><tr><td class='lessen'>42</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MORI_PRE_BI_LYMPHOCYTE_UP'>MORI_PRE_BI_LYMPHOCYTE_UP</a></td><td><a href='MORI_PRE_BI_LYMPHOCYTE_UP.html'>Details ...</a></td><td>73</td><td>-0.60</td><td>-2.51</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2379</td><td>tags=64%, list=23%, signal=83%</td></tr><tr><td class='lessen'>43</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HECKER_IFNB1_TARGETS'>HECKER_IFNB1_TARGETS</a></td><td><a href='HECKER_IFNB1_TARGETS.html'>Details ...</a></td><td>54</td><td>-0.64</td><td>-2.51</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1181</td><td>tags=57%, list=11%, signal=64%</td></tr><tr><td class='lessen'>44</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PUJANA_BRCA_CENTERED_NETWORK'>PUJANA_BRCA_CENTERED_NETWORK</a></td><td><a href='PUJANA_BRCA_CENTERED_NETWORK.html'>Details ...</a></td><td>113</td><td>-0.56</td><td>-2.51</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2371</td><td>tags=56%, list=23%, signal=71%</td></tr><tr><td class='lessen'>45</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LEE_EARLY_T_LYMPHOCYTE_UP'>LEE_EARLY_T_LYMPHOCYTE_UP</a></td><td><a href='LEE_EARLY_T_LYMPHOCYTE_UP.html'>Details ...</a></td><td>87</td><td>-0.57</td><td>-2.50</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1308</td><td>tags=52%, list=12%, signal=59%</td></tr><tr><td class='lessen'>46</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REN_BOUND_BY_E2F'>REN_BOUND_BY_E2F</a></td><td><a href='REN_BOUND_BY_E2F.html'>Details ...</a></td><td>56</td><td>-0.62</td><td>-2.49</td><td>0.000</td><td>0.000</td><td>0.000</td><td>3155</td><td>tags=80%, list=30%, signal=114%</td></tr><tr><td class='lessen'>47</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN'>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN</a></td><td><a href='LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN.html'>Details ...</a></td><td>135</td><td>-0.54</td><td>-2.49</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2369</td><td>tags=53%, list=23%, signal=67%</td></tr><tr><td class='lessen'>48</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/EGUCHI_CELL_CYCLE_RB1_TARGETS'>EGUCHI_CELL_CYCLE_RB1_TARGETS</a></td><td><a href='EGUCHI_CELL_CYCLE_RB1_TARGETS.html'>Details ...</a></td><td>22</td><td>-0.76</td><td>-2.47</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1572</td><td>tags=77%, list=15%, signal=91%</td></tr><tr><td class='lessen'>49</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PYEON_HPV_POSITIVE_TUMORS_UP'>PYEON_HPV_POSITIVE_TUMORS_UP</a></td><td><a href='PYEON_HPV_POSITIVE_TUMORS_UP.html'>Details ...</a></td><td>64</td><td>-0.61</td><td>-2.46</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2340</td><td>tags=63%, list=22%, signal=80%</td></tr><tr><td class='lessen'>50</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP'>BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP</a></td><td><a href='BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP.html'>Details ...</a></td><td>66</td><td>-0.59</td><td>-2.45</td><td>0.000</td><td>0.000</td><td>0.000</td><td>693</td><td>tags=39%, list=7%, signal=42%</td></tr><tr><td class='lessen'>51</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MISSIAGLIA_REGULATED_BY_METHYLATION_DN'>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</a></td><td><a href='MISSIAGLIA_REGULATED_BY_METHYLATION_DN.html'>Details ...</a></td><td>110</td><td>-0.55</td><td>-2.45</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2732</td><td>tags=66%, list=26%, signal=89%</td></tr><tr><td class='lessen'>52</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RADAEVA_RESPONSE_TO_IFNA1_UP'>RADAEVA_RESPONSE_TO_IFNA1_UP</a></td><td><a href='RADAEVA_RESPONSE_TO_IFNA1_UP.html'>Details ...</a></td><td>39</td><td>-0.67</td><td>-2.45</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1585</td><td>tags=56%, list=15%, signal=66%</td></tr><tr><td class='lessen'>53</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN'>FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN</a></td><td><a href='FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN.html'>Details ...</a></td><td>47</td><td>-0.63</td><td>-2.44</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1373</td><td>tags=57%, list=13%, signal=66%</td></tr><tr><td class='lessen'>54</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS'>BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS</a></td><td><a href='BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS.html'>Details ...</a></td><td>23</td><td>-0.75</td><td>-2.42</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1181</td><td>tags=65%, list=11%, signal=73%</td></tr><tr><td class='lessen'>55</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN'>PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN</a></td><td><a href='PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN.html'>Details ...</a></td><td>47</td><td>-0.64</td><td>-2.42</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2401</td><td>tags=68%, list=23%, signal=88%</td></tr><tr><td class='lessen'>56</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FISCHER_G2_M_CELL_CYCLE'>FISCHER_G2_M_CELL_CYCLE</a></td><td><a href='FISCHER_G2_M_CELL_CYCLE.html'>Details ...</a></td><td>215</td><td>-0.48</td><td>-2.41</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1891</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>57</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN'>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN</a></td><td><a href='GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN.html'>Details ...</a></td><td>45</td><td>-0.63</td><td>-2.40</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1772</td><td>tags=62%, list=17%, signal=75%</td></tr><tr><td class='lessen'>58</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP'>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP</a></td><td><a href='FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP.html'>Details ...</a></td><td>139</td><td>-0.51</td><td>-2.40</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2246</td><td>tags=46%, list=21%, signal=58%</td></tr><tr><td class='lessen'>59</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WIELAND_UP_BY_HBV_INFECTION'>WIELAND_UP_BY_HBV_INFECTION</a></td><td><a href='WIELAND_UP_BY_HBV_INFECTION.html'>Details ...</a></td><td>70</td><td>-0.58</td><td>-2.39</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1363</td><td>tags=47%, list=13%, signal=54%</td></tr><tr><td class='lessen'>60</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/YU_MYC_TARGETS_UP'>YU_MYC_TARGETS_UP</a></td><td><a href='YU_MYC_TARGETS_UP.html'>Details ...</a></td><td>40</td><td>-0.64</td><td>-2.39</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2286</td><td>tags=58%, list=22%, signal=73%</td></tr><tr><td class='lessen'>61</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/VERNELL_RETINOBLASTOMA_PATHWAY_UP'>VERNELL_RETINOBLASTOMA_PATHWAY_UP</a></td><td><a href='VERNELL_RETINOBLASTOMA_PATHWAY_UP.html'>Details ...</a></td><td>62</td><td>-0.60</td><td>-2.39</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2338</td><td>tags=63%, list=22%, signal=80%</td></tr><tr><td class='lessen'>62</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/UROSEVIC_RESPONSE_TO_IMIQUIMOD'>UROSEVIC_RESPONSE_TO_IMIQUIMOD</a></td><td><a href='UROSEVIC_RESPONSE_TO_IMIQUIMOD.html'>Details ...</a></td><td>15</td><td>-0.83</td><td>-2.39</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1479</td><td>tags=87%, list=14%, signal=101%</td></tr><tr><td class='lessen'>63</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP'>BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP</a></td><td><a href='BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP.html'>Details ...</a></td><td>434</td><td>-0.44</td><td>-2.37</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1607</td><td>tags=37%, list=15%, signal=41%</td></tr><tr><td class='lessen'>64</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP'>WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP</a></td><td><a href='WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP.html'>Details ...</a></td><td>58</td><td>-0.60</td><td>-2.37</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1644</td><td>tags=59%, list=16%, signal=69%</td></tr><tr><td class='lessen'>65</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KIM_LRRC3B_TARGETS'>KIM_LRRC3B_TARGETS</a></td><td><a href='KIM_LRRC3B_TARGETS.html'>Details ...</a></td><td>23</td><td>-0.74</td><td>-2.36</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2145</td><td>tags=78%, list=20%, signal=98%</td></tr><tr><td class='lessen'>66</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/VILLANUEVA_LIVER_CANCER_KRT19_UP'>VILLANUEVA_LIVER_CANCER_KRT19_UP</a></td><td><a href='VILLANUEVA_LIVER_CANCER_KRT19_UP.html'>Details ...</a></td><td>146</td><td>-0.50</td><td>-2.36</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1698</td><td>tags=42%, list=16%, signal=50%</td></tr><tr><td class='lessen'>67</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP'>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP</a></td><td><a href='CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP.html'>Details ...</a></td><td>155</td><td>-0.50</td><td>-2.34</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1891</td><td>tags=51%, list=18%, signal=61%</td></tr><tr><td class='lessen'>68</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_1'>FARMER_BREAST_CANCER_CLUSTER_1</a></td><td><a href='FARMER_BREAST_CANCER_CLUSTER_1.html'>Details ...</a></td><td>24</td><td>-0.72</td><td>-2.34</td><td>0.000</td><td>0.000</td><td>0.000</td><td>890</td><td>tags=50%, list=8%, signal=55%</td></tr><tr><td class='lessen'>69</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_24HR'>BURTON_ADIPOGENESIS_PEAK_AT_24HR</a></td><td><a href='BURTON_ADIPOGENESIS_PEAK_AT_24HR.html'>Details ...</a></td><td>45</td><td>-0.60</td><td>-2.32</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2041</td><td>tags=60%, list=19%, signal=74%</td></tr><tr><td class='lessen'>70</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MARKEY_RB1_ACUTE_LOF_UP'>MARKEY_RB1_ACUTE_LOF_UP</a></td><td><a href='MARKEY_RB1_ACUTE_LOF_UP.html'>Details ...</a></td><td>215</td><td>-0.47</td><td>-2.32</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2512</td><td>tags=50%, list=24%, signal=64%</td></tr><tr><td class='lessen'>71</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6'>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</a></td><td><a href='SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6.html'>Details ...</a></td><td>390</td><td>-0.43</td><td>-2.31</td><td>0.000</td><td>0.000</td><td>0.000</td><td>2690</td><td>tags=47%, list=26%, signal=61%</td></tr><tr><td class='lessen'>72</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP'>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP</a></td><td><a href='GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP.html'>Details ...</a></td><td>163</td><td>-0.48</td><td>-2.31</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1526</td><td>tags=40%, list=15%, signal=47%</td></tr><tr><td class='lessen'>73</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PEART_HDAC_PROLIFERATION_CLUSTER_DN'>PEART_HDAC_PROLIFERATION_CLUSTER_DN</a></td><td><a href='PEART_HDAC_PROLIFERATION_CLUSTER_DN.html'>Details ...</a></td><td>61</td><td>-0.57</td><td>-2.30</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1860</td><td>tags=49%, list=18%, signal=59%</td></tr><tr><td class='lessen'>74</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLUM_RESPONSE_TO_SALIRASIB_DN'>BLUM_RESPONSE_TO_SALIRASIB_DN</a></td><td><a href='BLUM_RESPONSE_TO_SALIRASIB_DN.html'>Details ...</a></td><td>293</td><td>-0.45</td><td>-2.28</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2366</td><td>tags=47%, list=23%, signal=59%</td></tr><tr><td class='lessen'>75</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FUJII_YBX1_TARGETS_DN'>FUJII_YBX1_TARGETS_DN</a></td><td><a href='FUJII_YBX1_TARGETS_DN.html'>Details ...</a></td><td>174</td><td>-0.47</td><td>-2.26</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2340</td><td>tags=49%, list=22%, signal=63%</td></tr><tr><td class='lessen'>76</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX'>BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX</a></td><td><a href='BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX.html'>Details ...</a></td><td>15</td><td>-0.79</td><td>-2.26</td><td>0.000</td><td>0.000</td><td>0.001</td><td>1640</td><td>tags=93%, list=16%, signal=110%</td></tr><tr><td class='lessen'>77</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KAUFFMANN_DNA_REPLICATION_GENES'>KAUFFMANN_DNA_REPLICATION_GENES</a></td><td><a href='KAUFFMANN_DNA_REPLICATION_GENES.html'>Details ...</a></td><td>125</td><td>-0.49</td><td>-2.25</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2746</td><td>tags=54%, list=26%, signal=73%</td></tr><tr><td class='lessen'>78</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP'>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP</a></td><td><a href='GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP.html'>Details ...</a></td><td>156</td><td>-0.47</td><td>-2.25</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2512</td><td>tags=55%, list=24%, signal=71%</td></tr><tr><td class='lessen'>79</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BENPORATH_PROLIFERATION'>BENPORATH_PROLIFERATION</a></td><td><a href='BENPORATH_PROLIFERATION.html'>Details ...</a></td><td>136</td><td>-0.49</td><td>-2.25</td><td>0.000</td><td>0.000</td><td>0.001</td><td>2286</td><td>tags=46%, list=22%, signal=58%</td></tr><tr><td class='lessen'>80</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP'>BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP</a></td><td><a href='BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP.html'>Details ...</a></td><td>179</td><td>-0.46</td><td>-2.23</td><td>0.000</td><td>0.000</td><td>0.003</td><td>1692</td><td>tags=42%, list=16%, signal=49%</td></tr><tr><td class='lessen'>81</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KAUFFMANN_DNA_REPAIR_GENES'>KAUFFMANN_DNA_REPAIR_GENES</a></td><td><a href='KAUFFMANN_DNA_REPAIR_GENES.html'>Details ...</a></td><td>196</td><td>-0.45</td><td>-2.23</td><td>0.000</td><td>0.000</td><td>0.004</td><td>2340</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>82</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN'>ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN</a></td><td><a href='ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN.html'>Details ...</a></td><td>41</td><td>-0.60</td><td>-2.21</td><td>0.000</td><td>0.000</td><td>0.007</td><td>2612</td><td>tags=63%, list=25%, signal=84%</td></tr><tr><td class='lessen'>83</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN'>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN</a></td><td><a href='STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN.html'>Details ...</a></td><td>35</td><td>-0.62</td><td>-2.21</td><td>0.000</td><td>0.000</td><td>0.007</td><td>1415</td><td>tags=60%, list=13%, signal=69%</td></tr><tr><td class='lessen'>84</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REICHERT_MITOSIS_LIN9_TARGETS'>REICHERT_MITOSIS_LIN9_TARGETS</a></td><td><a href='REICHERT_MITOSIS_LIN9_TARGETS.html'>Details ...</a></td><td>27</td><td>-0.66</td><td>-2.21</td><td>0.000</td><td>0.000</td><td>0.007</td><td>1917</td><td>tags=70%, list=18%, signal=86%</td></tr><tr><td class='lessen'>85</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DELPUECH_FOXO3_TARGETS_DN'>DELPUECH_FOXO3_TARGETS_DN</a></td><td><a href='DELPUECH_FOXO3_TARGETS_DN.html'>Details ...</a></td><td>33</td><td>-0.61</td><td>-2.20</td><td>0.000</td><td>0.000</td><td>0.007</td><td>1251</td><td>tags=42%, list=12%, signal=48%</td></tr><tr><td class='lessen'>86</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP'>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP</a></td><td><a href='NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP.html'>Details ...</a></td><td>60</td><td>-0.53</td><td>-2.20</td><td>0.000</td><td>0.000</td><td>0.007</td><td>2261</td><td>tags=60%, list=22%, signal=76%</td></tr><tr><td class='lessen'>87</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G2'>WHITFIELD_CELL_CYCLE_G2</a></td><td><a href='WHITFIELD_CELL_CYCLE_G2.html'>Details ...</a></td><td>142</td><td>-0.47</td><td>-2.19</td><td>0.000</td><td>0.000</td><td>0.007</td><td>2623</td><td>tags=51%, list=25%, signal=67%</td></tr><tr><td class='lessen'>88</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BOWIE_RESPONSE_TO_TAMOXIFEN'>BOWIE_RESPONSE_TO_TAMOXIFEN</a></td><td><a href='BOWIE_RESPONSE_TO_TAMOXIFEN.html'>Details ...</a></td><td>15</td><td>-0.76</td><td>-2.19</td><td>0.000</td><td>0.000</td><td>0.007</td><td>1640</td><td>tags=87%, list=16%, signal=103%</td></tr><tr><td class='lessen'>89</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN'>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN</a></td><td><a href='MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN.html'>Details ...</a></td><td>54</td><td>-0.55</td><td>-2.18</td><td>0.000</td><td>0.000</td><td>0.007</td><td>1619</td><td>tags=57%, list=15%, signal=68%</td></tr><tr><td class='lessen'>90</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LE_EGR2_TARGETS_UP'>LE_EGR2_TARGETS_UP</a></td><td><a href='LE_EGR2_TARGETS_UP.html'>Details ...</a></td><td>99</td><td>-0.49</td><td>-2.17</td><td>0.000</td><td>0.000</td><td>0.008</td><td>2314</td><td>tags=55%, list=22%, signal=69%</td></tr><tr><td class='lessen'>91</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WONG_PROTEASOME_GENE_MODULE'>WONG_PROTEASOME_GENE_MODULE</a></td><td><a href='WONG_PROTEASOME_GENE_MODULE.html'>Details ...</a></td><td>48</td><td>-0.58</td><td>-2.17</td><td>0.000</td><td>0.000</td><td>0.008</td><td>2401</td><td>tags=50%, list=23%, signal=65%</td></tr><tr><td class='lessen'>92</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN'>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN</a></td><td><a href='STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN.html'>Details ...</a></td><td>37</td><td>-0.60</td><td>-2.16</td><td>0.000</td><td>0.000</td><td>0.010</td><td>1181</td><td>tags=51%, list=11%, signal=58%</td></tr><tr><td class='lessen'>93</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MOOTHA_VOXPHOS'>MOOTHA_VOXPHOS</a></td><td><a href='MOOTHA_VOXPHOS.html'>Details ...</a></td><td>81</td><td>-0.50</td><td>-2.16</td><td>0.000</td><td>0.000</td><td>0.011</td><td>3722</td><td>tags=67%, list=35%, signal=103%</td></tr><tr><td class='lessen'>94</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LY_AGING_OLD_DN'>LY_AGING_OLD_DN</a></td><td><a href='LY_AGING_OLD_DN.html'>Details ...</a></td><td>52</td><td>-0.55</td><td>-2.15</td><td>0.000</td><td>0.000</td><td>0.016</td><td>2577</td><td>tags=60%, list=25%, signal=79%</td></tr><tr><td class='lessen'>95</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WALLACE_PROSTATE_CANCER_RACE_UP'>WALLACE_PROSTATE_CANCER_RACE_UP</a></td><td><a href='WALLACE_PROSTATE_CANCER_RACE_UP.html'>Details ...</a></td><td>165</td><td>-0.44</td><td>-2.15</td><td>0.000</td><td>0.000</td><td>0.019</td><td>1640</td><td>tags=33%, list=16%, signal=38%</td></tr><tr><td class='lessen'>96</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP'>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP</a></td><td><a href='CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP.html'>Details ...</a></td><td>120</td><td>-0.47</td><td>-2.13</td><td>0.000</td><td>0.000</td><td>0.024</td><td>2338</td><td>tags=50%, list=22%, signal=64%</td></tr><tr><td class='lessen'>97</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DER_IFN_ALPHA_RESPONSE_UP'>DER_IFN_ALPHA_RESPONSE_UP</a></td><td><a href='DER_IFN_ALPHA_RESPONSE_UP.html'>Details ...</a></td><td>64</td><td>-0.52</td><td>-2.13</td><td>0.000</td><td>0.000</td><td>0.024</td><td>1838</td><td>tags=50%, list=18%, signal=60%</td></tr><tr><td class='lessen'>98</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LI_WILMS_TUMOR_ANAPLASTIC_UP'>LI_WILMS_TUMOR_ANAPLASTIC_UP</a></td><td><a href='LI_WILMS_TUMOR_ANAPLASTIC_UP.html'>Details ...</a></td><td>16</td><td>-0.73</td><td>-2.11</td><td>0.000</td><td>0.000</td><td>0.032</td><td>2804</td><td>tags=94%, list=27%, signal=128%</td></tr><tr><td class='lessen'>99</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP'>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP</a></td><td><a href='SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP.html'>Details ...</a></td><td>138</td><td>-0.45</td><td>-2.11</td><td>0.000</td><td>0.000</td><td>0.033</td><td>1824</td><td>tags=43%, list=17%, signal=52%</td></tr><tr><td class='lessen'>100</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MARKEY_RB1_ACUTE_LOF_DN'>MARKEY_RB1_ACUTE_LOF_DN</a></td><td><a href='MARKEY_RB1_ACUTE_LOF_DN.html'>Details ...</a></td><td>196</td><td>-0.43</td><td>-2.11</td><td>0.000</td><td>0.000</td><td>0.034</td><td>1644</td><td>tags=34%, list=16%, signal=39%</td></tr><tr><td class='lessen'>101</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP'>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</a></td><td><a href='TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP.html'>Details ...</a></td><td>105</td><td>-0.47</td><td>-2.11</td><td>0.000</td><td>0.000</td><td>0.034</td><td>1181</td><td>tags=39%, list=11%, signal=44%</td></tr><tr><td class='lessen'>102</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/TANG_SENESCENCE_TP53_TARGETS_DN'>TANG_SENESCENCE_TP53_TARGETS_DN</a></td><td><a href='TANG_SENESCENCE_TP53_TARGETS_DN.html'>Details ...</a></td><td>46</td><td>-0.55</td><td>-2.10</td><td>0.000</td><td>0.000</td><td>0.035</td><td>2041</td><td>tags=59%, list=19%, signal=73%</td></tr><tr><td class='lessen'>103</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP'>MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP</a></td><td><a href='MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP.html'>Details ...</a></td><td>95</td><td>-0.48</td><td>-2.09</td><td>0.000</td><td>0.000</td><td>0.048</td><td>1479</td><td>tags=37%, list=14%, signal=43%</td></tr><tr><td class='lessen'>104</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/AFFAR_YY1_TARGETS_DN'>AFFAR_YY1_TARGETS_DN</a></td><td><a href='AFFAR_YY1_TARGETS_DN.html'>Details ...</a></td><td>195</td><td>-0.43</td><td>-2.08</td><td>0.000</td><td>0.000</td><td>0.052</td><td>1925</td><td>tags=41%, list=18%, signal=49%</td></tr><tr><td class='lessen'>105</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/YANG_BCL3_TARGETS_UP'>YANG_BCL3_TARGETS_UP</a></td><td><a href='YANG_BCL3_TARGETS_UP.html'>Details ...</a></td><td>242</td><td>-0.42</td><td>-2.08</td><td>0.000</td><td>0.000</td><td>0.055</td><td>1378</td><td>tags=34%, list=13%, signal=38%</td></tr><tr><td class='lessen'>106</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_S'>WHITFIELD_CELL_CYCLE_S</a></td><td><a href='WHITFIELD_CELL_CYCLE_S.html'>Details ...</a></td><td>102</td><td>-0.47</td><td>-2.08</td><td>0.000</td><td>0.000</td><td>0.056</td><td>2527</td><td>tags=46%, list=24%, signal=60%</td></tr><tr><td class='lessen'>107</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LY_AGING_MIDDLE_DN'>LY_AGING_MIDDLE_DN</a></td><td><a href='LY_AGING_MIDDLE_DN.html'>Details ...</a></td><td>16</td><td>-0.72</td><td>-2.08</td><td>0.000</td><td>0.000</td><td>0.060</td><td>1824</td><td>tags=75%, list=17%, signal=91%</td></tr><tr><td class='lessen'>108</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FURUKAWA_DUSP6_TARGETS_PCI35_DN'>FURUKAWA_DUSP6_TARGETS_PCI35_DN</a></td><td><a href='FURUKAWA_DUSP6_TARGETS_PCI35_DN.html'>Details ...</a></td><td>60</td><td>-0.51</td><td>-2.07</td><td>0.000</td><td>0.001</td><td>0.065</td><td>1908</td><td>tags=53%, list=18%, signal=65%</td></tr><tr><td class='lessen'>109</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DER_IFN_GAMMA_RESPONSE_UP'>DER_IFN_GAMMA_RESPONSE_UP</a></td><td><a href='DER_IFN_GAMMA_RESPONSE_UP.html'>Details ...</a></td><td>64</td><td>-0.52</td><td>-2.07</td><td>0.000</td><td>0.001</td><td>0.066</td><td>1838</td><td>tags=48%, list=18%, signal=58%</td></tr><tr><td class='lessen'>110</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_2'>FARMER_BREAST_CANCER_CLUSTER_2</a></td><td><a href='FARMER_BREAST_CANCER_CLUSTER_2.html'>Details ...</a></td><td>33</td><td>-0.59</td><td>-2.06</td><td>0.000</td><td>0.001</td><td>0.075</td><td>2847</td><td>tags=70%, list=27%, signal=95%</td></tr><tr><td class='lessen'>111</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/POOLA_INVASIVE_BREAST_CANCER_UP'>POOLA_INVASIVE_BREAST_CANCER_UP</a></td><td><a href='POOLA_INVASIVE_BREAST_CANCER_UP.html'>Details ...</a></td><td>165</td><td>-0.43</td><td>-2.05</td><td>0.000</td><td>0.001</td><td>0.079</td><td>2346</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>112</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP'>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP</a></td><td><a href='BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP.html'>Details ...</a></td><td>158</td><td>-0.43</td><td>-2.04</td><td>0.000</td><td>0.001</td><td>0.089</td><td>1252</td><td>tags=28%, list=12%, signal=31%</td></tr><tr><td class='lessen'>113</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_3_UP'>LINDGREN_BLADDER_CANCER_CLUSTER_3_UP</a></td><td><a href='LINDGREN_BLADDER_CANCER_CLUSTER_3_UP.html'>Details ...</a></td><td>277</td><td>-0.40</td><td>-2.03</td><td>0.000</td><td>0.001</td><td>0.099</td><td>2878</td><td>tags=48%, list=27%, signal=64%</td></tr><tr><td class='lessen'>114</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RHODES_UNDIFFERENTIATED_CANCER'>RHODES_UNDIFFERENTIATED_CANCER</a></td><td><a href='RHODES_UNDIFFERENTIATED_CANCER.html'>Details ...</a></td><td>65</td><td>-0.50</td><td>-2.03</td><td>0.000</td><td>0.001</td><td>0.101</td><td>2493</td><td>tags=60%, list=24%, signal=78%</td></tr><tr><td class='lessen'>115</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FISCHER_G1_S_CELL_CYCLE'>FISCHER_G1_S_CELL_CYCLE</a></td><td><a href='FISCHER_G1_S_CELL_CYCLE.html'>Details ...</a></td><td>149</td><td>-0.44</td><td>-2.03</td><td>0.000</td><td>0.001</td><td>0.105</td><td>2193</td><td>tags=46%, list=21%, signal=57%</td></tr><tr><td class='lessen'>116</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P6'>GAVIN_FOXP3_TARGETS_CLUSTER_P6</a></td><td><a href='GAVIN_FOXP3_TARGETS_CLUSTER_P6.html'>Details ...</a></td><td>75</td><td>-0.49</td><td>-2.03</td><td>0.000</td><td>0.001</td><td>0.107</td><td>2286</td><td>tags=53%, list=22%, signal=68%</td></tr><tr><td class='lessen'>117</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ABRAMSON_INTERACT_WITH_AIRE'>ABRAMSON_INTERACT_WITH_AIRE</a></td><td><a href='ABRAMSON_INTERACT_WITH_AIRE.html'>Details ...</a></td><td>40</td><td>-0.55</td><td>-2.02</td><td>0.000</td><td>0.001</td><td>0.115</td><td>3154</td><td>tags=55%, list=30%, signal=78%</td></tr><tr><td class='lessen'>118</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION'>ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION</a></td><td><a href='ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION.html'>Details ...</a></td><td>92</td><td>-0.47</td><td>-2.02</td><td>0.000</td><td>0.001</td><td>0.123</td><td>904</td><td>tags=28%, list=9%, signal=31%</td></tr><tr><td class='lessen'>119</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP'>BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP</a></td><td><a href='BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP.html'>Details ...</a></td><td>255</td><td>-0.40</td><td>-2.02</td><td>0.000</td><td>0.001</td><td>0.127</td><td>1573</td><td>tags=35%, list=15%, signal=41%</td></tr><tr><td class='lessen'>120</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP'>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP</a></td><td><a href='SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP.html'>Details ...</a></td><td>250</td><td>-0.40</td><td>-2.01</td><td>0.000</td><td>0.001</td><td>0.128</td><td>2182</td><td>tags=40%, list=21%, signal=50%</td></tr><tr><td class='lessen'>121</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN'>XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN</a></td><td><a href='XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN.html'>Details ...</a></td><td>16</td><td>-0.69</td><td>-2.00</td><td>0.000</td><td>0.001</td><td>0.158</td><td>2516</td><td>tags=69%, list=24%, signal=90%</td></tr><tr><td class='lessen'>122</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G1_S'>WHITFIELD_CELL_CYCLE_G1_S</a></td><td><a href='WHITFIELD_CELL_CYCLE_G1_S.html'>Details ...</a></td><td>108</td><td>-0.45</td><td>-2.00</td><td>0.000</td><td>0.001</td><td>0.160</td><td>2325</td><td>tags=46%, list=22%, signal=59%</td></tr><tr><td class='lessen'>123</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_16HR'>BURTON_ADIPOGENESIS_PEAK_AT_16HR</a></td><td><a href='BURTON_ADIPOGENESIS_PEAK_AT_16HR.html'>Details ...</a></td><td>40</td><td>-0.54</td><td>-1.99</td><td>0.000</td><td>0.001</td><td>0.184</td><td>2512</td><td>tags=58%, list=24%, signal=75%</td></tr><tr><td class='lessen'>124</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FINETTI_BREAST_CANCER_KINOME_RED'>FINETTI_BREAST_CANCER_KINOME_RED</a></td><td><a href='FINETTI_BREAST_CANCER_KINOME_RED.html'>Details ...</a></td><td>16</td><td>-0.70</td><td>-1.99</td><td>0.002</td><td>0.001</td><td>0.195</td><td>2732</td><td>tags=81%, list=26%, signal=110%</td></tr><tr><td class='lessen'>125</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FERRANDO_HOX11_NEIGHBORS'>FERRANDO_HOX11_NEIGHBORS</a></td><td><a href='FERRANDO_HOX11_NEIGHBORS.html'>Details ...</a></td><td>16</td><td>-0.67</td><td>-1.99</td><td>0.002</td><td>0.001</td><td>0.195</td><td>1373</td><td>tags=56%, list=13%, signal=65%</td></tr><tr><td class='lessen'>126</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SMID_BREAST_CANCER_LUMINAL_A_DN'>SMID_BREAST_CANCER_LUMINAL_A_DN</a></td><td><a href='SMID_BREAST_CANCER_LUMINAL_A_DN.html'>Details ...</a></td><td>17</td><td>-0.66</td><td>-1.98</td><td>0.000</td><td>0.001</td><td>0.203</td><td>1622</td><td>tags=53%, list=15%, signal=63%</td></tr><tr><td class='lessen'>127</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/NADERI_BREAST_CANCER_PROGNOSIS_UP'>NADERI_BREAST_CANCER_PROGNOSIS_UP</a></td><td><a href='NADERI_BREAST_CANCER_PROGNOSIS_UP.html'>Details ...</a></td><td>35</td><td>-0.55</td><td>-1.98</td><td>0.002</td><td>0.002</td><td>0.212</td><td>1891</td><td>tags=51%, list=18%, signal=63%</td></tr><tr><td class='lessen'>128</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ZHU_CMV_ALL_UP'>ZHU_CMV_ALL_UP</a></td><td><a href='ZHU_CMV_ALL_UP.html'>Details ...</a></td><td>90</td><td>-0.45</td><td>-1.96</td><td>0.000</td><td>0.002</td><td>0.259</td><td>1479</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>129</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_LB_DN'>ZHAN_MULTIPLE_MYELOMA_LB_DN</a></td><td><a href='ZHAN_MULTIPLE_MYELOMA_LB_DN.html'>Details ...</a></td><td>27</td><td>-0.57</td><td>-1.95</td><td>0.002</td><td>0.002</td><td>0.300</td><td>1267</td><td>tags=48%, list=12%, signal=55%</td></tr><tr><td class='lessen'>130</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP'>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</a></td><td><a href='MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP.html'>Details ...</a></td><td>103</td><td>-0.43</td><td>-1.93</td><td>0.000</td><td>0.003</td><td>0.384</td><td>3396</td><td>tags=56%, list=32%, signal=82%</td></tr><tr><td class='lessen'>131</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/YAN_ESCAPE_FROM_ANOIKIS'>YAN_ESCAPE_FROM_ANOIKIS</a></td><td><a href='YAN_ESCAPE_FROM_ANOIKIS.html'>Details ...</a></td><td>18</td><td>-0.63</td><td>-1.92</td><td>0.004</td><td>0.003</td><td>0.400</td><td>1181</td><td>tags=67%, list=11%, signal=75%</td></tr><tr><td class='lessen'>132</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BOSCO_TH1_CYTOTOXIC_MODULE'>BOSCO_TH1_CYTOTOXIC_MODULE</a></td><td><a href='BOSCO_TH1_CYTOTOXIC_MODULE.html'>Details ...</a></td><td>52</td><td>-0.48</td><td>-1.91</td><td>0.002</td><td>0.003</td><td>0.432</td><td>1619</td><td>tags=46%, list=15%, signal=54%</td></tr><tr><td class='lessen'>133</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_HP_UP'>ZHAN_MULTIPLE_MYELOMA_HP_UP</a></td><td><a href='ZHAN_MULTIPLE_MYELOMA_HP_UP.html'>Details ...</a></td><td>29</td><td>-0.56</td><td>-1.91</td><td>0.002</td><td>0.004</td><td>0.451</td><td>589</td><td>tags=28%, list=6%, signal=29%</td></tr><tr><td class='lessen'>134</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/NAKAMURA_CANCER_MICROENVIRONMENT_DN'>NAKAMURA_CANCER_MICROENVIRONMENT_DN</a></td><td><a href='NAKAMURA_CANCER_MICROENVIRONMENT_DN.html'>Details ...</a></td><td>41</td><td>-0.51</td><td>-1.91</td><td>0.000</td><td>0.004</td><td>0.456</td><td>2681</td><td>tags=68%, list=26%, signal=91%</td></tr><tr><td class='lessen'>135</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PUJANA_BREAST_CANCER_LIT_INT_NETWORK'>PUJANA_BREAST_CANCER_LIT_INT_NETWORK</a></td><td><a href='PUJANA_BREAST_CANCER_LIT_INT_NETWORK.html'>Details ...</a></td><td>97</td><td>-0.43</td><td>-1.91</td><td>0.000</td><td>0.004</td><td>0.457</td><td>2223</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>136</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MORI_PLASMA_CELL_UP'>MORI_PLASMA_CELL_UP</a></td><td><a href='MORI_PLASMA_CELL_UP.html'>Details ...</a></td><td>46</td><td>-0.50</td><td>-1.90</td><td>0.000</td><td>0.004</td><td>0.470</td><td>1694</td><td>tags=43%, list=16%, signal=52%</td></tr><tr><td class='lessen'>137</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G2_M'>WHITFIELD_CELL_CYCLE_G2_M</a></td><td><a href='WHITFIELD_CELL_CYCLE_G2_M.html'>Details ...</a></td><td>167</td><td>-0.39</td><td>-1.90</td><td>0.000</td><td>0.004</td><td>0.472</td><td>1875</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>138</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ONO_FOXP3_TARGETS_DN'>ONO_FOXP3_TARGETS_DN</a></td><td><a href='ONO_FOXP3_TARGETS_DN.html'>Details ...</a></td><td>22</td><td>-0.60</td><td>-1.90</td><td>0.000</td><td>0.004</td><td>0.490</td><td>2618</td><td>tags=59%, list=25%, signal=79%</td></tr><tr><td class='lessen'>139</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP'>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP</a></td><td><a href='SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP.html'>Details ...</a></td><td>50</td><td>-0.50</td><td>-1.89</td><td>0.000</td><td>0.004</td><td>0.506</td><td>2047</td><td>tags=46%, list=20%, signal=57%</td></tr><tr><td class='lessen'>140</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DER_IFN_BETA_RESPONSE_UP'>DER_IFN_BETA_RESPONSE_UP</a></td><td><a href='DER_IFN_BETA_RESPONSE_UP.html'>Details ...</a></td><td>92</td><td>-0.43</td><td>-1.87</td><td>0.000</td><td>0.005</td><td>0.584</td><td>1838</td><td>tags=42%, list=18%, signal=51%</td></tr><tr><td class='lessen'>141</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ZHU_CMV_8_HR_UP'>ZHU_CMV_8_HR_UP</a></td><td><a href='ZHU_CMV_8_HR_UP.html'>Details ...</a></td><td>32</td><td>-0.54</td><td>-1.87</td><td>0.000</td><td>0.005</td><td>0.594</td><td>838</td><td>tags=41%, list=8%, signal=44%</td></tr><tr><td class='lessen'>142</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FURUKAWA_DUSP6_TARGETS_PCI35_UP'>FURUKAWA_DUSP6_TARGETS_PCI35_UP</a></td><td><a href='FURUKAWA_DUSP6_TARGETS_PCI35_UP.html'>Details ...</a></td><td>36</td><td>-0.52</td><td>-1.87</td><td>0.000</td><td>0.005</td><td>0.597</td><td>1800</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>143</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GREENBAUM_E2A_TARGETS_UP'>GREENBAUM_E2A_TARGETS_UP</a></td><td><a href='GREENBAUM_E2A_TARGETS_UP.html'>Details ...</a></td><td>33</td><td>-0.53</td><td>-1.87</td><td>0.000</td><td>0.005</td><td>0.610</td><td>1963</td><td>tags=58%, list=19%, signal=71%</td></tr><tr><td class='lessen'>144</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MANALO_HYPOXIA_DN'>MANALO_HYPOXIA_DN</a></td><td><a href='MANALO_HYPOXIA_DN.html'>Details ...</a></td><td>272</td><td>-0.37</td><td>-1.86</td><td>0.000</td><td>0.006</td><td>0.628</td><td>2383</td><td>tags=34%, list=23%, signal=43%</td></tr><tr><td class='lessen'>145</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_GROWING'>CHICAS_RB1_TARGETS_GROWING</a></td><td><a href='CHICAS_RB1_TARGETS_GROWING.html'>Details ...</a></td><td>183</td><td>-0.38</td><td>-1.86</td><td>0.000</td><td>0.006</td><td>0.629</td><td>1881</td><td>tags=41%, list=18%, signal=49%</td></tr><tr><td class='lessen'>146</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LY_AGING_PREMATURE_DN'>LY_AGING_PREMATURE_DN</a></td><td><a href='LY_AGING_PREMATURE_DN.html'>Details ...</a></td><td>26</td><td>-0.56</td><td>-1.86</td><td>0.000</td><td>0.006</td><td>0.652</td><td>2577</td><td>tags=65%, list=25%, signal=86%</td></tr><tr><td class='lessen'>147</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/YEGNASUBRAMANIAN_PROSTATE_CANCER'>YEGNASUBRAMANIAN_PROSTATE_CANCER</a></td><td><a href='YEGNASUBRAMANIAN_PROSTATE_CANCER.html'>Details ...</a></td><td>73</td><td>-0.44</td><td>-1.85</td><td>0.000</td><td>0.006</td><td>0.683</td><td>1264</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>148</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP'>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP</a></td><td><a href='BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP.html'>Details ...</a></td><td>284</td><td>-0.36</td><td>-1.85</td><td>0.000</td><td>0.007</td><td>0.701</td><td>2522</td><td>tags=37%, list=24%, signal=48%</td></tr><tr><td class='lessen'>149</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION'>RIZ_ERYTHROID_DIFFERENTIATION</a></td><td><a href='RIZ_ERYTHROID_DIFFERENTIATION.html'>Details ...</a></td><td>72</td><td>-0.44</td><td>-1.84</td><td>0.000</td><td>0.007</td><td>0.709</td><td>2614</td><td>tags=50%, list=25%, signal=66%</td></tr><tr><td class='lessen'>150</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MOOTHA_TCA'>MOOTHA_TCA</a></td><td><a href='MOOTHA_TCA.html'>Details ...</a></td><td>15</td><td>-0.65</td><td>-1.84</td><td>0.000</td><td>0.007</td><td>0.719</td><td>3345</td><td>tags=73%, list=32%, signal=108%</td></tr><tr><td class='lessen'>151</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HU_GENOTOXIC_DAMAGE_4HR'>HU_GENOTOXIC_DAMAGE_4HR</a></td><td><a href='HU_GENOTOXIC_DAMAGE_4HR.html'>Details ...</a></td><td>35</td><td>-0.52</td><td>-1.84</td><td>0.005</td><td>0.007</td><td>0.736</td><td>1340</td><td>tags=40%, list=13%, signal=46%</td></tr><tr><td class='lessen'>152</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/COLINA_TARGETS_OF_4EBP1_AND_4EBP2'>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</a></td><td><a href='COLINA_TARGETS_OF_4EBP1_AND_4EBP2.html'>Details ...</a></td><td>289</td><td>-0.36</td><td>-1.84</td><td>0.000</td><td>0.007</td><td>0.736</td><td>1417</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>153</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SHEPARD_BMYB_TARGETS'>SHEPARD_BMYB_TARGETS</a></td><td><a href='SHEPARD_BMYB_TARGETS.html'>Details ...</a></td><td>50</td><td>-0.48</td><td>-1.84</td><td>0.000</td><td>0.007</td><td>0.736</td><td>2463</td><td>tags=56%, list=23%, signal=73%</td></tr><tr><td class='lessen'>154</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SANA_TNF_SIGNALING_UP'>SANA_TNF_SIGNALING_UP</a></td><td><a href='SANA_TNF_SIGNALING_UP.html'>Details ...</a></td><td>69</td><td>-0.44</td><td>-1.82</td><td>0.000</td><td>0.008</td><td>0.775</td><td>766</td><td>tags=30%, list=7%, signal=33%</td></tr><tr><td class='lessen'>155</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP'>PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP</a></td><td><a href='PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP.html'>Details ...</a></td><td>61</td><td>-0.45</td><td>-1.82</td><td>0.002</td><td>0.008</td><td>0.783</td><td>2455</td><td>tags=44%, list=23%, signal=57%</td></tr><tr><td class='lessen'>156</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MORI_MATURE_B_LYMPHOCYTE_DN'>MORI_MATURE_B_LYMPHOCYTE_DN</a></td><td><a href='MORI_MATURE_B_LYMPHOCYTE_DN.html'>Details ...</a></td><td>67</td><td>-0.44</td><td>-1.81</td><td>0.000</td><td>0.009</td><td>0.821</td><td>3164</td><td>tags=58%, list=30%, signal=83%</td></tr><tr><td class='lessen'>157</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RUIZ_TNC_TARGETS_DN'>RUIZ_TNC_TARGETS_DN</a></td><td><a href='RUIZ_TNC_TARGETS_DN.html'>Details ...</a></td><td>124</td><td>-0.40</td><td>-1.80</td><td>0.000</td><td>0.010</td><td>0.844</td><td>2382</td><td>tags=49%, list=23%, signal=63%</td></tr><tr><td class='lessen'>158</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_SENESCENT'>CHICAS_RB1_TARGETS_SENESCENT</a></td><td><a href='CHICAS_RB1_TARGETS_SENESCENT.html'>Details ...</a></td><td>422</td><td>-0.34</td><td>-1.80</td><td>0.000</td><td>0.010</td><td>0.853</td><td>2139</td><td>tags=35%, list=20%, signal=42%</td></tr><tr><td class='lessen'>159</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP'>MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP</a></td><td><a href='MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP.html'>Details ...</a></td><td>110</td><td>-0.40</td><td>-1.80</td><td>0.000</td><td>0.010</td><td>0.854</td><td>1508</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>160</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PAL_PRMT5_TARGETS_UP'>PAL_PRMT5_TARGETS_UP</a></td><td><a href='PAL_PRMT5_TARGETS_UP.html'>Details ...</a></td><td>187</td><td>-0.37</td><td>-1.79</td><td>0.000</td><td>0.011</td><td>0.870</td><td>2286</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>161</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN'>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN</a></td><td><a href='CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN.html'>Details ...</a></td><td>80</td><td>-0.42</td><td>-1.79</td><td>0.002</td><td>0.011</td><td>0.870</td><td>2310</td><td>tags=44%, list=22%, signal=56%</td></tr><tr><td class='lessen'>162</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GAL_LEUKEMIC_STEM_CELL_DN'>GAL_LEUKEMIC_STEM_CELL_DN</a></td><td><a href='GAL_LEUKEMIC_STEM_CELL_DN.html'>Details ...</a></td><td>145</td><td>-0.38</td><td>-1.79</td><td>0.000</td><td>0.011</td><td>0.872</td><td>2340</td><td>tags=41%, list=22%, signal=53%</td></tr><tr><td class='lessen'>163</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP'>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP</a></td><td><a href='BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP.html'>Details ...</a></td><td>37</td><td>-0.49</td><td>-1.79</td><td>0.000</td><td>0.011</td><td>0.878</td><td>2300</td><td>tags=49%, list=22%, signal=62%</td></tr><tr><td class='lessen'>164</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HORIUCHI_WTAP_TARGETS_DN'>HORIUCHI_WTAP_TARGETS_DN</a></td><td><a href='HORIUCHI_WTAP_TARGETS_DN.html'>Details ...</a></td><td>281</td><td>-0.35</td><td>-1.78</td><td>0.000</td><td>0.012</td><td>0.893</td><td>1891</td><td>tags=31%, list=18%, signal=37%</td></tr><tr><td class='lessen'>165</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LE_NEURONAL_DIFFERENTIATION_DN'>LE_NEURONAL_DIFFERENTIATION_DN</a></td><td><a href='LE_NEURONAL_DIFFERENTIATION_DN.html'>Details ...</a></td><td>18</td><td>-0.60</td><td>-1.77</td><td>0.002</td><td>0.013</td><td>0.916</td><td>1728</td><td>tags=50%, list=16%, signal=60%</td></tr><tr><td class='lessen'>166</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP'>WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP</a></td><td><a href='WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP.html'>Details ...</a></td><td>18</td><td>-0.57</td><td>-1.77</td><td>0.002</td><td>0.013</td><td>0.924</td><td>2804</td><td>tags=67%, list=27%, signal=91%</td></tr><tr><td class='lessen'>167</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KRIGE_AMINO_ACID_DEPRIVATION'>KRIGE_AMINO_ACID_DEPRIVATION</a></td><td><a href='KRIGE_AMINO_ACID_DEPRIVATION.html'>Details ...</a></td><td>25</td><td>-0.55</td><td>-1.76</td><td>0.007</td><td>0.014</td><td>0.939</td><td>1668</td><td>tags=40%, list=16%, signal=47%</td></tr><tr><td class='lessen'>168</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_UP'>BOYLAN_MULTIPLE_MYELOMA_C_UP</a></td><td><a href='BOYLAN_MULTIPLE_MYELOMA_C_UP.html'>Details ...</a></td><td>37</td><td>-0.49</td><td>-1.76</td><td>0.002</td><td>0.015</td><td>0.940</td><td>2605</td><td>tags=41%, list=25%, signal=54%</td></tr><tr><td class='lessen'>169</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MITSIADES_RESPONSE_TO_APLIDIN_DN'>MITSIADES_RESPONSE_TO_APLIDIN_DN</a></td><td><a href='MITSIADES_RESPONSE_TO_APLIDIN_DN.html'>Details ...</a></td><td>237</td><td>-0.35</td><td>-1.76</td><td>0.000</td><td>0.015</td><td>0.944</td><td>2490</td><td>tags=41%, list=24%, signal=52%</td></tr><tr><td class='lessen'>170</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BASAKI_YBX1_TARGETS_UP'>BASAKI_YBX1_TARGETS_UP</a></td><td><a href='BASAKI_YBX1_TARGETS_UP.html'>Details ...</a></td><td>252</td><td>-0.35</td><td>-1.76</td><td>0.000</td><td>0.015</td><td>0.944</td><td>2451</td><td>tags=41%, list=23%, signal=52%</td></tr><tr><td class='lessen'>171</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP'>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP</a></td><td><a href='ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP.html'>Details ...</a></td><td>121</td><td>-0.38</td><td>-1.75</td><td>0.000</td><td>0.015</td><td>0.947</td><td>897</td><td>tags=24%, list=9%, signal=26%</td></tr><tr><td class='lessen'>172</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2'>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</a></td><td><a href='CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2.html'>Details ...</a></td><td>195</td><td>-0.35</td><td>-1.75</td><td>0.000</td><td>0.015</td><td>0.950</td><td>1947</td><td>tags=31%, list=19%, signal=37%</td></tr><tr><td class='lessen'>173</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LIU_VAV3_PROSTATE_CARCINOGENESIS_UP'>LIU_VAV3_PROSTATE_CARCINOGENESIS_UP</a></td><td><a href='LIU_VAV3_PROSTATE_CARCINOGENESIS_UP.html'>Details ...</a></td><td>65</td><td>-0.42</td><td>-1.74</td><td>0.000</td><td>0.016</td><td>0.960</td><td>1238</td><td>tags=31%, list=12%, signal=35%</td></tr><tr><td class='lessen'>174</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN'>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN</a></td><td><a href='SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN.html'>Details ...</a></td><td>33</td><td>-0.50</td><td>-1.74</td><td>0.002</td><td>0.016</td><td>0.963</td><td>2300</td><td>tags=39%, list=22%, signal=50%</td></tr><tr><td class='lessen'>175</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP'>BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP</a></td><td><a href='BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP.html'>Details ...</a></td><td>47</td><td>-0.46</td><td>-1.74</td><td>0.007</td><td>0.017</td><td>0.975</td><td>1519</td><td>tags=43%, list=14%, signal=50%</td></tr><tr><td class='lessen'>176</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN'>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</a></td><td><a href='FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN.html'>Details ...</a></td><td>330</td><td>-0.33</td><td>-1.73</td><td>0.000</td><td>0.017</td><td>0.975</td><td>1688</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>177</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP'>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP</a></td><td><a href='DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP.html'>Details ...</a></td><td>23</td><td>-0.53</td><td>-1.73</td><td>0.011</td><td>0.018</td><td>0.978</td><td>1419</td><td>tags=35%, list=14%, signal=40%</td></tr><tr><td class='lessen'>178</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6'>MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6</a></td><td><a href='MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6.html'>Details ...</a></td><td>39</td><td>-0.47</td><td>-1.73</td><td>0.002</td><td>0.018</td><td>0.981</td><td>2114</td><td>tags=46%, list=20%, signal=58%</td></tr><tr><td class='lessen'>179</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/STEIN_ESR1_TARGETS'>STEIN_ESR1_TARGETS</a></td><td><a href='STEIN_ESR1_TARGETS.html'>Details ...</a></td><td>68</td><td>-0.42</td><td>-1.73</td><td>0.002</td><td>0.018</td><td>0.982</td><td>1094</td><td>tags=35%, list=10%, signal=39%</td></tr><tr><td class='lessen'>180</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP'>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</a></td><td><a href='GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP.html'>Details ...</a></td><td>444</td><td>-0.32</td><td>-1.72</td><td>0.000</td><td>0.018</td><td>0.983</td><td>2480</td><td>tags=37%, list=24%, signal=46%</td></tr><tr><td class='lessen'>181</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_EARLY_UP'>VECCHI_GASTRIC_CANCER_EARLY_UP</a></td><td><a href='VECCHI_GASTRIC_CANCER_EARLY_UP.html'>Details ...</a></td><td>358</td><td>-0.33</td><td>-1.72</td><td>0.000</td><td>0.019</td><td>0.984</td><td>1958</td><td>tags=32%, list=19%, signal=38%</td></tr><tr><td class='lessen'>182</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MUELLER_PLURINET'>MUELLER_PLURINET</a></td><td><a href='MUELLER_PLURINET.html'>Details ...</a></td><td>261</td><td>-0.34</td><td>-1.71</td><td>0.000</td><td>0.020</td><td>0.988</td><td>3153</td><td>tags=45%, list=30%, signal=63%</td></tr><tr><td class='lessen'>183</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LIANG_SILENCED_BY_METHYLATION_2'>LIANG_SILENCED_BY_METHYLATION_2</a></td><td><a href='LIANG_SILENCED_BY_METHYLATION_2.html'>Details ...</a></td><td>29</td><td>-0.50</td><td>-1.71</td><td>0.004</td><td>0.020</td><td>0.988</td><td>1181</td><td>tags=41%, list=11%, signal=46%</td></tr><tr><td class='lessen'>184</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP'>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP</a></td><td><a href='BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP.html'>Details ...</a></td><td>31</td><td>-0.50</td><td>-1.71</td><td>0.009</td><td>0.020</td><td>0.989</td><td>2753</td><td>tags=48%, list=26%, signal=65%</td></tr><tr><td class='lessen'>185</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_6'>RASHI_RESPONSE_TO_IONIZING_RADIATION_6</a></td><td><a href='RASHI_RESPONSE_TO_IONIZING_RADIATION_6.html'>Details ...</a></td><td>66</td><td>-0.42</td><td>-1.71</td><td>0.003</td><td>0.020</td><td>0.989</td><td>1717</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>186</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM'>IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM</a></td><td><a href='IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM.html'>Details ...</a></td><td>22</td><td>-0.54</td><td>-1.70</td><td>0.007</td><td>0.021</td><td>0.993</td><td>1878</td><td>tags=55%, list=18%, signal=66%</td></tr><tr><td class='lessen'>187</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SHEPARD_CRUSH_AND_BURN_MUTANT_DN'>SHEPARD_CRUSH_AND_BURN_MUTANT_DN</a></td><td><a href='SHEPARD_CRUSH_AND_BURN_MUTANT_DN.html'>Details ...</a></td><td>123</td><td>-0.37</td><td>-1.70</td><td>0.000</td><td>0.021</td><td>0.993</td><td>2463</td><td>tags=42%, list=23%, signal=55%</td></tr><tr><td class='lessen'>188</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WONG_EMBRYONIC_STEM_CELL_CORE'>WONG_EMBRYONIC_STEM_CELL_CORE</a></td><td><a href='WONG_EMBRYONIC_STEM_CELL_CORE.html'>Details ...</a></td><td>315</td><td>-0.32</td><td>-1.70</td><td>0.000</td><td>0.021</td><td>0.993</td><td>3167</td><td>tags=41%, list=30%, signal=57%</td></tr><tr><td class='lessen'>189</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SUNG_METASTASIS_STROMA_DN'>SUNG_METASTASIS_STROMA_DN</a></td><td><a href='SUNG_METASTASIS_STROMA_DN.html'>Details ...</a></td><td>43</td><td>-0.45</td><td>-1.70</td><td>0.002</td><td>0.022</td><td>0.994</td><td>2075</td><td>tags=37%, list=20%, signal=46%</td></tr><tr><td class='lessen'>190</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_POOR_PROGNOSIS'>VANTVEER_BREAST_CANCER_POOR_PROGNOSIS</a></td><td><a href='VANTVEER_BREAST_CANCER_POOR_PROGNOSIS.html'>Details ...</a></td><td>35</td><td>-0.48</td><td>-1.70</td><td>0.002</td><td>0.022</td><td>0.996</td><td>1986</td><td>tags=37%, list=19%, signal=46%</td></tr><tr><td class='lessen'>191</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/GOLDRATH_ANTIGEN_RESPONSE'>GOLDRATH_ANTIGEN_RESPONSE</a></td><td><a href='GOLDRATH_ANTIGEN_RESPONSE.html'>Details ...</a></td><td>303</td><td>-0.33</td><td>-1.69</td><td>0.000</td><td>0.023</td><td>0.996</td><td>1907</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>192</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C'>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</a></td><td><a href='TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C.html'>Details ...</a></td><td>373</td><td>-0.32</td><td>-1.69</td><td>0.000</td><td>0.023</td><td>0.997</td><td>1853</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>193</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/COLLIS_PRKDC_SUBSTRATES'>COLLIS_PRKDC_SUBSTRATES</a></td><td><a href='COLLIS_PRKDC_SUBSTRATES.html'>Details ...</a></td><td>17</td><td>-0.55</td><td>-1.69</td><td>0.013</td><td>0.024</td><td>0.998</td><td>1340</td><td>tags=53%, list=13%, signal=61%</td></tr><tr><td class='lessen'>194</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/LEE_TARGETS_OF_PTCH1_AND_SUFU_UP'>LEE_TARGETS_OF_PTCH1_AND_SUFU_UP</a></td><td><a href='LEE_TARGETS_OF_PTCH1_AND_SUFU_UP.html'>Details ...</a></td><td>48</td><td>-0.43</td><td>-1.68</td><td>0.002</td><td>0.025</td><td>0.999</td><td>1164</td><td>tags=31%, list=11%, signal=35%</td></tr><tr><td class='lessen'>195</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP'>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</a></td><td><a href='RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP.html'>Details ...</a></td><td>196</td><td>-0.34</td><td>-1.67</td><td>0.000</td><td>0.026</td><td>1.000</td><td>2290</td><td>tags=33%, list=22%, signal=41%</td></tr><tr><td class='lessen'>196</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RHODES_CANCER_META_SIGNATURE'>RHODES_CANCER_META_SIGNATURE</a></td><td><a href='RHODES_CANCER_META_SIGNATURE.html'>Details ...</a></td><td>63</td><td>-0.41</td><td>-1.67</td><td>0.002</td><td>0.027</td><td>1.000</td><td>3141</td><td>tags=49%, list=30%, signal=70%</td></tr><tr><td class='lessen'>197</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP'>BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP</a></td><td><a href='BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP.html'>Details ...</a></td><td>84</td><td>-0.39</td><td>-1.67</td><td>0.000</td><td>0.027</td><td>1.000</td><td>1961</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>198</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_24HR_5_DN'>CAFFAREL_RESPONSE_TO_THC_24HR_5_DN</a></td><td><a href='CAFFAREL_RESPONSE_TO_THC_24HR_5_DN.html'>Details ...</a></td><td>45</td><td>-0.44</td><td>-1.67</td><td>0.009</td><td>0.028</td><td>1.000</td><td>2325</td><td>tags=42%, list=22%, signal=54%</td></tr><tr><td class='lessen'>199</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/HELLER_SILENCED_BY_METHYLATION_UP'>HELLER_SILENCED_BY_METHYLATION_UP</a></td><td><a href='HELLER_SILENCED_BY_METHYLATION_UP.html'>Details ...</a></td><td>168</td><td>-0.35</td><td>-1.67</td><td>0.000</td><td>0.028</td><td>1.000</td><td>1939</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>200</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MATZUK_MEIOTIC_AND_DNA_REPAIR'>MATZUK_MEIOTIC_AND_DNA_REPAIR</a></td><td><a href='MATZUK_MEIOTIC_AND_DNA_REPAIR.html'>Details ...</a></td><td>22</td><td>-0.52</td><td>-1.66</td><td>0.009</td><td>0.028</td><td>1.000</td><td>995</td><td>tags=32%, list=9%, signal=35%</td></tr><tr><td class='lessen'>201</td><td>SU_TESTIS</td><td></td><td>45</td><td>-0.44</td><td>-1.66</td><td>0.014</td><td>0.029</td><td>1.000</td><td>2799</td><td>tags=56%, list=27%, signal=75%</td></tr><tr><td class='lessen'>202</td><td>CHOW_RASSF1_TARGETS_DN</td><td></td><td>29</td><td>-0.48</td><td>-1.66</td><td>0.006</td><td>0.029</td><td>1.000</td><td>1832</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>203</td><td>BIDUS_METASTASIS_UP</td><td></td><td>191</td><td>-0.34</td><td>-1.66</td><td>0.000</td><td>0.030</td><td>1.000</td><td>2751</td><td>tags=40%, list=26%, signal=53%</td></tr><tr><td class='lessen'>204</td><td>CHICAS_RB1_TARGETS_LOW_SERUM</td><td></td><td>71</td><td>-0.39</td><td>-1.65</td><td>0.002</td><td>0.030</td><td>1.000</td><td>1802</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>205</td><td>THILLAINADESAN_ZNF217_TARGETS_UP</td><td></td><td>37</td><td>-0.46</td><td>-1.65</td><td>0.011</td><td>0.029</td><td>1.000</td><td>2174</td><td>tags=49%, list=21%, signal=61%</td></tr><tr><td class='lessen'>206</td><td>SHEPARD_BMYB_MORPHOLINO_DN</td><td></td><td>137</td><td>-0.36</td><td>-1.65</td><td>0.000</td><td>0.030</td><td>1.000</td><td>1375</td><td>tags=31%, list=13%, signal=36%</td></tr><tr><td class='lessen'>207</td><td>SIMBULAN_PARP1_TARGETS_DN</td><td></td><td>16</td><td>-0.56</td><td>-1.65</td><td>0.015</td><td>0.030</td><td>1.000</td><td>1878</td><td>tags=63%, list=18%, signal=76%</td></tr><tr><td class='lessen'>208</td><td>BARIS_THYROID_CANCER_UP</td><td></td><td>20</td><td>-0.53</td><td>-1.65</td><td>0.010</td><td>0.031</td><td>1.000</td><td>3025</td><td>tags=65%, list=29%, signal=91%</td></tr><tr><td class='lessen'>209</td><td>LEE_EARLY_T_LYMPHOCYTE_DN</td><td></td><td>35</td><td>-0.46</td><td>-1.65</td><td>0.007</td><td>0.031</td><td>1.000</td><td>2122</td><td>tags=49%, list=20%, signal=61%</td></tr><tr><td class='lessen'>210</td><td>GAURNIER_PSMD4_TARGETS</td><td></td><td>37</td><td>-0.45</td><td>-1.64</td><td>0.018</td><td>0.034</td><td>1.000</td><td>2489</td><td>tags=54%, list=24%, signal=71%</td></tr><tr><td class='lessen'>211</td><td>CHEN_ETV5_TARGETS_TESTIS</td><td></td><td>15</td><td>-0.58</td><td>-1.63</td><td>0.011</td><td>0.034</td><td>1.000</td><td>1642</td><td>tags=60%, list=16%, signal=71%</td></tr><tr><td class='lessen'>212</td><td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</td><td></td><td>156</td><td>-0.34</td><td>-1.63</td><td>0.003</td><td>0.036</td><td>1.000</td><td>2092</td><td>tags=37%, list=20%, signal=45%</td></tr><tr><td class='lessen'>213</td><td>GOLUB_ALL_VS_AML_UP</td><td></td><td>20</td><td>-0.53</td><td>-1.62</td><td>0.022</td><td>0.037</td><td>1.000</td><td>2164</td><td>tags=45%, list=21%, signal=57%</td></tr><tr><td class='lessen'>214</td><td>XU_AKT1_TARGETS_6HR</td><td></td><td>21</td><td>-0.52</td><td>-1.62</td><td>0.015</td><td>0.038</td><td>1.000</td><td>804</td><td>tags=33%, list=8%, signal=36%</td></tr><tr><td class='lessen'>215</td><td>TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP</td><td></td><td>67</td><td>-0.39</td><td>-1.62</td><td>0.007</td><td>0.038</td><td>1.000</td><td>2406</td><td>tags=42%, list=23%, signal=54%</td></tr><tr><td class='lessen'>216</td><td>GAZIN_EPIGENETIC_SILENCING_BY_KRAS</td><td></td><td>19</td><td>-0.53</td><td>-1.62</td><td>0.014</td><td>0.038</td><td>1.000</td><td>2013</td><td>tags=47%, list=19%, signal=59%</td></tr><tr><td class='lessen'>217</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</td><td></td><td>107</td><td>-0.36</td><td>-1.61</td><td>0.008</td><td>0.040</td><td>1.000</td><td>1181</td><td>tags=30%, list=11%, signal=33%</td></tr><tr><td class='lessen'>218</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN</td><td></td><td>127</td><td>-0.35</td><td>-1.61</td><td>0.000</td><td>0.040</td><td>1.000</td><td>2084</td><td>tags=39%, list=20%, signal=49%</td></tr><tr><td class='lessen'>219</td><td>SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN</td><td></td><td>20</td><td>-0.53</td><td>-1.61</td><td>0.011</td><td>0.040</td><td>1.000</td><td>1373</td><td>tags=55%, list=13%, signal=63%</td></tr><tr><td class='lessen'>220</td><td>RODRIGUES_THYROID_CARCINOMA_UP</td><td></td><td>15</td><td>-0.56</td><td>-1.61</td><td>0.023</td><td>0.040</td><td>1.000</td><td>1388</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>221</td><td>VERHAAK_GLIOBLASTOMA_PRONEURAL</td><td></td><td>75</td><td>-0.37</td><td>-1.60</td><td>0.002</td><td>0.042</td><td>1.000</td><td>2229</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>222</td><td>WAKASUGI_HAVE_ZNF143_BINDING_SITES</td><td></td><td>49</td><td>-0.42</td><td>-1.60</td><td>0.000</td><td>0.043</td><td>1.000</td><td>2204</td><td>tags=39%, list=21%, signal=49%</td></tr><tr><td class='lessen'>223</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP</td><td></td><td>40</td><td>-0.43</td><td>-1.59</td><td>0.010</td><td>0.045</td><td>1.000</td><td>2804</td><td>tags=45%, list=27%, signal=61%</td></tr><tr><td class='lessen'>224</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>312</td><td>-0.31</td><td>-1.59</td><td>0.000</td><td>0.045</td><td>1.000</td><td>1932</td><td>tags=33%, list=18%, signal=39%</td></tr><tr><td class='lessen'>225</td><td>MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP</td><td></td><td>80</td><td>-0.38</td><td>-1.59</td><td>0.003</td><td>0.046</td><td>1.000</td><td>1537</td><td>tags=33%, list=15%, signal=38%</td></tr><tr><td class='lessen'>226</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_8</td><td></td><td>26</td><td>-0.47</td><td>-1.58</td><td>0.014</td><td>0.050</td><td>1.000</td><td>2166</td><td>tags=50%, list=21%, signal=63%</td></tr><tr><td class='lessen'>227</td><td>ALCALAY_AML_BY_NPM1_LOCALIZATION_DN</td><td></td><td>130</td><td>-0.34</td><td>-1.57</td><td>0.000</td><td>0.053</td><td>1.000</td><td>2166</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>228</td><td>BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP</td><td></td><td>90</td><td>-0.36</td><td>-1.57</td><td>0.007</td><td>0.054</td><td>1.000</td><td>1730</td><td>tags=34%, list=16%, signal=41%</td></tr><tr><td class='lessen'>229</td><td>VANTVEER_BREAST_CANCER_METASTASIS_DN</td><td></td><td>95</td><td>-0.35</td><td>-1.57</td><td>0.005</td><td>0.054</td><td>1.000</td><td>2277</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>230</td><td>MIKKELSEN_NPC_ICP_WITH_H3K4ME3</td><td></td><td>292</td><td>-0.31</td><td>-1.57</td><td>0.000</td><td>0.054</td><td>1.000</td><td>2417</td><td>tags=34%, list=23%, signal=43%</td></tr><tr><td class='lessen'>231</td><td>STEARMAN_TUMOR_FIELD_EFFECT_UP</td><td></td><td>32</td><td>-0.45</td><td>-1.56</td><td>0.019</td><td>0.055</td><td>1.000</td><td>1261</td><td>tags=31%, list=12%, signal=35%</td></tr><tr><td class='lessen'>232</td><td>YU_MYC_TARGETS_DN</td><td></td><td>40</td><td>-0.42</td><td>-1.56</td><td>0.009</td><td>0.055</td><td>1.000</td><td>1261</td><td>tags=33%, list=12%, signal=37%</td></tr><tr><td class='lessen'>233</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_DN</td><td></td><td>288</td><td>-0.30</td><td>-1.56</td><td>0.000</td><td>0.055</td><td>1.000</td><td>2903</td><td>tags=40%, list=28%, signal=54%</td></tr><tr><td class='lessen'>234</td><td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN</td><td></td><td>328</td><td>-0.30</td><td>-1.55</td><td>0.000</td><td>0.058</td><td>1.000</td><td>2300</td><td>tags=30%, list=22%, signal=37%</td></tr><tr><td class='lessen'>235</td><td>ZHU_CMV_24_HR_UP</td><td></td><td>73</td><td>-0.37</td><td>-1.55</td><td>0.012</td><td>0.057</td><td>1.000</td><td>3201</td><td>tags=44%, list=31%, signal=63%</td></tr><tr><td class='lessen'>236</td><td>SCIBETTA_KDM5B_TARGETS_UP</td><td></td><td>16</td><td>-0.52</td><td>-1.55</td><td>0.029</td><td>0.058</td><td>1.000</td><td>1348</td><td>tags=38%, list=13%, signal=43%</td></tr><tr><td class='lessen'>237</td><td>GROSS_HYPOXIA_VIA_ELK3_ONLY_DN</td><td></td><td>40</td><td>-0.41</td><td>-1.55</td><td>0.018</td><td>0.058</td><td>1.000</td><td>1901</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>238</td><td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN</td><td></td><td>135</td><td>-0.34</td><td>-1.55</td><td>0.000</td><td>0.059</td><td>1.000</td><td>2254</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>239</td><td>ABBUD_LIF_SIGNALING_1_UP</td><td></td><td>35</td><td>-0.44</td><td>-1.55</td><td>0.013</td><td>0.060</td><td>1.000</td><td>862</td><td>tags=29%, list=8%, signal=31%</td></tr><tr><td class='lessen'>240</td><td>MARKEY_RB1_CHRONIC_LOF_UP</td><td></td><td>95</td><td>-0.36</td><td>-1.55</td><td>0.005</td><td>0.060</td><td>1.000</td><td>1821</td><td>tags=38%, list=17%, signal=45%</td></tr><tr><td class='lessen'>241</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_2</td><td></td><td>265</td><td>-0.30</td><td>-1.53</td><td>0.000</td><td>0.067</td><td>1.000</td><td>2451</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>242</td><td>KIM_WT1_TARGETS_DN</td><td></td><td>401</td><td>-0.29</td><td>-1.53</td><td>0.000</td><td>0.069</td><td>1.000</td><td>2740</td><td>tags=36%, list=26%, signal=46%</td></tr><tr><td class='lessen'>243</td><td>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP</td><td></td><td>67</td><td>-0.37</td><td>-1.53</td><td>0.017</td><td>0.069</td><td>1.000</td><td>1626</td><td>tags=37%, list=15%, signal=44%</td></tr><tr><td class='lessen'>244</td><td>RICKMAN_HEAD_AND_NECK_CANCER_A</td><td></td><td>37</td><td>-0.42</td><td>-1.52</td><td>0.032</td><td>0.074</td><td>1.000</td><td>2595</td><td>tags=54%, list=25%, signal=72%</td></tr><tr><td class='lessen'>245</td><td>SEKI_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>64</td><td>-0.37</td><td>-1.51</td><td>0.018</td><td>0.074</td><td>1.000</td><td>1692</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>246</td><td>ONO_AML1_TARGETS_DN</td><td></td><td>20</td><td>-0.49</td><td>-1.51</td><td>0.042</td><td>0.076</td><td>1.000</td><td>2635</td><td>tags=45%, list=25%, signal=60%</td></tr><tr><td class='lessen'>247</td><td>SASAKI_ADULT_T_CELL_LEUKEMIA</td><td></td><td>136</td><td>-0.32</td><td>-1.51</td><td>0.000</td><td>0.079</td><td>1.000</td><td>1884</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>248</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</td><td></td><td>80</td><td>-0.35</td><td>-1.50</td><td>0.007</td><td>0.082</td><td>1.000</td><td>1052</td><td>tags=31%, list=10%, signal=34%</td></tr><tr><td class='lessen'>249</td><td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN</td><td></td><td>51</td><td>-0.39</td><td>-1.50</td><td>0.030</td><td>0.083</td><td>1.000</td><td>1261</td><td>tags=31%, list=12%, signal=35%</td></tr><tr><td class='lessen'>250</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP</td><td></td><td>18</td><td>-0.48</td><td>-1.49</td><td>0.058</td><td>0.089</td><td>1.000</td><td>2246</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>251</td><td>CAFFAREL_RESPONSE_TO_THC_DN</td><td></td><td>26</td><td>-0.45</td><td>-1.49</td><td>0.035</td><td>0.090</td><td>1.000</td><td>2254</td><td>tags=50%, list=21%, signal=64%</td></tr><tr><td class='lessen'>252</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17</td><td></td><td>15</td><td>-0.52</td><td>-1.48</td><td>0.052</td><td>0.091</td><td>1.000</td><td>2100</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>253</td><td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td><td></td><td>389</td><td>-0.28</td><td>-1.48</td><td>0.000</td><td>0.090</td><td>1.000</td><td>2343</td><td>tags=31%, list=22%, signal=38%</td></tr><tr><td class='lessen'>254</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN</td><td></td><td>59</td><td>-0.36</td><td>-1.48</td><td>0.021</td><td>0.095</td><td>1.000</td><td>2349</td><td>tags=42%, list=22%, signal=54%</td></tr><tr><td class='lessen'>255</td><td>SAGIV_CD24_TARGETS_UP</td><td></td><td>19</td><td>-0.48</td><td>-1.47</td><td>0.054</td><td>0.095</td><td>1.000</td><td>2233</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>256</td><td>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN</td><td></td><td>49</td><td>-0.38</td><td>-1.47</td><td>0.028</td><td>0.097</td><td>1.000</td><td>365</td><td>tags=22%, list=3%, signal=23%</td></tr><tr><td class='lessen'>257</td><td>HOEGERKORP_CD44_TARGETS_TEMPORAL_DN</td><td></td><td>18</td><td>-0.49</td><td>-1.47</td><td>0.057</td><td>0.097</td><td>1.000</td><td>2921</td><td>tags=44%, list=28%, signal=61%</td></tr><tr><td class='lessen'>258</td><td>DUTTA_APOPTOSIS_VIA_NFKB</td><td></td><td>27</td><td>-0.44</td><td>-1.47</td><td>0.067</td><td>0.099</td><td>1.000</td><td>1875</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>259</td><td>WILCOX_RESPONSE_TO_PROGESTERONE_UP</td><td></td><td>112</td><td>-0.33</td><td>-1.47</td><td>0.010</td><td>0.099</td><td>1.000</td><td>1010</td><td>tags=23%, list=10%, signal=25%</td></tr><tr><td class='lessen'>260</td><td>KIM_GLIS2_TARGETS_UP</td><td></td><td>74</td><td>-0.35</td><td>-1.47</td><td>0.009</td><td>0.100</td><td>1.000</td><td>1607</td><td>tags=31%, list=15%, signal=36%</td></tr><tr><td class='lessen'>261</td><td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN</td><td></td><td>66</td><td>-0.36</td><td>-1.46</td><td>0.020</td><td>0.100</td><td>1.000</td><td>3141</td><td>tags=44%, list=30%, signal=62%</td></tr><tr><td class='lessen'>262</td><td>STANELLE_E2F1_TARGETS</td><td></td><td>20</td><td>-0.47</td><td>-1.46</td><td>0.054</td><td>0.101</td><td>1.000</td><td>2297</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>263</td><td>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP</td><td></td><td>52</td><td>-0.37</td><td>-1.46</td><td>0.026</td><td>0.101</td><td>1.000</td><td>983</td><td>tags=38%, list=9%, signal=42%</td></tr><tr><td class='lessen'>264</td><td>WU_HBX_TARGETS_3_UP</td><td></td><td>15</td><td>-0.50</td><td>-1.46</td><td>0.050</td><td>0.101</td><td>1.000</td><td>1784</td><td>tags=53%, list=17%, signal=64%</td></tr><tr><td class='lessen'>265</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN</td><td></td><td>155</td><td>-0.31</td><td>-1.46</td><td>0.005</td><td>0.105</td><td>1.000</td><td>2166</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>266</td><td>NOJIMA_SFRP2_TARGETS_DN</td><td></td><td>21</td><td>-0.45</td><td>-1.45</td><td>0.064</td><td>0.111</td><td>1.000</td><td>1479</td><td>tags=48%, list=14%, signal=55%</td></tr><tr><td class='lessen'>267</td><td>BAUS_TFF2_TARGETS_UP</td><td></td><td>26</td><td>-0.43</td><td>-1.45</td><td>0.048</td><td>0.111</td><td>1.000</td><td>815</td><td>tags=46%, list=8%, signal=50%</td></tr><tr><td class='lessen'>268</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</td><td></td><td>316</td><td>-0.28</td><td>-1.44</td><td>0.000</td><td>0.114</td><td>1.000</td><td>2498</td><td>tags=38%, list=24%, signal=48%</td></tr><tr><td class='lessen'>269</td><td>KIM_ALL_DISORDERS_CALB1_CORR_DN</td><td></td><td>17</td><td>-0.49</td><td>-1.44</td><td>0.068</td><td>0.114</td><td>1.000</td><td>1677</td><td>tags=41%, list=16%, signal=49%</td></tr><tr><td class='lessen'>270</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP</td><td></td><td>122</td><td>-0.31</td><td>-1.44</td><td>0.009</td><td>0.115</td><td>1.000</td><td>2286</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>271</td><td>STREICHER_LSM1_TARGETS_UP</td><td></td><td>36</td><td>-0.39</td><td>-1.44</td><td>0.023</td><td>0.116</td><td>1.000</td><td>1800</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>272</td><td>HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP</td><td></td><td>18</td><td>-0.48</td><td>-1.44</td><td>0.085</td><td>0.116</td><td>1.000</td><td>3085</td><td>tags=44%, list=29%, signal=63%</td></tr><tr><td class='lessen'>273</td><td>GARY_CD5_TARGETS_DN</td><td></td><td>395</td><td>-0.27</td><td>-1.44</td><td>0.000</td><td>0.117</td><td>1.000</td><td>2980</td><td>tags=32%, list=28%, signal=43%</td></tr><tr><td class='lessen'>274</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_UP</td><td></td><td>128</td><td>-0.31</td><td>-1.44</td><td>0.010</td><td>0.117</td><td>1.000</td><td>2041</td><td>tags=34%, list=19%, signal=41%</td></tr><tr><td class='lessen'>275</td><td>NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP</td><td></td><td>28</td><td>-0.42</td><td>-1.43</td><td>0.056</td><td>0.116</td><td>1.000</td><td>1622</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>276</td><td>CUI_TCF21_TARGETS_2_UP</td><td></td><td>320</td><td>-0.27</td><td>-1.43</td><td>0.000</td><td>0.116</td><td>1.000</td><td>1619</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>277</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_UP</td><td></td><td>271</td><td>-0.28</td><td>-1.43</td><td>0.000</td><td>0.116</td><td>1.000</td><td>1699</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>278</td><td>ODONNELL_METASTASIS_UP</td><td></td><td>29</td><td>-0.42</td><td>-1.43</td><td>0.058</td><td>0.116</td><td>1.000</td><td>1261</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>279</td><td>FOSTER_TOLERANT_MACROPHAGE_DN</td><td></td><td>355</td><td>-0.27</td><td>-1.43</td><td>0.003</td><td>0.118</td><td>1.000</td><td>1735</td><td>tags=28%, list=17%, signal=32%</td></tr><tr><td class='lessen'>280</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN</td><td></td><td>53</td><td>-0.36</td><td>-1.43</td><td>0.034</td><td>0.119</td><td>1.000</td><td>2375</td><td>tags=40%, list=23%, signal=51%</td></tr><tr><td class='lessen'>281</td><td>ZHANG_RESPONSE_TO_CANTHARIDIN_DN</td><td></td><td>63</td><td>-0.35</td><td>-1.43</td><td>0.026</td><td>0.121</td><td>1.000</td><td>1851</td><td>tags=32%, list=18%, signal=38%</td></tr><tr><td class='lessen'>282</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN</td><td></td><td>69</td><td>-0.34</td><td>-1.42</td><td>0.032</td><td>0.123</td><td>1.000</td><td>2375</td><td>tags=42%, list=23%, signal=54%</td></tr><tr><td class='lessen'>283</td><td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN</td><td></td><td>74</td><td>-0.34</td><td>-1.42</td><td>0.024</td><td>0.128</td><td>1.000</td><td>1471</td><td>tags=26%, list=14%, signal=30%</td></tr><tr><td class='lessen'>284</td><td>FOSTER_TOLERANT_MACROPHAGE_UP</td><td></td><td>125</td><td>-0.31</td><td>-1.41</td><td>0.021</td><td>0.130</td><td>1.000</td><td>1402</td><td>tags=25%, list=13%, signal=28%</td></tr><tr><td class='lessen'>285</td><td>RIZ_ERYTHROID_DIFFERENTIATION_HBZ</td><td></td><td>24</td><td>-0.44</td><td>-1.41</td><td>0.070</td><td>0.130</td><td>1.000</td><td>2521</td><td>tags=54%, list=24%, signal=71%</td></tr><tr><td class='lessen'>286</td><td>BENPORATH_ES_CORE_NINE_CORRELATED</td><td></td><td>78</td><td>-0.33</td><td>-1.41</td><td>0.043</td><td>0.132</td><td>1.000</td><td>2222</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>287</td><td>PACHER_TARGETS_OF_IGF1_AND_IGF2_UP</td><td></td><td>25</td><td>-0.43</td><td>-1.41</td><td>0.050</td><td>0.136</td><td>1.000</td><td>584</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>288</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN</td><td></td><td>24</td><td>-0.44</td><td>-1.40</td><td>0.067</td><td>0.140</td><td>1.000</td><td>1355</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>289</td><td>AUNG_GASTRIC_CANCER</td><td></td><td>40</td><td>-0.38</td><td>-1.40</td><td>0.050</td><td>0.141</td><td>1.000</td><td>1875</td><td>tags=38%, list=18%, signal=45%</td></tr><tr><td class='lessen'>290</td><td>JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN</td><td></td><td>221</td><td>-0.28</td><td>-1.39</td><td>0.005</td><td>0.147</td><td>1.000</td><td>919</td><td>tags=20%, list=9%, signal=21%</td></tr><tr><td class='lessen'>291</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN</td><td></td><td>50</td><td>-0.36</td><td>-1.39</td><td>0.057</td><td>0.150</td><td>1.000</td><td>2808</td><td>tags=44%, list=27%, signal=60%</td></tr><tr><td class='lessen'>292</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN</td><td></td><td>23</td><td>-0.43</td><td>-1.39</td><td>0.087</td><td>0.152</td><td>1.000</td><td>2338</td><td>tags=57%, list=22%, signal=73%</td></tr><tr><td class='lessen'>293</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN</td><td></td><td>24</td><td>-0.43</td><td>-1.39</td><td>0.080</td><td>0.152</td><td>1.000</td><td>1832</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>294</td><td>VANASSE_BCL2_TARGETS_DN</td><td></td><td>39</td><td>-0.38</td><td>-1.38</td><td>0.041</td><td>0.156</td><td>1.000</td><td>1784</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>295</td><td>SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP</td><td></td><td>42</td><td>-0.37</td><td>-1.38</td><td>0.063</td><td>0.156</td><td>1.000</td><td>2804</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>296</td><td>BRUINS_UVC_RESPONSE_MIDDLE</td><td></td><td>80</td><td>-0.32</td><td>-1.38</td><td>0.050</td><td>0.157</td><td>1.000</td><td>1733</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>297</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15</td><td></td><td>27</td><td>-0.42</td><td>-1.37</td><td>0.078</td><td>0.164</td><td>1.000</td><td>823</td><td>tags=33%, list=8%, signal=36%</td></tr><tr><td class='lessen'>298</td><td>MOOTHA_MITOCHONDRIA</td><td></td><td>385</td><td>-0.26</td><td>-1.37</td><td>0.003</td><td>0.169</td><td>1.000</td><td>3670</td><td>tags=46%, list=35%, signal=68%</td></tr><tr><td class='lessen'>299</td><td>HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER</td><td></td><td>45</td><td>-0.36</td><td>-1.36</td><td>0.080</td><td>0.172</td><td>1.000</td><td>1837</td><td>tags=36%, list=18%, signal=43%</td></tr><tr><td class='lessen'>300</td><td>MOOTHA_HUMAN_MITODB_6_2002</td><td></td><td>369</td><td>-0.26</td><td>-1.36</td><td>0.000</td><td>0.171</td><td>1.000</td><td>3670</td><td>tags=47%, list=35%, signal=69%</td></tr><tr><td class='lessen'>301</td><td>WONG_MITOCHONDRIA_GENE_MODULE</td><td></td><td>201</td><td>-0.27</td><td>-1.36</td><td>0.011</td><td>0.174</td><td>1.000</td><td>3531</td><td>tags=45%, list=34%, signal=66%</td></tr><tr><td class='lessen'>302</td><td>WANG_RECURRENT_LIVER_CANCER_UP</td><td></td><td>20</td><td>-0.43</td><td>-1.36</td><td>0.084</td><td>0.173</td><td>1.000</td><td>1891</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>303</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_DN</td><td></td><td>39</td><td>-0.37</td><td>-1.36</td><td>0.098</td><td>0.173</td><td>1.000</td><td>2506</td><td>tags=51%, list=24%, signal=67%</td></tr><tr><td class='lessen'>304</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_DN</td><td></td><td>197</td><td>-0.28</td><td>-1.36</td><td>0.016</td><td>0.173</td><td>1.000</td><td>2947</td><td>tags=40%, list=28%, signal=54%</td></tr><tr><td class='lessen'>305</td><td>RIZ_ERYTHROID_DIFFERENTIATION_CCNE1</td><td></td><td>37</td><td>-0.37</td><td>-1.36</td><td>0.081</td><td>0.175</td><td>1.000</td><td>2592</td><td>tags=43%, list=25%, signal=57%</td></tr><tr><td class='lessen'>306</td><td>GROSS_ELK3_TARGETS_DN</td><td></td><td>29</td><td>-0.39</td><td>-1.36</td><td>0.073</td><td>0.175</td><td>1.000</td><td>1660</td><td>tags=34%, list=16%, signal=41%</td></tr><tr><td class='lessen'>307</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_UP</td><td></td><td>192</td><td>-0.28</td><td>-1.36</td><td>0.016</td><td>0.175</td><td>1.000</td><td>1905</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>308</td><td>MATTIOLI_MGUS_VS_PCL</td><td></td><td>94</td><td>-0.32</td><td>-1.36</td><td>0.062</td><td>0.175</td><td>1.000</td><td>1105</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>309</td><td>SANSOM_APC_TARGETS_REQUIRE_MYC</td><td></td><td>197</td><td>-0.28</td><td>-1.35</td><td>0.014</td><td>0.176</td><td>1.000</td><td>1821</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>310</td><td>VALK_AML_CLUSTER_12</td><td></td><td>15</td><td>-0.48</td><td>-1.35</td><td>0.111</td><td>0.179</td><td>1.000</td><td>2479</td><td>tags=47%, list=24%, signal=61%</td></tr><tr><td class='lessen'>311</td><td>NATSUME_RESPONSE_TO_INTERFERON_BETA_UP</td><td></td><td>54</td><td>-0.34</td><td>-1.35</td><td>0.078</td><td>0.180</td><td>1.000</td><td>2030</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>312</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP</td><td></td><td>191</td><td>-0.28</td><td>-1.35</td><td>0.020</td><td>0.182</td><td>1.000</td><td>2166</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>313</td><td>JAZAG_TGFB1_SIGNALING_UP</td><td></td><td>75</td><td>-0.32</td><td>-1.35</td><td>0.047</td><td>0.182</td><td>1.000</td><td>1835</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>314</td><td>LI_DCP2_BOUND_MRNA</td><td></td><td>80</td><td>-0.32</td><td>-1.34</td><td>0.054</td><td>0.188</td><td>1.000</td><td>2945</td><td>tags=40%, list=28%, signal=55%</td></tr><tr><td class='lessen'>315</td><td>AMIT_EGF_RESPONSE_40_MCF10A</td><td></td><td>15</td><td>-0.46</td><td>-1.34</td><td>0.126</td><td>0.189</td><td>1.000</td><td>2856</td><td>tags=53%, list=27%, signal=73%</td></tr><tr><td class='lessen'>316</td><td>RAMASWAMY_METASTASIS_UP</td><td></td><td>57</td><td>-0.34</td><td>-1.34</td><td>0.054</td><td>0.189</td><td>1.000</td><td>3626</td><td>tags=53%, list=35%, signal=80%</td></tr><tr><td class='lessen'>317</td><td>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</td><td></td><td>47</td><td>-0.35</td><td>-1.34</td><td>0.084</td><td>0.191</td><td>1.000</td><td>1607</td><td>tags=34%, list=15%, signal=40%</td></tr><tr><td class='lessen'>318</td><td>BENPORATH_ES_1</td><td></td><td>292</td><td>-0.26</td><td>-1.33</td><td>0.009</td><td>0.195</td><td>1.000</td><td>2254</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>319</td><td>BILD_E2F3_ONCOGENIC_SIGNATURE</td><td></td><td>177</td><td>-0.28</td><td>-1.33</td><td>0.019</td><td>0.195</td><td>1.000</td><td>1642</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>320</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA1_UP</td><td></td><td>71</td><td>-0.32</td><td>-1.33</td><td>0.051</td><td>0.195</td><td>1.000</td><td>1197</td><td>tags=23%, list=11%, signal=25%</td></tr><tr><td class='lessen'>321</td><td>CHIARETTI_T_ALL_RELAPSE_PROGNOSIS</td><td></td><td>16</td><td>-0.46</td><td>-1.33</td><td>0.141</td><td>0.195</td><td>1.000</td><td>1778</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>322</td><td>LEE_DIFFERENTIATING_T_LYMPHOCYTE</td><td></td><td>130</td><td>-0.29</td><td>-1.33</td><td>0.026</td><td>0.195</td><td>1.000</td><td>2253</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>323</td><td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN</td><td></td><td>31</td><td>-0.38</td><td>-1.33</td><td>0.103</td><td>0.199</td><td>1.000</td><td>1335</td><td>tags=32%, list=13%, signal=37%</td></tr><tr><td class='lessen'>324</td><td>XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR</td><td></td><td>17</td><td>-0.45</td><td>-1.33</td><td>0.139</td><td>0.202</td><td>1.000</td><td>804</td><td>tags=29%, list=8%, signal=32%</td></tr><tr><td class='lessen'>325</td><td>KONDO_PROSTATE_CANCER_WITH_H3K27ME3</td><td></td><td>38</td><td>-0.37</td><td>-1.32</td><td>0.098</td><td>0.202</td><td>1.000</td><td>2061</td><td>tags=42%, list=20%, signal=52%</td></tr><tr><td class='lessen'>326</td><td>SANSOM_APC_TARGETS</td><td></td><td>171</td><td>-0.28</td><td>-1.32</td><td>0.024</td><td>0.203</td><td>1.000</td><td>1906</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>327</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN</td><td></td><td>25</td><td>-0.40</td><td>-1.32</td><td>0.106</td><td>0.202</td><td>1.000</td><td>1174</td><td>tags=32%, list=11%, signal=36%</td></tr><tr><td class='lessen'>328</td><td>BECKER_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>44</td><td>-0.35</td><td>-1.32</td><td>0.109</td><td>0.207</td><td>1.000</td><td>1479</td><td>tags=30%, list=14%, signal=34%</td></tr><tr><td class='lessen'>329</td><td>MODY_HIPPOCAMPUS_PRENATAL</td><td></td><td>41</td><td>-0.36</td><td>-1.32</td><td>0.098</td><td>0.207</td><td>1.000</td><td>1465</td><td>tags=29%, list=14%, signal=34%</td></tr><tr><td class='lessen'>330</td><td>KRIEG_KDM3A_TARGETS_NOT_HYPOXIA</td><td></td><td>166</td><td>-0.27</td><td>-1.31</td><td>0.016</td><td>0.212</td><td>1.000</td><td>1629</td><td>tags=25%, list=16%, signal=29%</td></tr><tr><td class='lessen'>331</td><td>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>204</td><td>-0.27</td><td>-1.31</td><td>0.011</td><td>0.214</td><td>1.000</td><td>1454</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>332</td><td>DIRMEIER_LMP1_RESPONSE_LATE_DN</td><td></td><td>24</td><td>-0.40</td><td>-1.31</td><td>0.138</td><td>0.217</td><td>1.000</td><td>1849</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>333</td><td>ZHAN_EARLY_DIFFERENTIATION_GENES_DN</td><td></td><td>33</td><td>-0.37</td><td>-1.31</td><td>0.111</td><td>0.217</td><td>1.000</td><td>2832</td><td>tags=39%, list=27%, signal=54%</td></tr><tr><td class='lessen'>334</td><td>PLASARI_TGFB1_TARGETS_10HR_DN</td><td></td><td>159</td><td>-0.28</td><td>-1.31</td><td>0.032</td><td>0.219</td><td>1.000</td><td>1531</td><td>tags=25%, list=15%, signal=28%</td></tr><tr><td class='lessen'>335</td><td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP</td><td></td><td>56</td><td>-0.33</td><td>-1.31</td><td>0.068</td><td>0.220</td><td>1.000</td><td>1464</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>336</td><td>VERHAAK_AML_WITH_NPM1_MUTATED_UP</td><td></td><td>100</td><td>-0.29</td><td>-1.31</td><td>0.044</td><td>0.219</td><td>1.000</td><td>638</td><td>tags=15%, list=6%, signal=16%</td></tr><tr><td class='lessen'>337</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3</td><td></td><td>425</td><td>-0.24</td><td>-1.30</td><td>0.006</td><td>0.223</td><td>1.000</td><td>1867</td><td>tags=25%, list=18%, signal=29%</td></tr><tr><td class='lessen'>338</td><td>HOEBEKE_LYMPHOID_STEM_CELL_DN</td><td></td><td>74</td><td>-0.31</td><td>-1.30</td><td>0.091</td><td>0.223</td><td>1.000</td><td>392</td><td>tags=11%, list=4%, signal=11%</td></tr><tr><td class='lessen'>339</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_B</td><td></td><td>41</td><td>-0.35</td><td>-1.30</td><td>0.098</td><td>0.227</td><td>1.000</td><td>1977</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>340</td><td>WATANABE_COLON_CANCER_MSI_VS_MSS_UP</td><td></td><td>17</td><td>-0.44</td><td>-1.30</td><td>0.164</td><td>0.229</td><td>1.000</td><td>1080</td><td>tags=35%, list=10%, signal=39%</td></tr><tr><td class='lessen'>341</td><td>HOELZEL_NF1_TARGETS_DN</td><td></td><td>51</td><td>-0.33</td><td>-1.29</td><td>0.098</td><td>0.231</td><td>1.000</td><td>1484</td><td>tags=25%, list=14%, signal=30%</td></tr><tr><td class='lessen'>342</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP</td><td></td><td>105</td><td>-0.29</td><td>-1.29</td><td>0.058</td><td>0.232</td><td>1.000</td><td>2453</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>343</td><td>EPPERT_PROGENITOR</td><td></td><td>125</td><td>-0.28</td><td>-1.29</td><td>0.034</td><td>0.234</td><td>1.000</td><td>2322</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>344</td><td>ZWANG_DOWN_BY_2ND_EGF_PULSE</td><td></td><td>125</td><td>-0.29</td><td>-1.29</td><td>0.063</td><td>0.233</td><td>1.000</td><td>2577</td><td>tags=34%, list=25%, signal=45%</td></tr><tr><td class='lessen'>345</td><td>NEMETH_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>78</td><td>-0.30</td><td>-1.29</td><td>0.091</td><td>0.234</td><td>1.000</td><td>1668</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>346</td><td>SANSOM_APC_TARGETS_UP</td><td></td><td>116</td><td>-0.29</td><td>-1.29</td><td>0.046</td><td>0.236</td><td>1.000</td><td>2491</td><td>tags=43%, list=24%, signal=56%</td></tr><tr><td class='lessen'>347</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN</td><td></td><td>15</td><td>-0.45</td><td>-1.29</td><td>0.159</td><td>0.236</td><td>1.000</td><td>1308</td><td>tags=40%, list=12%, signal=46%</td></tr><tr><td class='lessen'>348</td><td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP</td><td></td><td>15</td><td>-0.45</td><td>-1.29</td><td>0.179</td><td>0.236</td><td>1.000</td><td>2382</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>349</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN</td><td></td><td>177</td><td>-0.27</td><td>-1.29</td><td>0.033</td><td>0.236</td><td>1.000</td><td>1740</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>350</td><td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td><td></td><td>109</td><td>-0.29</td><td>-1.29</td><td>0.061</td><td>0.236</td><td>1.000</td><td>3309</td><td>tags=45%, list=32%, signal=65%</td></tr><tr><td class='lessen'>351</td><td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP</td><td></td><td>43</td><td>-0.34</td><td>-1.29</td><td>0.096</td><td>0.235</td><td>1.000</td><td>1952</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>352</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</td><td></td><td>59</td><td>-0.33</td><td>-1.29</td><td>0.081</td><td>0.237</td><td>1.000</td><td>1825</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>353</td><td>LIU_COMMON_CANCER_GENES</td><td></td><td>52</td><td>-0.33</td><td>-1.28</td><td>0.090</td><td>0.238</td><td>1.000</td><td>1426</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>354</td><td>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP</td><td></td><td>18</td><td>-0.43</td><td>-1.28</td><td>0.158</td><td>0.238</td><td>1.000</td><td>1140</td><td>tags=39%, list=11%, signal=44%</td></tr><tr><td class='lessen'>355</td><td>MARTIN_VIRAL_GPCR_SIGNALING_DN</td><td></td><td>33</td><td>-0.36</td><td>-1.28</td><td>0.139</td><td>0.240</td><td>1.000</td><td>1056</td><td>tags=21%, list=10%, signal=24%</td></tr><tr><td class='lessen'>356</td><td>ZHU_CMV_8_HR_DN</td><td></td><td>41</td><td>-0.34</td><td>-1.28</td><td>0.119</td><td>0.242</td><td>1.000</td><td>1720</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>357</td><td>GREENBAUM_E2A_TARGETS_DN</td><td></td><td>18</td><td>-0.42</td><td>-1.28</td><td>0.157</td><td>0.241</td><td>1.000</td><td>2088</td><td>tags=44%, list=20%, signal=55%</td></tr><tr><td class='lessen'>358</td><td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP</td><td></td><td>74</td><td>-0.31</td><td>-1.28</td><td>0.079</td><td>0.242</td><td>1.000</td><td>2614</td><td>tags=32%, list=25%, signal=43%</td></tr><tr><td class='lessen'>359</td><td>JAZAG_TGFB1_SIGNALING_DN</td><td></td><td>21</td><td>-0.42</td><td>-1.28</td><td>0.151</td><td>0.242</td><td>1.000</td><td>1442</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>360</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</td><td></td><td>87</td><td>-0.30</td><td>-1.28</td><td>0.094</td><td>0.241</td><td>1.000</td><td>3178</td><td>tags=44%, list=30%, signal=62%</td></tr><tr><td class='lessen'>361</td><td>NADLER_OBESITY_DN</td><td></td><td>41</td><td>-0.34</td><td>-1.28</td><td>0.090</td><td>0.241</td><td>1.000</td><td>1601</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>362</td><td>HEIDENBLAD_AMPLICON_12P11_12_UP</td><td></td><td>27</td><td>-0.39</td><td>-1.27</td><td>0.126</td><td>0.247</td><td>1.000</td><td>1698</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>363</td><td>PRAMOONJAGO_SOX4_TARGETS_DN</td><td></td><td>42</td><td>-0.34</td><td>-1.27</td><td>0.131</td><td>0.250</td><td>1.000</td><td>2498</td><td>tags=43%, list=24%, signal=56%</td></tr><tr><td class='lessen'>364</td><td>GENTILE_RESPONSE_CLUSTER_D3</td><td></td><td>49</td><td>-0.33</td><td>-1.27</td><td>0.139</td><td>0.251</td><td>1.000</td><td>1496</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>365</td><td>SMIRNOV_RESPONSE_TO_IR_6HR_DN</td><td></td><td>87</td><td>-0.29</td><td>-1.27</td><td>0.081</td><td>0.251</td><td>1.000</td><td>1376</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>366</td><td>MAYBURD_RESPONSE_TO_L663536_UP</td><td></td><td>23</td><td>-0.39</td><td>-1.27</td><td>0.167</td><td>0.253</td><td>1.000</td><td>2698</td><td>tags=39%, list=26%, signal=53%</td></tr><tr><td class='lessen'>367</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</td><td></td><td>91</td><td>-0.29</td><td>-1.26</td><td>0.075</td><td>0.264</td><td>1.000</td><td>890</td><td>tags=23%, list=8%, signal=25%</td></tr><tr><td class='lessen'>368</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</td><td></td><td>252</td><td>-0.25</td><td>-1.26</td><td>0.061</td><td>0.264</td><td>1.000</td><td>1034</td><td>tags=16%, list=10%, signal=17%</td></tr><tr><td class='lessen'>369</td><td>PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP</td><td></td><td>64</td><td>-0.31</td><td>-1.26</td><td>0.106</td><td>0.265</td><td>1.000</td><td>1029</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>370</td><td>WARTERS_IR_RESPONSE_5GY</td><td></td><td>35</td><td>-0.35</td><td>-1.26</td><td>0.121</td><td>0.265</td><td>1.000</td><td>1746</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>371</td><td>CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY</td><td></td><td>20</td><td>-0.40</td><td>-1.26</td><td>0.163</td><td>0.265</td><td>1.000</td><td>1057</td><td>tags=30%, list=10%, signal=33%</td></tr><tr><td class='lessen'>372</td><td>GRADE_COLON_AND_RECTAL_CANCER_UP</td><td></td><td>276</td><td>-0.24</td><td>-1.26</td><td>0.015</td><td>0.266</td><td>1.000</td><td>2355</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>373</td><td>TOMLINS_METASTASIS_DN</td><td></td><td>17</td><td>-0.42</td><td>-1.26</td><td>0.169</td><td>0.266</td><td>1.000</td><td>1596</td><td>tags=35%, list=15%, signal=42%</td></tr><tr><td class='lessen'>374</td><td>LIU_NASOPHARYNGEAL_CARCINOMA</td><td></td><td>54</td><td>-0.31</td><td>-1.25</td><td>0.113</td><td>0.267</td><td>1.000</td><td>2644</td><td>tags=39%, list=25%, signal=52%</td></tr><tr><td class='lessen'>375</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP</td><td></td><td>28</td><td>-0.37</td><td>-1.25</td><td>0.160</td><td>0.269</td><td>1.000</td><td>795</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>376</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP</td><td></td><td>60</td><td>-0.31</td><td>-1.25</td><td>0.087</td><td>0.270</td><td>1.000</td><td>2309</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>377</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>37</td><td>-0.34</td><td>-1.25</td><td>0.123</td><td>0.272</td><td>1.000</td><td>1379</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>378</td><td>WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC</td><td></td><td>18</td><td>-0.41</td><td>-1.25</td><td>0.181</td><td>0.273</td><td>1.000</td><td>1957</td><td>tags=44%, list=19%, signal=55%</td></tr><tr><td class='lessen'>379</td><td>MIKKELSEN_IPS_LCP_WITH_H3K4ME3</td><td></td><td>84</td><td>-0.29</td><td>-1.25</td><td>0.089</td><td>0.273</td><td>1.000</td><td>2153</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>380</td><td>KRASNOSELSKAYA_ILF3_TARGETS_UP</td><td></td><td>26</td><td>-0.38</td><td>-1.25</td><td>0.162</td><td>0.274</td><td>1.000</td><td>1838</td><td>tags=50%, list=18%, signal=60%</td></tr><tr><td class='lessen'>381</td><td>JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN</td><td></td><td>190</td><td>-0.26</td><td>-1.25</td><td>0.051</td><td>0.274</td><td>1.000</td><td>2129</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>382</td><td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>34</td><td>-0.35</td><td>-1.25</td><td>0.163</td><td>0.274</td><td>1.000</td><td>2192</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>383</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP</td><td></td><td>24</td><td>-0.37</td><td>-1.24</td><td>0.198</td><td>0.277</td><td>1.000</td><td>1363</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>384</td><td>CAFFAREL_RESPONSE_TO_THC_UP</td><td></td><td>28</td><td>-0.36</td><td>-1.24</td><td>0.186</td><td>0.280</td><td>1.000</td><td>2325</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>385</td><td>SCIBETTA_KDM5B_TARGETS_DN</td><td></td><td>70</td><td>-0.30</td><td>-1.24</td><td>0.099</td><td>0.280</td><td>1.000</td><td>1881</td><td>tags=34%, list=18%, signal=41%</td></tr><tr><td class='lessen'>386</td><td>HOWLIN_CITED1_TARGETS_1_UP</td><td></td><td>21</td><td>-0.40</td><td>-1.24</td><td>0.173</td><td>0.280</td><td>1.000</td><td>2991</td><td>tags=43%, list=29%, signal=60%</td></tr><tr><td class='lessen'>387</td><td>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</td><td></td><td>58</td><td>-0.31</td><td>-1.24</td><td>0.130</td><td>0.280</td><td>1.000</td><td>1601</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>388</td><td>YIH_RESPONSE_TO_ARSENITE_C1</td><td></td><td>19</td><td>-0.41</td><td>-1.24</td><td>0.197</td><td>0.279</td><td>1.000</td><td>1824</td><td>tags=37%, list=17%, signal=45%</td></tr><tr><td class='lessen'>389</td><td>BROWNE_HCMV_INFECTION_12HR_UP</td><td></td><td>80</td><td>-0.29</td><td>-1.24</td><td>0.110</td><td>0.281</td><td>1.000</td><td>1245</td><td>tags=23%, list=12%, signal=25%</td></tr><tr><td class='lessen'>390</td><td>DOANE_BREAST_CANCER_ESR1_UP</td><td></td><td>64</td><td>-0.30</td><td>-1.24</td><td>0.135</td><td>0.286</td><td>1.000</td><td>469</td><td>tags=14%, list=4%, signal=15%</td></tr><tr><td class='lessen'>391</td><td>JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN</td><td></td><td>258</td><td>-0.24</td><td>-1.24</td><td>0.037</td><td>0.286</td><td>1.000</td><td>1225</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>392</td><td>TRAYNOR_RETT_SYNDROM_UP</td><td></td><td>20</td><td>-0.40</td><td>-1.24</td><td>0.173</td><td>0.285</td><td>1.000</td><td>1705</td><td>tags=40%, list=16%, signal=48%</td></tr><tr><td class='lessen'>393</td><td>MATZUK_SPERMATOCYTE</td><td></td><td>42</td><td>-0.33</td><td>-1.24</td><td>0.152</td><td>0.285</td><td>1.000</td><td>1896</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>394</td><td>HAN_JNK_SINGALING_UP</td><td></td><td>32</td><td>-0.35</td><td>-1.23</td><td>0.165</td><td>0.286</td><td>1.000</td><td>1058</td><td>tags=28%, list=10%, signal=31%</td></tr><tr><td class='lessen'>395</td><td>SANSOM_WNT_PATHWAY_REQUIRE_MYC</td><td></td><td>56</td><td>-0.32</td><td>-1.23</td><td>0.142</td><td>0.285</td><td>1.000</td><td>2896</td><td>tags=52%, list=28%, signal=71%</td></tr><tr><td class='lessen'>396</td><td>PROVENZANI_METASTASIS_UP</td><td></td><td>164</td><td>-0.26</td><td>-1.23</td><td>0.083</td><td>0.290</td><td>1.000</td><td>2091</td><td>tags=29%, list=20%, signal=35%</td></tr><tr><td class='lessen'>397</td><td>CUI_GLUCOSE_DEPRIVATION</td><td></td><td>47</td><td>-0.32</td><td>-1.23</td><td>0.130</td><td>0.291</td><td>1.000</td><td>2300</td><td>tags=38%, list=22%, signal=49%</td></tr><tr><td class='lessen'>398</td><td>MIKKELSEN_MEF_ICP_WITH_H3K27ME3</td><td></td><td>42</td><td>-0.33</td><td>-1.23</td><td>0.164</td><td>0.292</td><td>1.000</td><td>1011</td><td>tags=26%, list=10%, signal=29%</td></tr><tr><td class='lessen'>399</td><td>BHATTACHARYA_EMBRYONIC_STEM_CELL</td><td></td><td>65</td><td>-0.30</td><td>-1.23</td><td>0.133</td><td>0.292</td><td>1.000</td><td>2041</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>400</td><td>BEIER_GLIOMA_STEM_CELL_DN</td><td></td><td>48</td><td>-0.32</td><td>-1.23</td><td>0.135</td><td>0.292</td><td>1.000</td><td>1568</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>401</td><td>MORI_LARGE_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>42</td><td>-0.33</td><td>-1.23</td><td>0.149</td><td>0.292</td><td>1.000</td><td>701</td><td>tags=21%, list=7%, signal=23%</td></tr><tr><td class='lessen'>402</td><td>KRASNOSELSKAYA_ILF3_TARGETS_DN</td><td></td><td>32</td><td>-0.35</td><td>-1.23</td><td>0.163</td><td>0.294</td><td>1.000</td><td>2340</td><td>tags=47%, list=22%, signal=60%</td></tr><tr><td class='lessen'>403</td><td>MATZUK_MALE_REPRODUCTION_SERTOLI</td><td></td><td>16</td><td>-0.42</td><td>-1.22</td><td>0.233</td><td>0.294</td><td>1.000</td><td>73</td><td>tags=13%, list=1%, signal=13%</td></tr><tr><td class='lessen'>404</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN</td><td></td><td>264</td><td>-0.24</td><td>-1.22</td><td>0.059</td><td>0.294</td><td>1.000</td><td>2888</td><td>tags=34%, list=28%, signal=46%</td></tr><tr><td class='lessen'>405</td><td>MARKS_HDAC_TARGETS_UP</td><td></td><td>18</td><td>-0.40</td><td>-1.22</td><td>0.188</td><td>0.297</td><td>1.000</td><td>1994</td><td>tags=50%, list=19%, signal=62%</td></tr><tr><td class='lessen'>406</td><td>BROWNE_HCMV_INFECTION_18HR_UP</td><td></td><td>132</td><td>-0.27</td><td>-1.22</td><td>0.095</td><td>0.298</td><td>1.000</td><td>1967</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>407</td><td>MALONEY_RESPONSE_TO_17AAG_DN</td><td></td><td>71</td><td>-0.29</td><td>-1.22</td><td>0.130</td><td>0.297</td><td>1.000</td><td>3115</td><td>tags=35%, list=30%, signal=50%</td></tr><tr><td class='lessen'>408</td><td>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN</td><td></td><td>41</td><td>-0.33</td><td>-1.22</td><td>0.161</td><td>0.296</td><td>1.000</td><td>2736</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>409</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN</td><td></td><td>153</td><td>-0.26</td><td>-1.22</td><td>0.060</td><td>0.297</td><td>1.000</td><td>3155</td><td>tags=34%, list=30%, signal=48%</td></tr><tr><td class='lessen'>410</td><td>BROWNE_HCMV_INFECTION_6HR_UP</td><td></td><td>41</td><td>-0.33</td><td>-1.22</td><td>0.169</td><td>0.299</td><td>1.000</td><td>1391</td><td>tags=29%, list=13%, signal=34%</td></tr><tr><td class='lessen'>411</td><td>BEIER_GLIOMA_STEM_CELL_UP</td><td></td><td>22</td><td>-0.38</td><td>-1.22</td><td>0.221</td><td>0.301</td><td>1.000</td><td>1877</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>412</td><td>CHEN_HOXA5_TARGETS_9HR_DN</td><td></td><td>35</td><td>-0.33</td><td>-1.21</td><td>0.139</td><td>0.306</td><td>1.000</td><td>1384</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>413</td><td>HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP</td><td></td><td>21</td><td>-0.39</td><td>-1.21</td><td>0.212</td><td>0.308</td><td>1.000</td><td>2893</td><td>tags=43%, list=28%, signal=59%</td></tr><tr><td class='lessen'>414</td><td>LIU_PROSTATE_CANCER_UP</td><td></td><td>78</td><td>-0.29</td><td>-1.21</td><td>0.138</td><td>0.316</td><td>1.000</td><td>1256</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>415</td><td>MEISSNER_NPC_ICP_WITH_H3K4ME3</td><td></td><td>15</td><td>-0.43</td><td>-1.21</td><td>0.223</td><td>0.317</td><td>1.000</td><td>3371</td><td>tags=60%, list=32%, signal=88%</td></tr><tr><td class='lessen'>416</td><td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN</td><td></td><td>19</td><td>-0.39</td><td>-1.21</td><td>0.221</td><td>0.319</td><td>1.000</td><td>3492</td><td>tags=47%, list=33%, signal=71%</td></tr><tr><td class='lessen'>417</td><td>CROMER_METASTASIS_UP</td><td></td><td>57</td><td>-0.30</td><td>-1.21</td><td>0.174</td><td>0.318</td><td>1.000</td><td>1160</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>418</td><td>YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN</td><td></td><td>43</td><td>-0.32</td><td>-1.20</td><td>0.181</td><td>0.318</td><td>1.000</td><td>1040</td><td>tags=21%, list=10%, signal=23%</td></tr><tr><td class='lessen'>419</td><td>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP</td><td></td><td>238</td><td>-0.24</td><td>-1.20</td><td>0.059</td><td>0.325</td><td>1.000</td><td>2522</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>420</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_DN</td><td></td><td>43</td><td>-0.32</td><td>-1.20</td><td>0.167</td><td>0.327</td><td>1.000</td><td>3086</td><td>tags=42%, list=29%, signal=59%</td></tr><tr><td class='lessen'>421</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_DN</td><td></td><td>20</td><td>-0.39</td><td>-1.20</td><td>0.207</td><td>0.330</td><td>1.000</td><td>2261</td><td>tags=45%, list=22%, signal=57%</td></tr><tr><td class='lessen'>422</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN</td><td></td><td>40</td><td>-0.32</td><td>-1.20</td><td>0.159</td><td>0.331</td><td>1.000</td><td>1577</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>423</td><td>KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION</td><td></td><td>18</td><td>-0.40</td><td>-1.19</td><td>0.239</td><td>0.332</td><td>1.000</td><td>4021</td><td>tags=61%, list=38%, signal=99%</td></tr><tr><td class='lessen'>424</td><td>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP</td><td></td><td>33</td><td>-0.34</td><td>-1.19</td><td>0.185</td><td>0.336</td><td>1.000</td><td>2429</td><td>tags=42%, list=23%, signal=55%</td></tr><tr><td class='lessen'>425</td><td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN</td><td></td><td>68</td><td>-0.29</td><td>-1.19</td><td>0.169</td><td>0.336</td><td>1.000</td><td>3358</td><td>tags=38%, list=32%, signal=56%</td></tr><tr><td class='lessen'>426</td><td>NEWMAN_ERCC6_TARGETS_DN</td><td></td><td>15</td><td>-0.42</td><td>-1.19</td><td>0.217</td><td>0.337</td><td>1.000</td><td>509</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>427</td><td>KORKOLA_TERATOMA</td><td></td><td>32</td><td>-0.35</td><td>-1.19</td><td>0.203</td><td>0.337</td><td>1.000</td><td>2261</td><td>tags=50%, list=22%, signal=64%</td></tr><tr><td class='lessen'>428</td><td>ELLWOOD_MYC_TARGETS_DN</td><td></td><td>38</td><td>-0.32</td><td>-1.19</td><td>0.192</td><td>0.341</td><td>1.000</td><td>940</td><td>tags=24%, list=9%, signal=26%</td></tr><tr><td class='lessen'>429</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN</td><td></td><td>209</td><td>-0.24</td><td>-1.19</td><td>0.089</td><td>0.341</td><td>1.000</td><td>1668</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>430</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</td><td></td><td>295</td><td>-0.23</td><td>-1.19</td><td>0.062</td><td>0.341</td><td>1.000</td><td>2617</td><td>tags=34%, list=25%, signal=44%</td></tr><tr><td class='lessen'>431</td><td>WANG_SMARCE1_TARGETS_DN</td><td></td><td>278</td><td>-0.23</td><td>-1.19</td><td>0.057</td><td>0.342</td><td>1.000</td><td>1146</td><td>tags=16%, list=11%, signal=17%</td></tr><tr><td class='lessen'>432</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN</td><td></td><td>61</td><td>-0.29</td><td>-1.18</td><td>0.167</td><td>0.344</td><td>1.000</td><td>1373</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>433</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP</td><td></td><td>229</td><td>-0.24</td><td>-1.18</td><td>0.087</td><td>0.345</td><td>1.000</td><td>2018</td><td>tags=31%, list=19%, signal=37%</td></tr><tr><td class='lessen'>434</td><td>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP</td><td></td><td>28</td><td>-0.35</td><td>-1.18</td><td>0.208</td><td>0.344</td><td>1.000</td><td>1476</td><td>tags=21%, list=14%, signal=25%</td></tr><tr><td class='lessen'>435</td><td>VILIMAS_NOTCH1_TARGETS_UP</td><td></td><td>22</td><td>-0.36</td><td>-1.18</td><td>0.242</td><td>0.347</td><td>1.000</td><td>2310</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>436</td><td>CAIRO_LIVER_DEVELOPMENT_DN</td><td></td><td>134</td><td>-0.26</td><td>-1.18</td><td>0.113</td><td>0.346</td><td>1.000</td><td>1770</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>437</td><td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP</td><td></td><td>89</td><td>-0.27</td><td>-1.18</td><td>0.134</td><td>0.347</td><td>1.000</td><td>2379</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>438</td><td>WEST_ADRENOCORTICAL_TUMOR_UP</td><td></td><td>267</td><td>-0.23</td><td>-1.18</td><td>0.083</td><td>0.354</td><td>1.000</td><td>2390</td><td>tags=31%, list=23%, signal=39%</td></tr><tr><td class='lessen'>439</td><td>MIKKELSEN_IPS_WITH_HCP_H3K27ME3</td><td></td><td>18</td><td>-0.38</td><td>-1.18</td><td>0.268</td><td>0.356</td><td>1.000</td><td>1671</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>440</td><td>CHUNG_BLISTER_CYTOTOXICITY_UP</td><td></td><td>104</td><td>-0.26</td><td>-1.17</td><td>0.172</td><td>0.357</td><td>1.000</td><td>2573</td><td>tags=32%, list=25%, signal=42%</td></tr><tr><td class='lessen'>441</td><td>CASTELLANO_NRAS_TARGETS_UP</td><td></td><td>55</td><td>-0.30</td><td>-1.17</td><td>0.175</td><td>0.357</td><td>1.000</td><td>2030</td><td>tags=38%, list=19%, signal=47%</td></tr><tr><td class='lessen'>442</td><td>BURTON_ADIPOGENESIS_12</td><td></td><td>30</td><td>-0.34</td><td>-1.17</td><td>0.220</td><td>0.363</td><td>1.000</td><td>3280</td><td>tags=50%, list=31%, signal=73%</td></tr><tr><td class='lessen'>443</td><td>CADWELL_ATG16L1_TARGETS_UP</td><td></td><td>50</td><td>-0.30</td><td>-1.17</td><td>0.206</td><td>0.363</td><td>1.000</td><td>1429</td><td>tags=26%, list=14%, signal=30%</td></tr><tr><td class='lessen'>444</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN</td><td></td><td>81</td><td>-0.27</td><td>-1.17</td><td>0.166</td><td>0.366</td><td>1.000</td><td>2053</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>445</td><td>PARK_HSC_MARKERS</td><td></td><td>37</td><td>-0.32</td><td>-1.17</td><td>0.242</td><td>0.368</td><td>1.000</td><td>3331</td><td>tags=51%, list=32%, signal=75%</td></tr><tr><td class='lessen'>446</td><td>LEE_CALORIE_RESTRICTION_MUSCLE_UP</td><td></td><td>29</td><td>-0.33</td><td>-1.17</td><td>0.204</td><td>0.370</td><td>1.000</td><td>1372</td><td>tags=31%, list=13%, signal=36%</td></tr><tr><td class='lessen'>447</td><td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN</td><td></td><td>36</td><td>-0.32</td><td>-1.16</td><td>0.243</td><td>0.372</td><td>1.000</td><td>1949</td><td>tags=31%, list=19%, signal=37%</td></tr><tr><td class='lessen'>448</td><td>NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON</td><td></td><td>27</td><td>-0.35</td><td>-1.16</td><td>0.246</td><td>0.374</td><td>1.000</td><td>2498</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>449</td><td>MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP</td><td></td><td>16</td><td>-0.40</td><td>-1.16</td><td>0.259</td><td>0.373</td><td>1.000</td><td>2127</td><td>tags=44%, list=20%, signal=55%</td></tr><tr><td class='lessen'>450</td><td>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP</td><td></td><td>21</td><td>-0.37</td><td>-1.16</td><td>0.248</td><td>0.374</td><td>1.000</td><td>1479</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>451</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13</td><td></td><td>164</td><td>-0.24</td><td>-1.16</td><td>0.117</td><td>0.375</td><td>1.000</td><td>3528</td><td>tags=43%, list=34%, signal=63%</td></tr><tr><td class='lessen'>452</td><td>LIM_MAMMARY_LUMINAL_MATURE_UP</td><td></td><td>83</td><td>-0.27</td><td>-1.16</td><td>0.194</td><td>0.375</td><td>1.000</td><td>1784</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>453</td><td>LEE_AGING_CEREBELLUM_UP</td><td></td><td>67</td><td>-0.28</td><td>-1.16</td><td>0.220</td><td>0.375</td><td>1.000</td><td>1963</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>454</td><td>MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER</td><td></td><td>16</td><td>-0.39</td><td>-1.16</td><td>0.269</td><td>0.376</td><td>1.000</td><td>1607</td><td>tags=31%, list=15%, signal=37%</td></tr><tr><td class='lessen'>455</td><td>ZHAN_MULTIPLE_MYELOMA_HP_DN</td><td></td><td>39</td><td>-0.32</td><td>-1.16</td><td>0.231</td><td>0.377</td><td>1.000</td><td>1401</td><td>tags=26%, list=13%, signal=29%</td></tr><tr><td class='lessen'>456</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN</td><td></td><td>36</td><td>-0.32</td><td>-1.15</td><td>0.258</td><td>0.391</td><td>1.000</td><td>942</td><td>tags=25%, list=9%, signal=27%</td></tr><tr><td class='lessen'>457</td><td>MARZEC_IL2_SIGNALING_DN</td><td></td><td>30</td><td>-0.33</td><td>-1.15</td><td>0.233</td><td>0.392</td><td>1.000</td><td>1787</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>458</td><td>KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3</td><td></td><td>49</td><td>-0.30</td><td>-1.15</td><td>0.208</td><td>0.393</td><td>1.000</td><td>3229</td><td>tags=49%, list=31%, signal=70%</td></tr><tr><td class='lessen'>459</td><td>BARRIER_COLON_CANCER_RECURRENCE_DN</td><td></td><td>16</td><td>-0.39</td><td>-1.15</td><td>0.297</td><td>0.393</td><td>1.000</td><td>677</td><td>tags=25%, list=6%, signal=27%</td></tr><tr><td class='lessen'>460</td><td>ABE_VEGFA_TARGETS_30MIN</td><td></td><td>18</td><td>-0.38</td><td>-1.15</td><td>0.247</td><td>0.399</td><td>1.000</td><td>1461</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>461</td><td>PETROVA_PROX1_TARGETS_UP</td><td></td><td>20</td><td>-0.36</td><td>-1.14</td><td>0.286</td><td>0.404</td><td>1.000</td><td>1251</td><td>tags=35%, list=12%, signal=40%</td></tr><tr><td class='lessen'>462</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN</td><td></td><td>202</td><td>-0.23</td><td>-1.14</td><td>0.148</td><td>0.408</td><td>1.000</td><td>2898</td><td>tags=35%, list=28%, signal=48%</td></tr><tr><td class='lessen'>463</td><td>BARRIER_COLON_CANCER_RECURRENCE_UP</td><td></td><td>36</td><td>-0.32</td><td>-1.14</td><td>0.265</td><td>0.409</td><td>1.000</td><td>1918</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>464</td><td>BROWNE_HCMV_INFECTION_48HR_UP</td><td></td><td>132</td><td>-0.24</td><td>-1.14</td><td>0.188</td><td>0.409</td><td>1.000</td><td>2656</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>465</td><td>RODWELL_AGING_KIDNEY_UP</td><td></td><td>341</td><td>-0.22</td><td>-1.14</td><td>0.106</td><td>0.409</td><td>1.000</td><td>1601</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>466</td><td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</td><td></td><td>56</td><td>-0.29</td><td>-1.14</td><td>0.229</td><td>0.410</td><td>1.000</td><td>778</td><td>tags=16%, list=7%, signal=17%</td></tr><tr><td class='lessen'>467</td><td>IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR</td><td></td><td>119</td><td>-0.25</td><td>-1.14</td><td>0.185</td><td>0.412</td><td>1.000</td><td>1743</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>468</td><td>YU_BAP1_TARGETS</td><td></td><td>26</td><td>-0.35</td><td>-1.13</td><td>0.282</td><td>0.418</td><td>1.000</td><td>2986</td><td>tags=50%, list=28%, signal=70%</td></tr><tr><td class='lessen'>469</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_5_UP</td><td></td><td>29</td><td>-0.33</td><td>-1.13</td><td>0.259</td><td>0.419</td><td>1.000</td><td>1567</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>470</td><td>WOOD_EBV_EBNA1_TARGETS_UP</td><td></td><td>84</td><td>-0.26</td><td>-1.13</td><td>0.208</td><td>0.418</td><td>1.000</td><td>991</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>471</td><td>IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR</td><td></td><td>359</td><td>-0.22</td><td>-1.13</td><td>0.102</td><td>0.419</td><td>1.000</td><td>2389</td><td>tags=25%, list=23%, signal=31%</td></tr><tr><td class='lessen'>472</td><td>ZHAN_MULTIPLE_MYELOMA_DN</td><td></td><td>24</td><td>-0.34</td><td>-1.13</td><td>0.260</td><td>0.420</td><td>1.000</td><td>548</td><td>tags=21%, list=5%, signal=22%</td></tr><tr><td class='lessen'>473</td><td>JISON_SICKLE_CELL_DISEASE_UP</td><td></td><td>137</td><td>-0.24</td><td>-1.13</td><td>0.206</td><td>0.423</td><td>1.000</td><td>890</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>474</td><td>MOHANKUMAR_HOXA1_TARGETS_UP</td><td></td><td>340</td><td>-0.22</td><td>-1.13</td><td>0.115</td><td>0.424</td><td>1.000</td><td>1582</td><td>tags=20%, list=15%, signal=22%</td></tr><tr><td class='lessen'>475</td><td>DELASERNA_MYOD_TARGETS_DN</td><td></td><td>50</td><td>-0.29</td><td>-1.13</td><td>0.273</td><td>0.425</td><td>1.000</td><td>982</td><td>tags=22%, list=9%, signal=24%</td></tr><tr><td class='lessen'>476</td><td>OUILLETTE_CLL_13Q14_DELETION_UP</td><td></td><td>54</td><td>-0.29</td><td>-1.13</td><td>0.267</td><td>0.428</td><td>1.000</td><td>2561</td><td>tags=37%, list=24%, signal=49%</td></tr><tr><td class='lessen'>477</td><td>SESTO_RESPONSE_TO_UV_C7</td><td></td><td>58</td><td>-0.28</td><td>-1.12</td><td>0.257</td><td>0.431</td><td>1.000</td><td>481</td><td>tags=16%, list=5%, signal=16%</td></tr><tr><td class='lessen'>478</td><td>VALK_AML_CLUSTER_6</td><td></td><td>23</td><td>-0.35</td><td>-1.12</td><td>0.323</td><td>0.436</td><td>1.000</td><td>588</td><td>tags=22%, list=6%, signal=23%</td></tr><tr><td class='lessen'>479</td><td>RICKMAN_METASTASIS_UP</td><td></td><td>245</td><td>-0.22</td><td>-1.12</td><td>0.151</td><td>0.436</td><td>1.000</td><td>2431</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>480</td><td>WOTTON_RUNX_TARGETS_DN</td><td></td><td>22</td><td>-0.35</td><td>-1.12</td><td>0.303</td><td>0.436</td><td>1.000</td><td>1890</td><td>tags=41%, list=18%, signal=50%</td></tr><tr><td class='lessen'>481</td><td>LEE_LIVER_CANCER_MYC_E2F1_DN</td><td></td><td>32</td><td>-0.32</td><td>-1.12</td><td>0.245</td><td>0.435</td><td>1.000</td><td>1557</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>482</td><td>BROWNE_HCMV_INFECTION_4HR_UP</td><td></td><td>34</td><td>-0.32</td><td>-1.12</td><td>0.282</td><td>0.437</td><td>1.000</td><td>890</td><td>tags=21%, list=8%, signal=22%</td></tr><tr><td class='lessen'>483</td><td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN</td><td></td><td>59</td><td>-0.28</td><td>-1.12</td><td>0.263</td><td>0.437</td><td>1.000</td><td>2453</td><td>tags=39%, list=23%, signal=51%</td></tr><tr><td class='lessen'>484</td><td>KAAB_FAILED_HEART_ATRIUM_UP</td><td></td><td>21</td><td>-0.35</td><td>-1.12</td><td>0.287</td><td>0.441</td><td>1.000</td><td>284</td><td>tags=10%, list=3%, signal=10%</td></tr><tr><td class='lessen'>485</td><td>WELCH_GATA1_TARGETS</td><td></td><td>15</td><td>-0.39</td><td>-1.11</td><td>0.305</td><td>0.445</td><td>1.000</td><td>1419</td><td>tags=33%, list=14%, signal=38%</td></tr><tr><td class='lessen'>486</td><td>JIANG_VHL_TARGETS</td><td></td><td>78</td><td>-0.26</td><td>-1.11</td><td>0.246</td><td>0.445</td><td>1.000</td><td>1395</td><td>tags=21%, list=13%, signal=23%</td></tr><tr><td class='lessen'>487</td><td>JAEGER_METASTASIS_UP</td><td></td><td>34</td><td>-0.31</td><td>-1.11</td><td>0.278</td><td>0.450</td><td>1.000</td><td>2426</td><td>tags=47%, list=23%, signal=61%</td></tr><tr><td class='lessen'>488</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL</td><td></td><td>55</td><td>-0.28</td><td>-1.11</td><td>0.276</td><td>0.452</td><td>1.000</td><td>1429</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>489</td><td>CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN</td><td></td><td>28</td><td>-0.32</td><td>-1.11</td><td>0.299</td><td>0.454</td><td>1.000</td><td>1663</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>490</td><td>JEON_SMAD6_TARGETS_DN</td><td></td><td>17</td><td>-0.37</td><td>-1.11</td><td>0.316</td><td>0.454</td><td>1.000</td><td>1376</td><td>tags=29%, list=13%, signal=34%</td></tr><tr><td class='lessen'>491</td><td>RASHI_NFKB1_TARGETS</td><td></td><td>19</td><td>-0.36</td><td>-1.11</td><td>0.312</td><td>0.455</td><td>1.000</td><td>1831</td><td>tags=37%, list=17%, signal=45%</td></tr><tr><td class='lessen'>492</td><td>PARENT_MTOR_SIGNALING_UP</td><td></td><td>463</td><td>-0.20</td><td>-1.11</td><td>0.116</td><td>0.461</td><td>1.000</td><td>2346</td><td>tags=27%, list=22%, signal=33%</td></tr><tr><td class='lessen'>493</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP</td><td></td><td>173</td><td>-0.23</td><td>-1.10</td><td>0.222</td><td>0.461</td><td>1.000</td><td>1063</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>494</td><td>AMUNDSON_RESPONSE_TO_ARSENITE</td><td></td><td>183</td><td>-0.23</td><td>-1.10</td><td>0.232</td><td>0.461</td><td>1.000</td><td>1841</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>495</td><td>DOANE_RESPONSE_TO_ANDROGEN_DN</td><td></td><td>191</td><td>-0.23</td><td>-1.10</td><td>0.189</td><td>0.461</td><td>1.000</td><td>1537</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>496</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP</td><td></td><td>182</td><td>-0.23</td><td>-1.10</td><td>0.218</td><td>0.461</td><td>1.000</td><td>1551</td><td>tags=18%, list=15%, signal=20%</td></tr><tr><td class='lessen'>497</td><td>BROWNE_HCMV_INFECTION_10HR_UP</td><td></td><td>66</td><td>-0.27</td><td>-1.10</td><td>0.261</td><td>0.463</td><td>1.000</td><td>2491</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>498</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP</td><td></td><td>423</td><td>-0.21</td><td>-1.10</td><td>0.150</td><td>0.467</td><td>1.000</td><td>1897</td><td>tags=22%, list=18%, signal=25%</td></tr><tr><td class='lessen'>499</td><td>BROWNE_HCMV_INFECTION_2HR_UP</td><td></td><td>24</td><td>-0.34</td><td>-1.10</td><td>0.306</td><td>0.467</td><td>1.000</td><td>1730</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>500</td><td>KLEIN_TARGETS_OF_BCR_ABL1_FUSION</td><td></td><td>22</td><td>-0.34</td><td>-1.10</td><td>0.311</td><td>0.467</td><td>1.000</td><td>2346</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>501</td><td>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</td><td></td><td>43</td><td>-0.29</td><td>-1.10</td><td>0.310</td><td>0.470</td><td>1.000</td><td>1072</td><td>tags=21%, list=10%, signal=23%</td></tr><tr><td class='lessen'>502</td><td>HELLER_HDAC_TARGETS_DN</td><td></td><td>219</td><td>-0.22</td><td>-1.10</td><td>0.218</td><td>0.470</td><td>1.000</td><td>1976</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>503</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_UP</td><td></td><td>103</td><td>-0.25</td><td>-1.10</td><td>0.261</td><td>0.470</td><td>1.000</td><td>1963</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>504</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP</td><td></td><td>34</td><td>-0.31</td><td>-1.10</td><td>0.302</td><td>0.469</td><td>1.000</td><td>909</td><td>tags=21%, list=9%, signal=22%</td></tr><tr><td class='lessen'>505</td><td>STARK_HYPPOCAMPUS_22Q11_DELETION_DN</td><td></td><td>18</td><td>-0.37</td><td>-1.10</td><td>0.335</td><td>0.469</td><td>1.000</td><td>3514</td><td>tags=44%, list=33%, signal=67%</td></tr><tr><td class='lessen'>506</td><td>MIKKELSEN_MEF_LCP_WITH_H3K4ME3</td><td></td><td>86</td><td>-0.25</td><td>-1.10</td><td>0.268</td><td>0.470</td><td>1.000</td><td>2167</td><td>tags=37%, list=21%, signal=47%</td></tr><tr><td class='lessen'>507</td><td>WENG_POR_TARGETS_GLOBAL_DN</td><td></td><td>17</td><td>-0.38</td><td>-1.09</td><td>0.331</td><td>0.474</td><td>1.000</td><td>2856</td><td>tags=47%, list=27%, signal=65%</td></tr><tr><td class='lessen'>508</td><td>MCCLUNG_COCAINE_REWARD_5D</td><td></td><td>47</td><td>-0.28</td><td>-1.09</td><td>0.285</td><td>0.473</td><td>1.000</td><td>1718</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>509</td><td>BURTON_ADIPOGENESIS_11</td><td></td><td>47</td><td>-0.29</td><td>-1.09</td><td>0.308</td><td>0.474</td><td>1.000</td><td>1359</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>510</td><td>BROWNE_HCMV_INFECTION_8HR_UP</td><td></td><td>73</td><td>-0.26</td><td>-1.09</td><td>0.305</td><td>0.479</td><td>1.000</td><td>2045</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>511</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14</td><td></td><td>136</td><td>-0.24</td><td>-1.09</td><td>0.260</td><td>0.481</td><td>1.000</td><td>2604</td><td>tags=29%, list=25%, signal=39%</td></tr><tr><td class='lessen'>512</td><td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN</td><td></td><td>41</td><td>-0.29</td><td>-1.08</td><td>0.323</td><td>0.493</td><td>1.000</td><td>867</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>513</td><td>GEORGES_CELL_CYCLE_MIR192_TARGETS</td><td></td><td>58</td><td>-0.28</td><td>-1.08</td><td>0.322</td><td>0.493</td><td>1.000</td><td>1948</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>514</td><td>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN</td><td></td><td>29</td><td>-0.32</td><td>-1.08</td><td>0.343</td><td>0.492</td><td>1.000</td><td>2079</td><td>tags=41%, list=20%, signal=51%</td></tr><tr><td class='lessen'>515</td><td>CHEN_HOXA5_TARGETS_9HR_UP</td><td></td><td>179</td><td>-0.22</td><td>-1.08</td><td>0.263</td><td>0.502</td><td>1.000</td><td>2646</td><td>tags=32%, list=25%, signal=43%</td></tr><tr><td class='lessen'>516</td><td>LU_IL4_SIGNALING</td><td></td><td>59</td><td>-0.27</td><td>-1.08</td><td>0.321</td><td>0.502</td><td>1.000</td><td>1610</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>517</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</td><td></td><td>214</td><td>-0.22</td><td>-1.08</td><td>0.269</td><td>0.503</td><td>1.000</td><td>737</td><td>tags=13%, list=7%, signal=13%</td></tr><tr><td class='lessen'>518</td><td>BILANGES_SERUM_SENSITIVE_GENES</td><td></td><td>54</td><td>-0.28</td><td>-1.07</td><td>0.336</td><td>0.510</td><td>1.000</td><td>2350</td><td>tags=28%, list=22%, signal=36%</td></tr><tr><td class='lessen'>519</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>418</td><td>-0.20</td><td>-1.07</td><td>0.206</td><td>0.511</td><td>1.000</td><td>2753</td><td>tags=29%, list=26%, signal=38%</td></tr><tr><td class='lessen'>520</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_D</td><td></td><td>49</td><td>-0.28</td><td>-1.07</td><td>0.336</td><td>0.522</td><td>1.000</td><td>1849</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>521</td><td>LEE_LIVER_CANCER_MYC_UP</td><td></td><td>45</td><td>-0.28</td><td>-1.07</td><td>0.357</td><td>0.525</td><td>1.000</td><td>2240</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>522</td><td>SMITH_TERT_TARGETS_UP</td><td></td><td>128</td><td>-0.23</td><td>-1.07</td><td>0.279</td><td>0.524</td><td>1.000</td><td>2693</td><td>tags=31%, list=26%, signal=42%</td></tr><tr><td class='lessen'>523</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</td><td></td><td>41</td><td>-0.29</td><td>-1.07</td><td>0.343</td><td>0.523</td><td>1.000</td><td>1952</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>524</td><td>HOLLERN_MICROACINAR_BREAST_TUMOR_UP</td><td></td><td>37</td><td>-0.29</td><td>-1.06</td><td>0.349</td><td>0.540</td><td>1.000</td><td>1838</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>525</td><td>BROWNE_HCMV_INFECTION_20HR_UP</td><td></td><td>180</td><td>-0.22</td><td>-1.06</td><td>0.298</td><td>0.541</td><td>1.000</td><td>2226</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>526</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP</td><td></td><td>123</td><td>-0.23</td><td>-1.06</td><td>0.320</td><td>0.545</td><td>1.000</td><td>1044</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>527</td><td>LEE_LIVER_CANCER_CIPROFIBRATE_DN</td><td></td><td>27</td><td>-0.31</td><td>-1.05</td><td>0.369</td><td>0.556</td><td>1.000</td><td>1958</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>528</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION</td><td></td><td>49</td><td>-0.28</td><td>-1.05</td><td>0.352</td><td>0.556</td><td>1.000</td><td>84</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>529</td><td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP</td><td></td><td>56</td><td>-0.26</td><td>-1.05</td><td>0.349</td><td>0.560</td><td>1.000</td><td>2005</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>530</td><td>WALLACE_JAK2_TARGETS_UP</td><td></td><td>20</td><td>-0.34</td><td>-1.05</td><td>0.401</td><td>0.567</td><td>1.000</td><td>1160</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>531</td><td>KORKOLA_YOLK_SAC_TUMOR</td><td></td><td>31</td><td>-0.30</td><td>-1.05</td><td>0.390</td><td>0.571</td><td>1.000</td><td>1481</td><td>tags=29%, list=14%, signal=34%</td></tr><tr><td class='lessen'>532</td><td>BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN</td><td></td><td>81</td><td>-0.25</td><td>-1.05</td><td>0.355</td><td>0.570</td><td>1.000</td><td>2043</td><td>tags=23%, list=19%, signal=29%</td></tr><tr><td class='lessen'>533</td><td>ZHAN_MULTIPLE_MYELOMA_SUBGROUPS</td><td></td><td>30</td><td>-0.30</td><td>-1.05</td><td>0.374</td><td>0.569</td><td>1.000</td><td>3191</td><td>tags=50%, list=30%, signal=72%</td></tr><tr><td class='lessen'>534</td><td>SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC</td><td></td><td>92</td><td>-0.24</td><td>-1.05</td><td>0.356</td><td>0.570</td><td>1.000</td><td>2317</td><td>tags=30%, list=22%, signal=39%</td></tr><tr><td class='lessen'>535</td><td>KASLER_HDAC7_TARGETS_2_DN</td><td></td><td>24</td><td>-0.32</td><td>-1.05</td><td>0.390</td><td>0.570</td><td>1.000</td><td>1177</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>536</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_E2</td><td></td><td>17</td><td>-0.35</td><td>-1.04</td><td>0.387</td><td>0.575</td><td>1.000</td><td>2249</td><td>tags=47%, list=21%, signal=60%</td></tr><tr><td class='lessen'>537</td><td>MORI_SMALL_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>68</td><td>-0.25</td><td>-1.04</td><td>0.384</td><td>0.576</td><td>1.000</td><td>1880</td><td>tags=24%, list=18%, signal=28%</td></tr><tr><td class='lessen'>538</td><td>DORSAM_HOXA9_TARGETS_UP</td><td></td><td>33</td><td>-0.29</td><td>-1.04</td><td>0.394</td><td>0.586</td><td>1.000</td><td>2043</td><td>tags=30%, list=19%, signal=38%</td></tr><tr><td class='lessen'>539</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</td><td></td><td>48</td><td>-0.27</td><td>-1.04</td><td>0.371</td><td>0.588</td><td>1.000</td><td>1330</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>540</td><td>HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP</td><td></td><td>59</td><td>-0.26</td><td>-1.04</td><td>0.381</td><td>0.593</td><td>1.000</td><td>1034</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>541</td><td>DAZARD_UV_RESPONSE_CLUSTER_G6</td><td></td><td>133</td><td>-0.22</td><td>-1.03</td><td>0.352</td><td>0.592</td><td>1.000</td><td>1639</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>542</td><td>SUBTIL_PROGESTIN_TARGETS</td><td></td><td>30</td><td>-0.30</td><td>-1.03</td><td>0.401</td><td>0.591</td><td>1.000</td><td>824</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>543</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_4</td><td></td><td>38</td><td>-0.29</td><td>-1.03</td><td>0.395</td><td>0.597</td><td>1.000</td><td>1994</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>544</td><td>SAGIV_CD24_TARGETS_DN</td><td></td><td>31</td><td>-0.30</td><td>-1.03</td><td>0.417</td><td>0.599</td><td>1.000</td><td>1668</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>545</td><td>TSAI_RESPONSE_TO_RADIATION_THERAPY</td><td></td><td>24</td><td>-0.32</td><td>-1.03</td><td>0.384</td><td>0.599</td><td>1.000</td><td>390</td><td>tags=21%, list=4%, signal=22%</td></tr><tr><td class='lessen'>546</td><td>SMITH_LIVER_CANCER</td><td></td><td>39</td><td>-0.29</td><td>-1.03</td><td>0.412</td><td>0.598</td><td>1.000</td><td>1745</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>547</td><td>LIU_SMARCA4_TARGETS</td><td></td><td>34</td><td>-0.29</td><td>-1.03</td><td>0.394</td><td>0.605</td><td>1.000</td><td>869</td><td>tags=24%, list=8%, signal=26%</td></tr><tr><td class='lessen'>548</td><td>LIAO_METASTASIS</td><td></td><td>410</td><td>-0.19</td><td>-1.03</td><td>0.368</td><td>0.608</td><td>1.000</td><td>2225</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>549</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_UP</td><td></td><td>60</td><td>-0.25</td><td>-1.03</td><td>0.405</td><td>0.609</td><td>1.000</td><td>1496</td><td>tags=23%, list=14%, signal=27%</td></tr><tr><td class='lessen'>550</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN</td><td></td><td>16</td><td>-0.36</td><td>-1.02</td><td>0.435</td><td>0.614</td><td>1.000</td><td>970</td><td>tags=25%, list=9%, signal=28%</td></tr><tr><td class='lessen'>551</td><td>BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP</td><td></td><td>82</td><td>-0.24</td><td>-1.02</td><td>0.410</td><td>0.618</td><td>1.000</td><td>3179</td><td>tags=38%, list=30%, signal=54%</td></tr><tr><td class='lessen'>552</td><td>QI_PLASMACYTOMA_UP</td><td></td><td>181</td><td>-0.21</td><td>-1.02</td><td>0.372</td><td>0.619</td><td>1.000</td><td>1717</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>553</td><td>NGUYEN_NOTCH1_TARGETS_DN</td><td></td><td>73</td><td>-0.24</td><td>-1.02</td><td>0.372</td><td>0.620</td><td>1.000</td><td>1725</td><td>tags=27%, list=16%, signal=33%</td></tr><tr><td class='lessen'>554</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_UP</td><td></td><td>213</td><td>-0.20</td><td>-1.02</td><td>0.403</td><td>0.620</td><td>1.000</td><td>2140</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>555</td><td>YAGI_AML_WITH_T_8_21_TRANSLOCATION</td><td></td><td>265</td><td>-0.20</td><td>-1.02</td><td>0.403</td><td>0.619</td><td>1.000</td><td>1765</td><td>tags=20%, list=17%, signal=23%</td></tr><tr><td class='lessen'>556</td><td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</td><td></td><td>290</td><td>-0.20</td><td>-1.02</td><td>0.379</td><td>0.619</td><td>1.000</td><td>1072</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>557</td><td>MORI_IMMATURE_B_LYMPHOCYTE_UP</td><td></td><td>37</td><td>-0.28</td><td>-1.02</td><td>0.419</td><td>0.618</td><td>1.000</td><td>1137</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>558</td><td>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS</td><td></td><td>21</td><td>-0.32</td><td>-1.02</td><td>0.432</td><td>0.620</td><td>1.000</td><td>1402</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>559</td><td>CHIBA_RESPONSE_TO_TSA</td><td></td><td>43</td><td>-0.27</td><td>-1.02</td><td>0.430</td><td>0.620</td><td>1.000</td><td>1436</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>560</td><td>JEON_SMAD6_TARGETS_UP</td><td></td><td>19</td><td>-0.33</td><td>-1.02</td><td>0.422</td><td>0.620</td><td>1.000</td><td>1691</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>561</td><td>MEISSNER_ES_ICP_WITH_H3K4ME3</td><td></td><td>19</td><td>-0.33</td><td>-1.02</td><td>0.439</td><td>0.623</td><td>1.000</td><td>2411</td><td>tags=42%, list=23%, signal=55%</td></tr><tr><td class='lessen'>562</td><td>PAL_PRMT5_TARGETS_DN</td><td></td><td>18</td><td>-0.34</td><td>-1.02</td><td>0.404</td><td>0.622</td><td>1.000</td><td>2300</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>563</td><td>KIM_MYC_AMPLIFICATION_TARGETS_DN</td><td></td><td>67</td><td>-0.25</td><td>-1.02</td><td>0.413</td><td>0.622</td><td>1.000</td><td>1009</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>564</td><td>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN</td><td></td><td>109</td><td>-0.23</td><td>-1.02</td><td>0.422</td><td>0.621</td><td>1.000</td><td>2002</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>565</td><td>WILLIAMS_ESR1_TARGETS_UP</td><td></td><td>19</td><td>-0.34</td><td>-1.02</td><td>0.438</td><td>0.622</td><td>1.000</td><td>1901</td><td>tags=37%, list=18%, signal=45%</td></tr><tr><td class='lessen'>566</td><td>SCHEIDEREIT_IKK_INTERACTING_PROTEINS</td><td></td><td>48</td><td>-0.27</td><td>-1.01</td><td>0.435</td><td>0.626</td><td>1.000</td><td>2390</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>567</td><td>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP</td><td></td><td>18</td><td>-0.34</td><td>-1.01</td><td>0.416</td><td>0.632</td><td>1.000</td><td>352</td><td>tags=17%, list=3%, signal=17%</td></tr><tr><td class='lessen'>568</td><td>BASSO_CD40_SIGNALING_UP</td><td></td><td>71</td><td>-0.25</td><td>-1.01</td><td>0.435</td><td>0.633</td><td>1.000</td><td>2390</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>569</td><td>HU_ANGIOGENESIS_DN</td><td></td><td>32</td><td>-0.29</td><td>-1.01</td><td>0.441</td><td>0.634</td><td>1.000</td><td>3099</td><td>tags=44%, list=30%, signal=62%</td></tr><tr><td class='lessen'>570</td><td>IRITANI_MAD1_TARGETS_DN</td><td></td><td>43</td><td>-0.27</td><td>-1.01</td><td>0.436</td><td>0.634</td><td>1.000</td><td>3361</td><td>tags=40%, list=32%, signal=58%</td></tr><tr><td class='lessen'>571</td><td>HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN</td><td></td><td>34</td><td>-0.29</td><td>-1.01</td><td>0.443</td><td>0.643</td><td>1.000</td><td>1314</td><td>tags=21%, list=13%, signal=23%</td></tr><tr><td class='lessen'>572</td><td>KAAB_FAILED_HEART_VENTRICLE_DN</td><td></td><td>36</td><td>-0.28</td><td>-1.00</td><td>0.485</td><td>0.643</td><td>1.000</td><td>374</td><td>tags=14%, list=4%, signal=14%</td></tr><tr><td class='lessen'>573</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_1_UP</td><td></td><td>61</td><td>-0.25</td><td>-1.00</td><td>0.433</td><td>0.644</td><td>1.000</td><td>589</td><td>tags=15%, list=6%, signal=16%</td></tr><tr><td class='lessen'>574</td><td>CHUANG_OXIDATIVE_STRESS_RESPONSE_UP</td><td></td><td>23</td><td>-0.32</td><td>-1.00</td><td>0.452</td><td>0.647</td><td>1.000</td><td>3823</td><td>tags=48%, list=36%, signal=75%</td></tr><tr><td class='lessen'>575</td><td>ZHAN_MULTIPLE_MYELOMA_UP</td><td></td><td>52</td><td>-0.26</td><td>-1.00</td><td>0.466</td><td>0.650</td><td>1.000</td><td>2779</td><td>tags=33%, list=26%, signal=44%</td></tr><tr><td class='lessen'>576</td><td>ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP</td><td></td><td>41</td><td>-0.27</td><td>-1.00</td><td>0.422</td><td>0.654</td><td>1.000</td><td>2276</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>577</td><td>HUANG_DASATINIB_RESISTANCE_DN</td><td></td><td>60</td><td>-0.25</td><td>-1.00</td><td>0.467</td><td>0.666</td><td>1.000</td><td>1562</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>578</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12</td><td></td><td>151</td><td>-0.21</td><td>-1.00</td><td>0.447</td><td>0.665</td><td>1.000</td><td>1013</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>579</td><td>CHO_NR4A1_TARGETS</td><td></td><td>18</td><td>-0.32</td><td>-0.99</td><td>0.457</td><td>0.666</td><td>1.000</td><td>1952</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>580</td><td>GROSS_HYPOXIA_VIA_ELK3_UP</td><td></td><td>191</td><td>-0.21</td><td>-0.99</td><td>0.455</td><td>0.665</td><td>1.000</td><td>1992</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>581</td><td>FIRESTEIN_CTNNB1_PATHWAY</td><td></td><td>25</td><td>-0.30</td><td>-0.99</td><td>0.447</td><td>0.664</td><td>1.000</td><td>1929</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>582</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_DN</td><td></td><td>99</td><td>-0.22</td><td>-0.99</td><td>0.461</td><td>0.663</td><td>1.000</td><td>2466</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>583</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION</td><td></td><td>56</td><td>-0.25</td><td>-0.99</td><td>0.467</td><td>0.674</td><td>1.000</td><td>2124</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>584</td><td>DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP</td><td></td><td>217</td><td>-0.20</td><td>-0.99</td><td>0.467</td><td>0.676</td><td>1.000</td><td>2041</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>585</td><td>DUAN_PRDM5_TARGETS</td><td></td><td>41</td><td>-0.26</td><td>-0.99</td><td>0.480</td><td>0.676</td><td>1.000</td><td>2156</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>586</td><td>SANSOM_APC_MYC_TARGETS</td><td></td><td>220</td><td>-0.20</td><td>-0.99</td><td>0.483</td><td>0.676</td><td>1.000</td><td>2491</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>587</td><td>PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP</td><td></td><td>201</td><td>-0.20</td><td>-0.99</td><td>0.506</td><td>0.677</td><td>1.000</td><td>560</td><td>tags=9%, list=5%, signal=10%</td></tr><tr><td class='lessen'>588</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_DN</td><td></td><td>22</td><td>-0.31</td><td>-0.99</td><td>0.510</td><td>0.680</td><td>1.000</td><td>1583</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>589</td><td>WORSCHECH_TUMOR_REJECTION_UP</td><td></td><td>29</td><td>-0.29</td><td>-0.98</td><td>0.473</td><td>0.682</td><td>1.000</td><td>1640</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>590</td><td>XU_CREBBP_TARGETS_UP</td><td></td><td>18</td><td>-0.33</td><td>-0.98</td><td>0.455</td><td>0.684</td><td>1.000</td><td>2571</td><td>tags=39%, list=25%, signal=51%</td></tr><tr><td class='lessen'>591</td><td>DAZARD_RESPONSE_TO_UV_NHEK_DN</td><td></td><td>271</td><td>-0.19</td><td>-0.98</td><td>0.512</td><td>0.683</td><td>1.000</td><td>1979</td><td>tags=23%, list=19%, signal=27%</td></tr><tr><td class='lessen'>592</td><td>VANHARANTA_UTERINE_FIBROID_DN</td><td></td><td>54</td><td>-0.25</td><td>-0.98</td><td>0.488</td><td>0.685</td><td>1.000</td><td>1870</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>593</td><td>BAKKER_FOXO3_TARGETS_DN</td><td></td><td>131</td><td>-0.21</td><td>-0.98</td><td>0.509</td><td>0.686</td><td>1.000</td><td>2018</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>594</td><td>LEE_LIVER_CANCER_MYC_E2F1_UP</td><td></td><td>48</td><td>-0.25</td><td>-0.98</td><td>0.458</td><td>0.690</td><td>1.000</td><td>850</td><td>tags=19%, list=8%, signal=20%</td></tr><tr><td class='lessen'>595</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN</td><td></td><td>33</td><td>-0.28</td><td>-0.98</td><td>0.488</td><td>0.689</td><td>1.000</td><td>399</td><td>tags=12%, list=4%, signal=13%</td></tr><tr><td class='lessen'>596</td><td>NEMETH_INFLAMMATORY_RESPONSE_LPS_DN</td><td></td><td>25</td><td>-0.30</td><td>-0.98</td><td>0.476</td><td>0.692</td><td>1.000</td><td>3946</td><td>tags=52%, list=38%, signal=83%</td></tr><tr><td class='lessen'>597</td><td>GYORFFY_MITOXANTRONE_RESISTANCE</td><td></td><td>17</td><td>-0.34</td><td>-0.98</td><td>0.478</td><td>0.692</td><td>1.000</td><td>765</td><td>tags=18%, list=7%, signal=19%</td></tr><tr><td class='lessen'>598</td><td>TOMIDA_METASTASIS_UP</td><td></td><td>20</td><td>-0.31</td><td>-0.98</td><td>0.476</td><td>0.700</td><td>1.000</td><td>2625</td><td>tags=35%, list=25%, signal=47%</td></tr><tr><td class='lessen'>599</td><td>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP</td><td></td><td>17</td><td>-0.33</td><td>-0.97</td><td>0.487</td><td>0.707</td><td>1.000</td><td>1836</td><td>tags=35%, list=18%, signal=43%</td></tr><tr><td class='lessen'>600</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP</td><td></td><td>16</td><td>-0.33</td><td>-0.97</td><td>0.515</td><td>0.708</td><td>1.000</td><td>1014</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>601</td><td>GEISS_RESPONSE_TO_DSRNA_UP</td><td></td><td>29</td><td>-0.28</td><td>-0.97</td><td>0.487</td><td>0.710</td><td>1.000</td><td>1878</td><td>tags=34%, list=18%, signal=42%</td></tr><tr><td class='lessen'>602</td><td>LEE_RECENT_THYMIC_EMIGRANT</td><td></td><td>178</td><td>-0.20</td><td>-0.97</td><td>0.545</td><td>0.712</td><td>1.000</td><td>1640</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>603</td><td>NIKOLSKY_BREAST_CANCER_7P22_AMPLICON</td><td></td><td>26</td><td>-0.29</td><td>-0.97</td><td>0.499</td><td>0.717</td><td>1.000</td><td>3489</td><td>tags=42%, list=33%, signal=63%</td></tr><tr><td class='lessen'>604</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA</td><td></td><td>43</td><td>-0.26</td><td>-0.97</td><td>0.495</td><td>0.717</td><td>1.000</td><td>3382</td><td>tags=44%, list=32%, signal=65%</td></tr><tr><td class='lessen'>605</td><td>HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2</td><td></td><td>15</td><td>-0.33</td><td>-0.97</td><td>0.511</td><td>0.721</td><td>1.000</td><td>1875</td><td>tags=40%, list=18%, signal=49%</td></tr><tr><td class='lessen'>606</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5</td><td></td><td>45</td><td>-0.25</td><td>-0.96</td><td>0.508</td><td>0.720</td><td>1.000</td><td>2014</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>607</td><td>KUMAR_AUTOPHAGY_NETWORK</td><td></td><td>38</td><td>-0.26</td><td>-0.96</td><td>0.533</td><td>0.722</td><td>1.000</td><td>182</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>608</td><td>MASSARWEH_RESPONSE_TO_ESTRADIOL</td><td></td><td>44</td><td>-0.25</td><td>-0.96</td><td>0.502</td><td>0.724</td><td>1.000</td><td>1901</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>609</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10</td><td></td><td>67</td><td>-0.23</td><td>-0.96</td><td>0.525</td><td>0.723</td><td>1.000</td><td>2300</td><td>tags=24%, list=22%, signal=30%</td></tr><tr><td class='lessen'>610</td><td>SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP</td><td></td><td>15</td><td>-0.34</td><td>-0.96</td><td>0.500</td><td>0.723</td><td>1.000</td><td>2218</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>611</td><td>NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON</td><td></td><td>90</td><td>-0.22</td><td>-0.96</td><td>0.488</td><td>0.721</td><td>1.000</td><td>2065</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>612</td><td>POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN</td><td></td><td>40</td><td>-0.26</td><td>-0.96</td><td>0.501</td><td>0.720</td><td>1.000</td><td>884</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>613</td><td>DOANE_BREAST_CANCER_CLASSES_UP</td><td></td><td>40</td><td>-0.26</td><td>-0.96</td><td>0.518</td><td>0.721</td><td>1.000</td><td>297</td><td>tags=13%, list=3%, signal=13%</td></tr><tr><td class='lessen'>614</td><td>RODWELL_AGING_KIDNEY_DN</td><td></td><td>98</td><td>-0.22</td><td>-0.96</td><td>0.525</td><td>0.720</td><td>1.000</td><td>2896</td><td>tags=31%, list=28%, signal=42%</td></tr><tr><td class='lessen'>615</td><td>MCLACHLAN_DENTAL_CARIES_UP</td><td></td><td>167</td><td>-0.20</td><td>-0.96</td><td>0.574</td><td>0.720</td><td>1.000</td><td>947</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>616</td><td>RAHMAN_TP53_TARGETS_PHOSPHORYLATED</td><td></td><td>19</td><td>-0.31</td><td>-0.96</td><td>0.497</td><td>0.720</td><td>1.000</td><td>2909</td><td>tags=47%, list=28%, signal=65%</td></tr><tr><td class='lessen'>617</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP</td><td></td><td>51</td><td>-0.25</td><td>-0.96</td><td>0.517</td><td>0.719</td><td>1.000</td><td>2486</td><td>tags=37%, list=24%, signal=49%</td></tr><tr><td class='lessen'>618</td><td>WANG_HCP_PROSTATE_CANCER</td><td></td><td>79</td><td>-0.22</td><td>-0.96</td><td>0.509</td><td>0.722</td><td>1.000</td><td>1491</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>619</td><td>KAMMINGA_SENESCENCE</td><td></td><td>27</td><td>-0.29</td><td>-0.96</td><td>0.510</td><td>0.722</td><td>1.000</td><td>3677</td><td>tags=48%, list=35%, signal=74%</td></tr><tr><td class='lessen'>620</td><td>CHEN_ETV5_TARGETS_SERTOLI</td><td></td><td>21</td><td>-0.30</td><td>-0.96</td><td>0.516</td><td>0.721</td><td>1.000</td><td>2453</td><td>tags=29%, list=23%, signal=37%</td></tr><tr><td class='lessen'>621</td><td>RIZKI_TUMOR_INVASIVENESS_3D_UP</td><td></td><td>141</td><td>-0.21</td><td>-0.96</td><td>0.585</td><td>0.721</td><td>1.000</td><td>2247</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>622</td><td>GRESHOCK_CANCER_COPY_NUMBER_UP</td><td></td><td>250</td><td>-0.19</td><td>-0.96</td><td>0.583</td><td>0.721</td><td>1.000</td><td>1926</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>623</td><td>BYSTROEM_CORRELATED_WITH_IL5_DN</td><td></td><td>52</td><td>-0.24</td><td>-0.96</td><td>0.540</td><td>0.721</td><td>1.000</td><td>1463</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>624</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_DN</td><td></td><td>69</td><td>-0.23</td><td>-0.96</td><td>0.537</td><td>0.723</td><td>1.000</td><td>2616</td><td>tags=32%, list=25%, signal=42%</td></tr><tr><td class='lessen'>625</td><td>IKEDA_MIR30_TARGETS_DN</td><td></td><td>16</td><td>-0.33</td><td>-0.96</td><td>0.512</td><td>0.725</td><td>1.000</td><td>2595</td><td>tags=38%, list=25%, signal=50%</td></tr><tr><td class='lessen'>626</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR</td><td></td><td>25</td><td>-0.29</td><td>-0.95</td><td>0.526</td><td>0.727</td><td>1.000</td><td>556</td><td>tags=16%, list=5%, signal=17%</td></tr><tr><td class='lessen'>627</td><td>DOANE_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>117</td><td>-0.21</td><td>-0.95</td><td>0.565</td><td>0.726</td><td>1.000</td><td>1032</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>628</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4</td><td></td><td>212</td><td>-0.19</td><td>-0.95</td><td>0.598</td><td>0.727</td><td>1.000</td><td>2118</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>629</td><td>MITSIADES_RESPONSE_TO_APLIDIN_UP</td><td></td><td>339</td><td>-0.18</td><td>-0.95</td><td>0.650</td><td>0.727</td><td>1.000</td><td>2221</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>630</td><td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN</td><td></td><td>24</td><td>-0.30</td><td>-0.95</td><td>0.501</td><td>0.727</td><td>1.000</td><td>148</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>631</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>258</td><td>-0.19</td><td>-0.95</td><td>0.629</td><td>0.726</td><td>1.000</td><td>2105</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>632</td><td>YANG_BREAST_CANCER_ESR1_LASER_UP</td><td></td><td>24</td><td>-0.29</td><td>-0.95</td><td>0.530</td><td>0.725</td><td>1.000</td><td>1275</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>633</td><td>KORKOLA_YOLK_SAC_TUMOR_UP</td><td></td><td>18</td><td>-0.32</td><td>-0.95</td><td>0.533</td><td>0.729</td><td>1.000</td><td>2682</td><td>tags=50%, list=26%, signal=67%</td></tr><tr><td class='lessen'>634</td><td>KORKOLA_EMBRYONAL_CARCINOMA_UP</td><td></td><td>35</td><td>-0.27</td><td>-0.95</td><td>0.554</td><td>0.731</td><td>1.000</td><td>2682</td><td>tags=43%, list=26%, signal=57%</td></tr><tr><td class='lessen'>635</td><td>MARSHALL_VIRAL_INFECTION_RESPONSE_DN</td><td></td><td>22</td><td>-0.30</td><td>-0.95</td><td>0.534</td><td>0.733</td><td>1.000</td><td>2261</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>636</td><td>GENTLES_LEUKEMIC_STEM_CELL_UP</td><td></td><td>16</td><td>-0.32</td><td>-0.95</td><td>0.533</td><td>0.735</td><td>1.000</td><td>3083</td><td>tags=50%, list=29%, signal=71%</td></tr><tr><td class='lessen'>637</td><td>JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP</td><td></td><td>242</td><td>-0.19</td><td>-0.95</td><td>0.636</td><td>0.736</td><td>1.000</td><td>1707</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>638</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP</td><td></td><td>61</td><td>-0.23</td><td>-0.95</td><td>0.544</td><td>0.737</td><td>1.000</td><td>1784</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>639</td><td>HU_GENOTOXIC_DAMAGE_24HR</td><td></td><td>30</td><td>-0.28</td><td>-0.95</td><td>0.545</td><td>0.737</td><td>1.000</td><td>2552</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>640</td><td>MMS_MOUSE_LYMPH_HIGH_4HRS_UP</td><td></td><td>34</td><td>-0.26</td><td>-0.94</td><td>0.551</td><td>0.738</td><td>1.000</td><td>2254</td><td>tags=32%, list=21%, signal=41%</td></tr><tr><td class='lessen'>641</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP</td><td></td><td>57</td><td>-0.24</td><td>-0.94</td><td>0.543</td><td>0.741</td><td>1.000</td><td>3545</td><td>tags=42%, list=34%, signal=63%</td></tr><tr><td class='lessen'>642</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN</td><td></td><td>33</td><td>-0.28</td><td>-0.94</td><td>0.545</td><td>0.741</td><td>1.000</td><td>1117</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>643</td><td>ROSS_AML_WITH_AML1_ETO_FUSION</td><td></td><td>47</td><td>-0.24</td><td>-0.94</td><td>0.591</td><td>0.741</td><td>1.000</td><td>295</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>644</td><td>WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1</td><td></td><td>20</td><td>-0.31</td><td>-0.94</td><td>0.523</td><td>0.742</td><td>1.000</td><td>1901</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>645</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T7</td><td></td><td>90</td><td>-0.22</td><td>-0.94</td><td>0.614</td><td>0.748</td><td>1.000</td><td>1193</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>646</td><td>CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS</td><td></td><td>35</td><td>-0.26</td><td>-0.94</td><td>0.551</td><td>0.748</td><td>1.000</td><td>2085</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>647</td><td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP</td><td></td><td>106</td><td>-0.21</td><td>-0.94</td><td>0.593</td><td>0.747</td><td>1.000</td><td>1467</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>648</td><td>HWANG_PROSTATE_CANCER_MARKERS</td><td></td><td>23</td><td>-0.29</td><td>-0.94</td><td>0.566</td><td>0.747</td><td>1.000</td><td>676</td><td>tags=17%, list=6%, signal=19%</td></tr><tr><td class='lessen'>649</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_2_UP</td><td></td><td>27</td><td>-0.28</td><td>-0.94</td><td>0.549</td><td>0.750</td><td>1.000</td><td>2942</td><td>tags=44%, list=28%, signal=62%</td></tr><tr><td class='lessen'>650</td><td>SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY</td><td></td><td>33</td><td>-0.27</td><td>-0.94</td><td>0.542</td><td>0.752</td><td>1.000</td><td>3328</td><td>tags=42%, list=32%, signal=62%</td></tr><tr><td class='lessen'>651</td><td>LIU_SOX4_TARGETS_DN</td><td></td><td>276</td><td>-0.18</td><td>-0.93</td><td>0.729</td><td>0.757</td><td>1.000</td><td>2176</td><td>tags=22%, list=21%, signal=28%</td></tr><tr><td class='lessen'>652</td><td>ALCALA_APOPTOSIS</td><td></td><td>70</td><td>-0.22</td><td>-0.93</td><td>0.632</td><td>0.758</td><td>1.000</td><td>3345</td><td>tags=37%, list=32%, signal=54%</td></tr><tr><td class='lessen'>653</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN</td><td></td><td>16</td><td>-0.32</td><td>-0.93</td><td>0.528</td><td>0.757</td><td>1.000</td><td>1966</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>654</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP</td><td></td><td>159</td><td>-0.20</td><td>-0.93</td><td>0.628</td><td>0.756</td><td>1.000</td><td>3354</td><td>tags=38%, list=32%, signal=56%</td></tr><tr><td class='lessen'>655</td><td>FOSTER_KDM1A_TARGETS_DN</td><td></td><td>174</td><td>-0.19</td><td>-0.93</td><td>0.665</td><td>0.754</td><td>1.000</td><td>2258</td><td>tags=26%, list=22%, signal=32%</td></tr><tr><td class='lessen'>656</td><td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN</td><td></td><td>41</td><td>-0.25</td><td>-0.93</td><td>0.550</td><td>0.754</td><td>1.000</td><td>701</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>657</td><td>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP</td><td></td><td>20</td><td>-0.30</td><td>-0.93</td><td>0.536</td><td>0.755</td><td>1.000</td><td>584</td><td>tags=15%, list=6%, signal=16%</td></tr><tr><td class='lessen'>658</td><td>LEE_AGING_CEREBELLUM_DN</td><td></td><td>43</td><td>-0.25</td><td>-0.93</td><td>0.588</td><td>0.755</td><td>1.000</td><td>1588</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>659</td><td>HELLER_SILENCED_BY_METHYLATION_DN</td><td></td><td>76</td><td>-0.23</td><td>-0.93</td><td>0.582</td><td>0.757</td><td>1.000</td><td>2297</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>660</td><td>TSENG_IRS1_TARGETS_UP</td><td></td><td>87</td><td>-0.21</td><td>-0.93</td><td>0.609</td><td>0.758</td><td>1.000</td><td>1840</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>661</td><td>SU_LIVER</td><td></td><td>18</td><td>-0.32</td><td>-0.93</td><td>0.557</td><td>0.759</td><td>1.000</td><td>1623</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>662</td><td>PETRETTO_HEART_MASS_QTL_CIS_DN</td><td></td><td>24</td><td>-0.29</td><td>-0.93</td><td>0.550</td><td>0.759</td><td>1.000</td><td>1893</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>663</td><td>BLUM_RESPONSE_TO_SALIRASIB_UP</td><td></td><td>220</td><td>-0.19</td><td>-0.93</td><td>0.703</td><td>0.761</td><td>1.000</td><td>2390</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>664</td><td>NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON</td><td></td><td>218</td><td>-0.19</td><td>-0.93</td><td>0.710</td><td>0.761</td><td>1.000</td><td>2815</td><td>tags=29%, list=27%, signal=39%</td></tr><tr><td class='lessen'>665</td><td>MACLACHLAN_BRCA1_TARGETS_UP</td><td></td><td>20</td><td>-0.30</td><td>-0.93</td><td>0.563</td><td>0.761</td><td>1.000</td><td>1901</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>666</td><td>SU_PANCREAS</td><td></td><td>22</td><td>-0.29</td><td>-0.93</td><td>0.568</td><td>0.762</td><td>1.000</td><td>1664</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>667</td><td>HOEBEKE_LYMPHOID_STEM_CELL_UP</td><td></td><td>70</td><td>-0.22</td><td>-0.92</td><td>0.627</td><td>0.762</td><td>1.000</td><td>2617</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>668</td><td>CHOW_RASSF1_TARGETS_UP</td><td></td><td>23</td><td>-0.29</td><td>-0.92</td><td>0.576</td><td>0.762</td><td>1.000</td><td>995</td><td>tags=17%, list=9%, signal=19%</td></tr><tr><td class='lessen'>669</td><td>CAMPS_COLON_CANCER_COPY_NUMBER_UP</td><td></td><td>49</td><td>-0.23</td><td>-0.92</td><td>0.597</td><td>0.767</td><td>1.000</td><td>2572</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>670</td><td>ZAMORA_NOS2_TARGETS_UP</td><td></td><td>52</td><td>-0.23</td><td>-0.92</td><td>0.596</td><td>0.774</td><td>1.000</td><td>1094</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>671</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN</td><td></td><td>30</td><td>-0.26</td><td>-0.92</td><td>0.612</td><td>0.774</td><td>1.000</td><td>1825</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>672</td><td>GALE_APL_WITH_FLT3_MUTATED_UP</td><td></td><td>50</td><td>-0.24</td><td>-0.92</td><td>0.594</td><td>0.774</td><td>1.000</td><td>2809</td><td>tags=32%, list=27%, signal=43%</td></tr><tr><td class='lessen'>673</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_5_DN</td><td></td><td>25</td><td>-0.28</td><td>-0.92</td><td>0.612</td><td>0.773</td><td>1.000</td><td>2186</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>674</td><td>GUILLAUMOND_KLF10_TARGETS_DN</td><td></td><td>21</td><td>-0.29</td><td>-0.92</td><td>0.564</td><td>0.772</td><td>1.000</td><td>1439</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>675</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_DN</td><td></td><td>106</td><td>-0.20</td><td>-0.91</td><td>0.701</td><td>0.782</td><td>1.000</td><td>3366</td><td>tags=36%, list=32%, signal=52%</td></tr><tr><td class='lessen'>676</td><td>LEE_METASTASIS_AND_RNA_PROCESSING_UP</td><td></td><td>16</td><td>-0.31</td><td>-0.91</td><td>0.567</td><td>0.781</td><td>1.000</td><td>4537</td><td>tags=63%, list=43%, signal=110%</td></tr><tr><td class='lessen'>677</td><td>NOUZOVA_TRETINOIN_AND_H4_ACETYLATION</td><td></td><td>112</td><td>-0.20</td><td>-0.91</td><td>0.661</td><td>0.782</td><td>1.000</td><td>3257</td><td>tags=38%, list=31%, signal=55%</td></tr><tr><td class='lessen'>678</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN</td><td></td><td>16</td><td>-0.31</td><td>-0.91</td><td>0.592</td><td>0.783</td><td>1.000</td><td>662</td><td>tags=19%, list=6%, signal=20%</td></tr><tr><td class='lessen'>679</td><td>OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP</td><td></td><td>272</td><td>-0.18</td><td>-0.91</td><td>0.788</td><td>0.798</td><td>1.000</td><td>3070</td><td>tags=34%, list=29%, signal=47%</td></tr><tr><td class='lessen'>680</td><td>AIYAR_COBRA1_TARGETS_UP</td><td></td><td>31</td><td>-0.27</td><td>-0.91</td><td>0.620</td><td>0.798</td><td>1.000</td><td>2107</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>681</td><td>BROWNE_HCMV_INFECTION_1HR_DN</td><td></td><td>141</td><td>-0.19</td><td>-0.90</td><td>0.709</td><td>0.802</td><td>1.000</td><td>1966</td><td>tags=21%, list=19%, signal=25%</td></tr><tr><td class='lessen'>682</td><td>SHEN_SMARCA2_TARGETS_DN</td><td></td><td>94</td><td>-0.21</td><td>-0.90</td><td>0.683</td><td>0.804</td><td>1.000</td><td>1478</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>683</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_UP</td><td></td><td>31</td><td>-0.26</td><td>-0.90</td><td>0.602</td><td>0.806</td><td>1.000</td><td>1793</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>684</td><td>GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN</td><td></td><td>69</td><td>-0.22</td><td>-0.90</td><td>0.691</td><td>0.807</td><td>1.000</td><td>450</td><td>tags=10%, list=4%, signal=11%</td></tr><tr><td class='lessen'>685</td><td>MORI_SMALL_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>57</td><td>-0.22</td><td>-0.90</td><td>0.649</td><td>0.809</td><td>1.000</td><td>2072</td><td>tags=21%, list=20%, signal=26%</td></tr><tr><td class='lessen'>686</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP</td><td></td><td>50</td><td>-0.23</td><td>-0.90</td><td>0.690</td><td>0.809</td><td>1.000</td><td>1976</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>687</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</td><td></td><td>51</td><td>-0.23</td><td>-0.90</td><td>0.670</td><td>0.810</td><td>1.000</td><td>1439</td><td>tags=18%, list=14%, signal=20%</td></tr><tr><td class='lessen'>688</td><td>MIKKELSEN_NPC_LCP_WITH_H3K4ME3</td><td></td><td>28</td><td>-0.27</td><td>-0.90</td><td>0.636</td><td>0.809</td><td>1.000</td><td>1495</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>689</td><td>BRACHAT_RESPONSE_TO_METHOTREXATE_DN</td><td></td><td>24</td><td>-0.27</td><td>-0.90</td><td>0.602</td><td>0.810</td><td>1.000</td><td>867</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>690</td><td>CAIRO_HEPATOBLASTOMA_UP</td><td></td><td>179</td><td>-0.18</td><td>-0.89</td><td>0.799</td><td>0.818</td><td>1.000</td><td>2093</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>691</td><td>TERAMOTO_OPN_TARGETS_CLUSTER_6</td><td></td><td>21</td><td>-0.28</td><td>-0.89</td><td>0.620</td><td>0.823</td><td>1.000</td><td>1127</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>692</td><td>BURTON_ADIPOGENESIS_6</td><td></td><td>161</td><td>-0.19</td><td>-0.89</td><td>0.773</td><td>0.823</td><td>1.000</td><td>2494</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>693</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>247</td><td>-0.17</td><td>-0.89</td><td>0.832</td><td>0.826</td><td>1.000</td><td>3135</td><td>tags=33%, list=30%, signal=46%</td></tr><tr><td class='lessen'>694</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN</td><td></td><td>26</td><td>-0.27</td><td>-0.89</td><td>0.629</td><td>0.829</td><td>1.000</td><td>2240</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>695</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td><td></td><td>327</td><td>-0.17</td><td>-0.89</td><td>0.883</td><td>0.832</td><td>1.000</td><td>1934</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>696</td><td>KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES</td><td></td><td>150</td><td>-0.19</td><td>-0.88</td><td>0.817</td><td>0.837</td><td>1.000</td><td>952</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>697</td><td>JIANG_HYPOXIA_VIA_VHL</td><td></td><td>17</td><td>-0.29</td><td>-0.88</td><td>0.623</td><td>0.836</td><td>1.000</td><td>1395</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>698</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN</td><td></td><td>24</td><td>-0.27</td><td>-0.88</td><td>0.616</td><td>0.849</td><td>1.000</td><td>2141</td><td>tags=29%, list=20%, signal=37%</td></tr><tr><td class='lessen'>699</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_UP</td><td></td><td>291</td><td>-0.17</td><td>-0.87</td><td>0.863</td><td>0.854</td><td>1.000</td><td>2669</td><td>tags=26%, list=25%, signal=34%</td></tr><tr><td class='lessen'>700</td><td>GENTILE_UV_HIGH_DOSE_UP</td><td></td><td>15</td><td>-0.31</td><td>-0.87</td><td>0.655</td><td>0.856</td><td>1.000</td><td>2268</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>701</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17</td><td></td><td>179</td><td>-0.18</td><td>-0.87</td><td>0.833</td><td>0.865</td><td>1.000</td><td>2681</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>702</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td><td></td><td>103</td><td>-0.20</td><td>-0.87</td><td>0.790</td><td>0.869</td><td>1.000</td><td>2490</td><td>tags=23%, list=24%, signal=30%</td></tr><tr><td class='lessen'>703</td><td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP</td><td></td><td>24</td><td>-0.27</td><td>-0.86</td><td>0.679</td><td>0.871</td><td>1.000</td><td>1213</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>704</td><td>NAGY_TFTC_COMPONENTS_HUMAN</td><td></td><td>17</td><td>-0.30</td><td>-0.86</td><td>0.661</td><td>0.870</td><td>1.000</td><td>3157</td><td>tags=47%, list=30%, signal=67%</td></tr><tr><td class='lessen'>705</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td><td></td><td>244</td><td>-0.17</td><td>-0.86</td><td>0.869</td><td>0.870</td><td>1.000</td><td>1784</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>706</td><td>PARK_HSC_AND_MULTIPOTENT_PROGENITORS</td><td></td><td>40</td><td>-0.23</td><td>-0.86</td><td>0.708</td><td>0.875</td><td>1.000</td><td>2675</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>707</td><td>LI_LUNG_CANCER</td><td></td><td>35</td><td>-0.24</td><td>-0.86</td><td>0.683</td><td>0.875</td><td>1.000</td><td>1622</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>708</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP</td><td></td><td>232</td><td>-0.17</td><td>-0.86</td><td>0.880</td><td>0.876</td><td>1.000</td><td>1993</td><td>tags=22%, list=19%, signal=26%</td></tr><tr><td class='lessen'>709</td><td>WIERENGA_PML_INTERACTOME</td><td></td><td>36</td><td>-0.24</td><td>-0.86</td><td>0.676</td><td>0.877</td><td>1.000</td><td>1111</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>710</td><td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP</td><td></td><td>38</td><td>-0.23</td><td>-0.86</td><td>0.721</td><td>0.877</td><td>1.000</td><td>2498</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>711</td><td>RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP</td><td></td><td>92</td><td>-0.20</td><td>-0.85</td><td>0.784</td><td>0.884</td><td>1.000</td><td>1825</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>712</td><td>NUTT_GBM_VS_AO_GLIOMA_DN</td><td></td><td>33</td><td>-0.24</td><td>-0.85</td><td>0.695</td><td>0.889</td><td>1.000</td><td>2317</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>713</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</td><td></td><td>57</td><td>-0.21</td><td>-0.85</td><td>0.757</td><td>0.887</td><td>1.000</td><td>775</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>714</td><td>MCCABE_BOUND_BY_HOXC6</td><td></td><td>227</td><td>-0.17</td><td>-0.85</td><td>0.911</td><td>0.889</td><td>1.000</td><td>2906</td><td>tags=31%, list=28%, signal=42%</td></tr><tr><td class='lessen'>715</td><td>UDAYAKUMAR_MED1_TARGETS_UP</td><td></td><td>125</td><td>-0.19</td><td>-0.85</td><td>0.830</td><td>0.889</td><td>1.000</td><td>1239</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>716</td><td>LEE_CALORIE_RESTRICTION_NEOCORTEX_UP</td><td></td><td>48</td><td>-0.22</td><td>-0.85</td><td>0.720</td><td>0.888</td><td>1.000</td><td>2044</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>717</td><td>CROONQUIST_NRAS_SIGNALING_UP</td><td></td><td>24</td><td>-0.26</td><td>-0.84</td><td>0.676</td><td>0.897</td><td>1.000</td><td>1031</td><td>tags=17%, list=10%, signal=18%</td></tr><tr><td class='lessen'>718</td><td>GENTILE_UV_RESPONSE_CLUSTER_D8</td><td></td><td>34</td><td>-0.23</td><td>-0.84</td><td>0.724</td><td>0.897</td><td>1.000</td><td>1603</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>719</td><td>NOUZOVA_METHYLATED_IN_APL</td><td></td><td>33</td><td>-0.24</td><td>-0.84</td><td>0.735</td><td>0.898</td><td>1.000</td><td>2964</td><td>tags=36%, list=28%, signal=51%</td></tr><tr><td class='lessen'>720</td><td>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN</td><td></td><td>56</td><td>-0.21</td><td>-0.84</td><td>0.790</td><td>0.908</td><td>1.000</td><td>2060</td><td>tags=21%, list=20%, signal=27%</td></tr><tr><td class='lessen'>721</td><td>LEONARD_HYPOXIA</td><td></td><td>35</td><td>-0.24</td><td>-0.83</td><td>0.745</td><td>0.913</td><td>1.000</td><td>638</td><td>tags=9%, list=6%, signal=9%</td></tr><tr><td class='lessen'>722</td><td>MUNSHI_MULTIPLE_MYELOMA_UP</td><td></td><td>67</td><td>-0.20</td><td>-0.83</td><td>0.817</td><td>0.912</td><td>1.000</td><td>3013</td><td>tags=34%, list=29%, signal=48%</td></tr><tr><td class='lessen'>723</td><td>HAHTOLA_CTCL_CUTANEOUS</td><td></td><td>16</td><td>-0.28</td><td>-0.83</td><td>0.690</td><td>0.913</td><td>1.000</td><td>2524</td><td>tags=38%, list=24%, signal=49%</td></tr><tr><td class='lessen'>724</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN</td><td></td><td>28</td><td>-0.25</td><td>-0.83</td><td>0.709</td><td>0.912</td><td>1.000</td><td>3698</td><td>tags=54%, list=35%, signal=83%</td></tr><tr><td class='lessen'>725</td><td>LANDIS_ERBB2_BREAST_TUMORS_65_DN</td><td></td><td>33</td><td>-0.24</td><td>-0.83</td><td>0.735</td><td>0.911</td><td>1.000</td><td>1225</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>726</td><td>BIDUS_METASTASIS_DN</td><td></td><td>118</td><td>-0.18</td><td>-0.83</td><td>0.861</td><td>0.912</td><td>1.000</td><td>1885</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>727</td><td>VANASSE_BCL2_TARGETS_UP</td><td></td><td>20</td><td>-0.27</td><td>-0.83</td><td>0.729</td><td>0.912</td><td>1.000</td><td>275</td><td>tags=10%, list=3%, signal=10%</td></tr><tr><td class='lessen'>728</td><td>FAELT_B_CLL_WITH_VH3_21_UP</td><td></td><td>37</td><td>-0.23</td><td>-0.83</td><td>0.766</td><td>0.911</td><td>1.000</td><td>971</td><td>tags=16%, list=9%, signal=18%</td></tr><tr><td class='lessen'>729</td><td>ZHAN_MULTIPLE_MYELOMA_MS_UP</td><td></td><td>31</td><td>-0.24</td><td>-0.82</td><td>0.760</td><td>0.921</td><td>1.000</td><td>2167</td><td>tags=32%, list=21%, signal=41%</td></tr><tr><td class='lessen'>730</td><td>CHANDRAN_METASTASIS_UP</td><td></td><td>148</td><td>-0.17</td><td>-0.82</td><td>0.894</td><td>0.923</td><td>1.000</td><td>2315</td><td>tags=23%, list=22%, signal=29%</td></tr><tr><td class='lessen'>731</td><td>VALK_AML_CLUSTER_1</td><td></td><td>17</td><td>-0.28</td><td>-0.82</td><td>0.710</td><td>0.923</td><td>1.000</td><td>2617</td><td>tags=53%, list=25%, signal=70%</td></tr><tr><td class='lessen'>732</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11</td><td></td><td>93</td><td>-0.19</td><td>-0.82</td><td>0.830</td><td>0.923</td><td>1.000</td><td>3095</td><td>tags=31%, list=30%, signal=44%</td></tr><tr><td class='lessen'>733</td><td>FIRESTEIN_PROLIFERATION</td><td></td><td>114</td><td>-0.18</td><td>-0.82</td><td>0.884</td><td>0.924</td><td>1.000</td><td>2810</td><td>tags=36%, list=27%, signal=49%</td></tr><tr><td class='lessen'>734</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_3</td><td></td><td>38</td><td>-0.22</td><td>-0.82</td><td>0.806</td><td>0.926</td><td>1.000</td><td>1142</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>735</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP</td><td></td><td>28</td><td>-0.25</td><td>-0.82</td><td>0.734</td><td>0.928</td><td>1.000</td><td>1965</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>736</td><td>EPPERT_LSC_R</td><td></td><td>31</td><td>-0.24</td><td>-0.81</td><td>0.736</td><td>0.930</td><td>1.000</td><td>3953</td><td>tags=48%, list=38%, signal=77%</td></tr><tr><td class='lessen'>737</td><td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP</td><td></td><td>43</td><td>-0.21</td><td>-0.81</td><td>0.788</td><td>0.935</td><td>1.000</td><td>1534</td><td>tags=16%, list=15%, signal=19%</td></tr><tr><td class='lessen'>738</td><td>JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER</td><td></td><td>36</td><td>-0.22</td><td>-0.81</td><td>0.797</td><td>0.936</td><td>1.000</td><td>1791</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>739</td><td>BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP</td><td></td><td>15</td><td>-0.28</td><td>-0.81</td><td>0.722</td><td>0.937</td><td>1.000</td><td>2286</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>740</td><td>CADWELL_ATG16L1_TARGETS_DN</td><td></td><td>55</td><td>-0.20</td><td>-0.81</td><td>0.834</td><td>0.937</td><td>1.000</td><td>1809</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>741</td><td>WILLIAMS_ESR2_TARGETS_UP</td><td></td><td>22</td><td>-0.26</td><td>-0.81</td><td>0.766</td><td>0.936</td><td>1.000</td><td>652</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>742</td><td>GUO_HEX_TARGETS_UP</td><td></td><td>61</td><td>-0.20</td><td>-0.81</td><td>0.821</td><td>0.935</td><td>1.000</td><td>2380</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>743</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP</td><td></td><td>15</td><td>-0.28</td><td>-0.81</td><td>0.754</td><td>0.934</td><td>1.000</td><td>2327</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>744</td><td>BILBAN_B_CLL_LPL_UP</td><td></td><td>46</td><td>-0.21</td><td>-0.80</td><td>0.823</td><td>0.938</td><td>1.000</td><td>2482</td><td>tags=30%, list=24%, signal=40%</td></tr><tr><td class='lessen'>745</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR</td><td></td><td>45</td><td>-0.21</td><td>-0.80</td><td>0.805</td><td>0.940</td><td>1.000</td><td>654</td><td>tags=9%, list=6%, signal=9%</td></tr><tr><td class='lessen'>746</td><td>GUO_HEX_TARGETS_DN</td><td></td><td>49</td><td>-0.21</td><td>-0.80</td><td>0.818</td><td>0.940</td><td>1.000</td><td>2584</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>747</td><td>MCCABE_HOXC6_TARGETS_CANCER_UP</td><td></td><td>17</td><td>-0.27</td><td>-0.80</td><td>0.763</td><td>0.939</td><td>1.000</td><td>1013</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>748</td><td>LIN_MELANOMA_COPY_NUMBER_DN</td><td></td><td>38</td><td>-0.22</td><td>-0.80</td><td>0.790</td><td>0.938</td><td>1.000</td><td>1741</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>749</td><td>SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM</td><td></td><td>149</td><td>-0.17</td><td>-0.80</td><td>0.926</td><td>0.939</td><td>1.000</td><td>3191</td><td>tags=30%, list=30%, signal=43%</td></tr><tr><td class='lessen'>750</td><td>WALLACE_PROSTATE_CANCER_RACE_DN</td><td></td><td>60</td><td>-0.20</td><td>-0.80</td><td>0.827</td><td>0.939</td><td>1.000</td><td>1834</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>751</td><td>OLSSON_E2F3_TARGETS_DN</td><td></td><td>29</td><td>-0.23</td><td>-0.79</td><td>0.812</td><td>0.943</td><td>1.000</td><td>3263</td><td>tags=48%, list=31%, signal=70%</td></tr><tr><td class='lessen'>752</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td><td></td><td>98</td><td>-0.18</td><td>-0.79</td><td>0.897</td><td>0.943</td><td>1.000</td><td>1643</td><td>tags=18%, list=16%, signal=22%</td></tr><tr><td class='lessen'>753</td><td>JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP</td><td></td><td>66</td><td>-0.19</td><td>-0.79</td><td>0.859</td><td>0.946</td><td>1.000</td><td>1804</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>754</td><td>LAU_APOPTOSIS_CDKN2A_UP</td><td></td><td>53</td><td>-0.20</td><td>-0.79</td><td>0.862</td><td>0.945</td><td>1.000</td><td>2095</td><td>tags=26%, list=20%, signal=33%</td></tr><tr><td class='lessen'>755</td><td>HEIDENBLAD_AMPLICON_8Q24_UP</td><td></td><td>31</td><td>-0.23</td><td>-0.79</td><td>0.828</td><td>0.946</td><td>1.000</td><td>1074</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>756</td><td>CHEOK_RESPONSE_TO_HD_MTX_DN</td><td></td><td>18</td><td>-0.26</td><td>-0.79</td><td>0.768</td><td>0.945</td><td>1.000</td><td>27</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>757</td><td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP</td><td></td><td>34</td><td>-0.22</td><td>-0.78</td><td>0.836</td><td>0.950</td><td>1.000</td><td>1496</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>758</td><td>MEISSNER_BRAIN_ICP_WITH_H3K4ME3</td><td></td><td>19</td><td>-0.26</td><td>-0.78</td><td>0.786</td><td>0.949</td><td>1.000</td><td>2411</td><td>tags=37%, list=23%, signal=48%</td></tr><tr><td class='lessen'>759</td><td>URS_ADIPOCYTE_DIFFERENTIATION_UP</td><td></td><td>45</td><td>-0.20</td><td>-0.78</td><td>0.839</td><td>0.949</td><td>1.000</td><td>1127</td><td>tags=13%, list=11%, signal=15%</td></tr><tr><td class='lessen'>760</td><td>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN</td><td></td><td>22</td><td>-0.25</td><td>-0.78</td><td>0.783</td><td>0.951</td><td>1.000</td><td>1397</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>761</td><td>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</td><td></td><td>16</td><td>-0.27</td><td>-0.78</td><td>0.748</td><td>0.951</td><td>1.000</td><td>1404</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>762</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN</td><td></td><td>30</td><td>-0.23</td><td>-0.78</td><td>0.830</td><td>0.953</td><td>1.000</td><td>2443</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>763</td><td>XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN</td><td></td><td>39</td><td>-0.21</td><td>-0.78</td><td>0.856</td><td>0.953</td><td>1.000</td><td>2894</td><td>tags=38%, list=28%, signal=53%</td></tr><tr><td class='lessen'>764</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN</td><td></td><td>466</td><td>-0.14</td><td>-0.78</td><td>1.000</td><td>0.952</td><td>1.000</td><td>3163</td><td>tags=30%, list=30%, signal=41%</td></tr><tr><td class='lessen'>765</td><td>ROVERSI_GLIOMA_COPY_NUMBER_UP</td><td></td><td>63</td><td>-0.19</td><td>-0.78</td><td>0.900</td><td>0.952</td><td>1.000</td><td>2062</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>766</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</td><td></td><td>192</td><td>-0.16</td><td>-0.77</td><td>0.968</td><td>0.951</td><td>1.000</td><td>2406</td><td>tags=24%, list=23%, signal=31%</td></tr><tr><td class='lessen'>767</td><td>MULLIGHAN_NPM1_SIGNATURE_3_UP</td><td></td><td>243</td><td>-0.15</td><td>-0.77</td><td>0.988</td><td>0.950</td><td>1.000</td><td>2250</td><td>tags=21%, list=21%, signal=26%</td></tr><tr><td class='lessen'>768</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>42</td><td>-0.21</td><td>-0.77</td><td>0.830</td><td>0.950</td><td>1.000</td><td>3133</td><td>tags=38%, list=30%, signal=54%</td></tr><tr><td class='lessen'>769</td><td>ELVIDGE_HYPOXIA_DN</td><td></td><td>129</td><td>-0.17</td><td>-0.77</td><td>0.946</td><td>0.959</td><td>1.000</td><td>2741</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>770</td><td>ZHAN_MULTIPLE_MYELOMA_CD2_DN</td><td></td><td>37</td><td>-0.21</td><td>-0.76</td><td>0.887</td><td>0.964</td><td>1.000</td><td>105</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>771</td><td>WANG_RESPONSE_TO_BEXAROTENE_UP</td><td></td><td>24</td><td>-0.23</td><td>-0.76</td><td>0.830</td><td>0.967</td><td>1.000</td><td>1070</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>772</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP</td><td></td><td>25</td><td>-0.23</td><td>-0.76</td><td>0.833</td><td>0.966</td><td>1.000</td><td>135</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>773</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_5</td><td></td><td>103</td><td>-0.17</td><td>-0.76</td><td>0.950</td><td>0.966</td><td>1.000</td><td>1562</td><td>tags=17%, list=15%, signal=19%</td></tr><tr><td class='lessen'>774</td><td>CHANDRAN_METASTASIS_TOP50_UP</td><td></td><td>31</td><td>-0.22</td><td>-0.75</td><td>0.835</td><td>0.966</td><td>1.000</td><td>2992</td><td>tags=35%, list=29%, signal=49%</td></tr><tr><td class='lessen'>775</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN</td><td></td><td>35</td><td>-0.21</td><td>-0.75</td><td>0.869</td><td>0.966</td><td>1.000</td><td>2405</td><td>tags=29%, list=23%, signal=37%</td></tr><tr><td class='lessen'>776</td><td>GROSS_HYPOXIA_VIA_HIF1A_UP</td><td></td><td>71</td><td>-0.18</td><td>-0.75</td><td>0.927</td><td>0.965</td><td>1.000</td><td>2254</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>777</td><td>CHANG_IMMORTALIZED_BY_HPV31_UP</td><td></td><td>43</td><td>-0.20</td><td>-0.75</td><td>0.886</td><td>0.965</td><td>1.000</td><td>1123</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>778</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN</td><td></td><td>45</td><td>-0.20</td><td>-0.75</td><td>0.904</td><td>0.964</td><td>1.000</td><td>765</td><td>tags=11%, list=7%, signal=12%</td></tr><tr><td class='lessen'>779</td><td>BAE_BRCA1_TARGETS_DN</td><td></td><td>25</td><td>-0.23</td><td>-0.75</td><td>0.834</td><td>0.963</td><td>1.000</td><td>2390</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>780</td><td>BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP</td><td></td><td>27</td><td>-0.22</td><td>-0.75</td><td>0.842</td><td>0.963</td><td>1.000</td><td>1634</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>781</td><td>BROWNE_HCMV_INFECTION_14HR_UP</td><td></td><td>121</td><td>-0.17</td><td>-0.75</td><td>0.980</td><td>0.965</td><td>1.000</td><td>2577</td><td>tags=28%, list=25%, signal=37%</td></tr><tr><td class='lessen'>782</td><td>WANG_TARGETS_OF_MLL_CBP_FUSION_UP</td><td></td><td>36</td><td>-0.21</td><td>-0.74</td><td>0.870</td><td>0.968</td><td>1.000</td><td>3134</td><td>tags=39%, list=30%, signal=55%</td></tr><tr><td class='lessen'>783</td><td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN</td><td></td><td>89</td><td>-0.17</td><td>-0.74</td><td>0.923</td><td>0.967</td><td>1.000</td><td>1849</td><td>tags=18%, list=18%, signal=22%</td></tr><tr><td class='lessen'>784</td><td>HOFMANN_CELL_LYMPHOMA_UP</td><td></td><td>37</td><td>-0.20</td><td>-0.74</td><td>0.868</td><td>0.969</td><td>1.000</td><td>1331</td><td>tags=16%, list=13%, signal=19%</td></tr><tr><td class='lessen'>785</td><td>OUYANG_PROSTATE_CANCER_PROGRESSION_UP</td><td></td><td>18</td><td>-0.24</td><td>-0.73</td><td>0.847</td><td>0.973</td><td>1.000</td><td>1181</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>786</td><td>LIAN_LIPA_TARGETS_6M</td><td></td><td>53</td><td>-0.19</td><td>-0.73</td><td>0.902</td><td>0.973</td><td>1.000</td><td>1221</td><td>tags=13%, list=12%, signal=15%</td></tr><tr><td class='lessen'>787</td><td>GROSS_HIF1A_TARGETS_DN</td><td></td><td>18</td><td>-0.24</td><td>-0.73</td><td>0.856</td><td>0.973</td><td>1.000</td><td>1644</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>788</td><td>AIYAR_COBRA1_TARGETS_DN</td><td></td><td>28</td><td>-0.22</td><td>-0.73</td><td>0.889</td><td>0.972</td><td>1.000</td><td>1800</td><td>tags=21%, list=17%, signal=26%</td></tr><tr><td class='lessen'>789</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP</td><td></td><td>239</td><td>-0.15</td><td>-0.73</td><td>0.995</td><td>0.972</td><td>1.000</td><td>1899</td><td>tags=18%, list=18%, signal=21%</td></tr><tr><td class='lessen'>790</td><td>BECKER_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>39</td><td>-0.20</td><td>-0.73</td><td>0.890</td><td>0.975</td><td>1.000</td><td>1279</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>791</td><td>SHIPP_DLBCL_CURED_VS_FATAL_DN</td><td></td><td>34</td><td>-0.20</td><td>-0.72</td><td>0.899</td><td>0.979</td><td>1.000</td><td>3077</td><td>tags=38%, list=29%, signal=54%</td></tr><tr><td class='lessen'>792</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN</td><td></td><td>19</td><td>-0.24</td><td>-0.72</td><td>0.855</td><td>0.979</td><td>1.000</td><td>642</td><td>tags=11%, list=6%, signal=11%</td></tr><tr><td class='lessen'>793</td><td>JIANG_AGING_CEREBRAL_CORTEX_UP</td><td></td><td>26</td><td>-0.22</td><td>-0.72</td><td>0.897</td><td>0.979</td><td>1.000</td><td>495</td><td>tags=12%, list=5%, signal=12%</td></tr><tr><td class='lessen'>794</td><td>CHESLER_BRAIN_HIGHEST_EXPRESSION</td><td></td><td>31</td><td>-0.21</td><td>-0.72</td><td>0.906</td><td>0.979</td><td>1.000</td><td>1509</td><td>tags=19%, list=14%, signal=23%</td></tr><tr><td class='lessen'>795</td><td>ZHOU_TNF_SIGNALING_4HR</td><td></td><td>48</td><td>-0.19</td><td>-0.71</td><td>0.941</td><td>0.978</td><td>1.000</td><td>2489</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>796</td><td>FARMER_BREAST_CANCER_CLUSTER_7</td><td></td><td>15</td><td>-0.25</td><td>-0.71</td><td>0.865</td><td>0.980</td><td>1.000</td><td>3024</td><td>tags=40%, list=29%, signal=56%</td></tr><tr><td class='lessen'>797</td><td>PETROVA_PROX1_TARGETS_DN</td><td></td><td>35</td><td>-0.20</td><td>-0.71</td><td>0.885</td><td>0.979</td><td>1.000</td><td>1021</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>798</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP</td><td></td><td>21</td><td>-0.23</td><td>-0.71</td><td>0.858</td><td>0.977</td><td>1.000</td><td>2208</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>799</td><td>PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN</td><td></td><td>117</td><td>-0.15</td><td>-0.71</td><td>0.992</td><td>0.979</td><td>1.000</td><td>3293</td><td>tags=32%, list=31%, signal=47%</td></tr><tr><td class='lessen'>800</td><td>OUYANG_PROSTATE_CANCER_MARKERS</td><td></td><td>19</td><td>-0.23</td><td>-0.70</td><td>0.898</td><td>0.979</td><td>1.000</td><td>1622</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>801</td><td>MODY_HIPPOCAMPUS_NEONATAL</td><td></td><td>27</td><td>-0.20</td><td>-0.70</td><td>0.925</td><td>0.983</td><td>1.000</td><td>3187</td><td>tags=37%, list=30%, signal=53%</td></tr><tr><td class='lessen'>802</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5</td><td></td><td>47</td><td>-0.18</td><td>-0.70</td><td>0.945</td><td>0.982</td><td>1.000</td><td>2363</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>803</td><td>HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN</td><td></td><td>22</td><td>-0.22</td><td>-0.70</td><td>0.918</td><td>0.982</td><td>1.000</td><td>2694</td><td>tags=41%, list=26%, signal=55%</td></tr><tr><td class='lessen'>804</td><td>YUAN_ZNF143_PARTNERS</td><td></td><td>21</td><td>-0.22</td><td>-0.69</td><td>0.883</td><td>0.982</td><td>1.000</td><td>3372</td><td>tags=33%, list=32%, signal=49%</td></tr><tr><td class='lessen'>805</td><td>ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN</td><td></td><td>23</td><td>-0.21</td><td>-0.69</td><td>0.918</td><td>0.983</td><td>1.000</td><td>1800</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>806</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP</td><td></td><td>20</td><td>-0.22</td><td>-0.68</td><td>0.905</td><td>0.987</td><td>1.000</td><td>1965</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>807</td><td>KONDO_COLON_CANCER_HCP_WITH_H3K27ME1</td><td></td><td>16</td><td>-0.23</td><td>-0.67</td><td>0.908</td><td>0.990</td><td>1.000</td><td>2365</td><td>tags=38%, list=23%, signal=48%</td></tr><tr><td class='lessen'>808</td><td>MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP</td><td></td><td>31</td><td>-0.19</td><td>-0.67</td><td>0.936</td><td>0.991</td><td>1.000</td><td>2813</td><td>tags=39%, list=27%, signal=53%</td></tr><tr><td class='lessen'>809</td><td>BUFFA_HYPOXIA_METAGENE</td><td></td><td>49</td><td>-0.17</td><td>-0.67</td><td>0.965</td><td>0.990</td><td>1.000</td><td>2602</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>810</td><td>TIAN_TNF_SIGNALING_VIA_NFKB</td><td></td><td>19</td><td>-0.22</td><td>-0.67</td><td>0.903</td><td>0.989</td><td>1.000</td><td>440</td><td>tags=11%, list=4%, signal=11%</td></tr><tr><td class='lessen'>811</td><td>BROWNE_HCMV_INFECTION_1HR_UP</td><td></td><td>27</td><td>-0.20</td><td>-0.67</td><td>0.917</td><td>0.989</td><td>1.000</td><td>2006</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>812</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</td><td></td><td>35</td><td>-0.19</td><td>-0.65</td><td>0.950</td><td>0.994</td><td>1.000</td><td>2211</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>813</td><td>LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS</td><td></td><td>18</td><td>-0.22</td><td>-0.65</td><td>0.913</td><td>0.993</td><td>1.000</td><td>2021</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>814</td><td>FARMER_BREAST_CANCER_CLUSTER_5</td><td></td><td>17</td><td>-0.22</td><td>-0.65</td><td>0.928</td><td>0.993</td><td>1.000</td><td>3701</td><td>tags=47%, list=35%, signal=73%</td></tr><tr><td class='lessen'>815</td><td>WILENSKY_RESPONSE_TO_DARAPLADIB</td><td></td><td>16</td><td>-0.22</td><td>-0.65</td><td>0.926</td><td>0.993</td><td>1.000</td><td>255</td><td>tags=6%, list=2%, signal=6%</td></tr><tr><td class='lessen'>816</td><td>KANG_DOXORUBICIN_RESISTANCE_DN</td><td></td><td>19</td><td>-0.21</td><td>-0.65</td><td>0.933</td><td>0.993</td><td>1.000</td><td>836</td><td>tags=16%, list=8%, signal=17%</td></tr><tr><td class='lessen'>817</td><td>MARCHINI_TRABECTEDIN_RESISTANCE_DN</td><td></td><td>42</td><td>-0.18</td><td>-0.64</td><td>0.978</td><td>0.992</td><td>1.000</td><td>2371</td><td>tags=29%, list=23%, signal=37%</td></tr><tr><td class='lessen'>818</td><td>DIRMEIER_LMP1_RESPONSE_EARLY</td><td></td><td>48</td><td>-0.17</td><td>-0.63</td><td>0.979</td><td>0.995</td><td>1.000</td><td>1692</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>819</td><td>KIM_GASTRIC_CANCER_CHEMOSENSITIVITY</td><td></td><td>59</td><td>-0.16</td><td>-0.63</td><td>0.986</td><td>0.994</td><td>1.000</td><td>2536</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>820</td><td>CAIRO_PML_TARGETS_BOUND_BY_MYC_UP</td><td></td><td>21</td><td>-0.20</td><td>-0.63</td><td>0.944</td><td>0.994</td><td>1.000</td><td>3086</td><td>tags=33%, list=29%, signal=47%</td></tr><tr><td class='lessen'>821</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN</td><td></td><td>16</td><td>-0.22</td><td>-0.63</td><td>0.939</td><td>0.993</td><td>1.000</td><td>2446</td><td>tags=25%, list=23%, signal=33%</td></tr><tr><td class='lessen'>822</td><td>GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION</td><td></td><td>28</td><td>-0.19</td><td>-0.62</td><td>0.958</td><td>0.993</td><td>1.000</td><td>1934</td><td>tags=18%, list=18%, signal=22%</td></tr><tr><td class='lessen'>823</td><td>SILIGAN_BOUND_BY_EWS_FLT1_FUSION</td><td></td><td>25</td><td>-0.19</td><td>-0.62</td><td>0.954</td><td>0.992</td><td>1.000</td><td>3259</td><td>tags=36%, list=31%, signal=52%</td></tr><tr><td class='lessen'>824</td><td>GRADE_COLON_VS_RECTAL_CANCER_DN</td><td></td><td>38</td><td>-0.17</td><td>-0.62</td><td>0.975</td><td>0.993</td><td>1.000</td><td>1920</td><td>tags=18%, list=18%, signal=22%</td></tr><tr><td class='lessen'>825</td><td>ZWANG_EGF_PERSISTENTLY_UP</td><td></td><td>22</td><td>-0.19</td><td>-0.61</td><td>0.958</td><td>0.993</td><td>1.000</td><td>890</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>826</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR</td><td></td><td>26</td><td>-0.19</td><td>-0.61</td><td>0.970</td><td>0.992</td><td>1.000</td><td>588</td><td>tags=8%, list=6%, signal=8%</td></tr><tr><td class='lessen'>827</td><td>AMIT_SERUM_RESPONSE_40_MCF10A</td><td></td><td>25</td><td>-0.18</td><td>-0.61</td><td>0.947</td><td>0.991</td><td>1.000</td><td>3114</td><td>tags=36%, list=30%, signal=51%</td></tr><tr><td class='lessen'>828</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_7</td><td></td><td>23</td><td>-0.19</td><td>-0.60</td><td>0.969</td><td>0.992</td><td>1.000</td><td>3549</td><td>tags=43%, list=34%, signal=66%</td></tr><tr><td class='lessen'>829</td><td>POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP</td><td></td><td>39</td><td>-0.16</td><td>-0.59</td><td>0.989</td><td>0.993</td><td>1.000</td><td>2803</td><td>tags=31%, list=27%, signal=42%</td></tr><tr><td class='lessen'>830</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN</td><td></td><td>20</td><td>-0.19</td><td>-0.59</td><td>0.956</td><td>0.993</td><td>1.000</td><td>3587</td><td>tags=40%, list=34%, signal=61%</td></tr><tr><td class='lessen'>831</td><td>WHITEHURST_PACLITAXEL_SENSITIVITY</td><td></td><td>18</td><td>-0.19</td><td>-0.58</td><td>0.964</td><td>0.994</td><td>1.000</td><td>1848</td><td>tags=22%, list=18%, signal=27%</td></tr><tr><td class='lessen'>832</td><td>WENG_POR_TARGETS_LIVER_DN</td><td></td><td>15</td><td>-0.20</td><td>-0.56</td><td>0.964</td><td>0.995</td><td>1.000</td><td>128</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>833</td><td>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN</td><td></td><td>15</td><td>-0.19</td><td>-0.55</td><td>0.960</td><td>0.996</td><td>1.000</td><td>2345</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>834</td><td>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP</td><td></td><td>25</td><td>-0.16</td><td>-0.55</td><td>0.991</td><td>0.995</td><td>1.000</td><td>3297</td><td>tags=36%, list=31%, signal=52%</td></tr><tr><td class='lessen'>835</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</td><td></td><td>55</td><td>-0.13</td><td>-0.51</td><td>1.000</td><td>0.997</td><td>1.000</td><td>2819</td><td>tags=25%, list=27%, signal=35%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>0 (8 samples)<b>&nbsp<a href='gsea_report_for_0_1612915605297.xls'>[plain text format]</a></caption></table></div><br></body></html>